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ABSTRACT

As a cell mediated-process, valvular heart disease (VHD) results in significant
morbidity and mortality world-wide. In the US alone, valvular heart disease VHD
is estimated to affect 2.5% of the population with a disproportionate impact on an
increasing elderly populous. It is well understood that the primary driver for
valvular calcification is the differentiation of valvular interstitial cells (VICs) into an
osteoblastic-like phenotype. However, the factors leading to the onset of
osteoblastic-like VICs (obVICs) and resulting calcification are not fully understood
and a more complete characterization of VIC differentiation and phenotypic
v

change is required before treatment of valve disease or growth of tissue
engineered heart valves (TEHVs) can be realized. By investigating the
microenvironmental cues at the cell-material interface, surface chemistry, protein
adhesion, and integrin expression we have identified cell-material signaling that
may be responsible for heart valve tissue calcification as well as healthy in vitro
growth environments. These studies were then translated into a threedimensional hydrogel system for the study of VICs in a more physically relevant
cell culture system.
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Abstract
The human heart contains four valves which control the unidirectional flow of
blood through the circulatory system. Of the two distinct types, the aortic valve is
of primary research interest due to the increased likelihood for damage and
disease development, as well as the origin of the coronary arteries and
importance in feeding the musculature of the heart. Primarily composed of
valvular interstitial cells (VICs), the aortic valve arises from endocardial cushions
in the primitive heart. Fully formed, the aortic valve contains three distinct layers
of tissue: fibrosa, spongiosa, and ventricularis. Due to as of yet unknown
mechanisms, VICs have been shown to result in valve thickening, produce
foreign calcified material, and obstruct blood flow necessitating replacement.
While current biological and mechanical valves represent the gold standard for
replacements, numerous limitations have spurred research into tissue
engineered alternatives that will more closely mimic native valve tissue. Overall,
this review is designed to explain the structure and function of the aortic valve,
including formation, an explanation of cell types, extracellular matrix, disease and
dysfunction, and current replacement options, and the design requirements for
tissue engineered heart valve replacements.

Keywords: Heart Valve, Tissue Engineering, Aortic Valve, Anatomy, Valvular
Interstitial Cells
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Introduction
The human heart beats over 3 billion times in the average lifespan.1 In a
single year it pumps enough blood to fill an Olympic-sized swimming pool.2 It is
the driving force of the cardiovascular system, regulates blood flow of
oxygenated blood throughout the body, and aids in the removal of waste
products. However, cardiovascular disease (CVD) remains the number one killer
in the United States every year, with an average of 1,600 deaths daily—1 death
every 51 seconds. This is more than cancer or the next six leading causes
combined (Table 1). [1] Death from CVD related illness dropped by 30.6% from
1998-2008 but still accounts for 32.8% of all deaths in the US annually.
Meanwhile, an estimated 82,600,000 American adults (>1 in 3) have one or more
types of CVD. [2] According to the National Center for Health Statistic’s (NCHS)
latest report on “eliminating causes of death,” the probability at birth of eventually
dying of major CVD is 47%. However, if CVD was eliminated, the average life
expectancy could increase by almost 7 years. [3]
In order to understand the causes of CVD we have to further sub-divide the
heart into finer anatomical systems for study. Heart valve disease is the sixth
leading cause of death due to CVD, but is often linked with more prevalent forms

1

75 beats/min [avg. resting heart rate] * 60 min/hr * 24 hr/day * 365
days/year * 76.83 years [avg. lifespan, US, NVSR 91-2001] = 3,028,638,600
beats in the average human lifespan
2
75 beats/min [avg. resting heart rate] * 60 min/hr * 24 hr/day * 365
days/year * 0.07 L/beat (stroke volume) = 2,759,400 L/year [Olympic pool (50m x
25m x 2m) = 2,500,000 L].
3

of cardiovascular failure through increased overall strain on the heart. [4] An
estimated one in eight persons over the age of 75 has at least moderate heart
valve disease, [1] with more than 5 million Americans diagnosed each year. [5]
Calcified aortic valve sclerosis, the prevailing form of valve disease, is
associated with a 50% increase in likelihood of dying within two years without
surgical replacement. [6] As such, aortic heart valve replacement is the second
most common, major (open-heart), cardiac operation, behind aortic bypass
grafts, [4] and the second highest in cost, after complete heart transplantation
(Table 2). [2] More than 76,000 aortic heart valve replacements were surgically
implanted in 2009; resulting in over $3.6 billion in health care related costs.
[7,8,9,10]
In recent years, significant advancements have been made in our ability to
reproduce the tissues of the heart. However, a better understanding of the
interplay between cellular signaling and differentiation leading to disease
progression needs to be characterized in order for in vitro heart valve formation
to be realized. By focusing on these research areas in the coming years we may
begin to see plausible treatments and the development of technologies
appropriate for tissue engineered heart valve (TEHV) replacements.
While heart valve disease can occur in any valve or a combination of the four
valves, this review focuses on the aortic valve (AV) as the primary interest of
scientific research. We begin by explaining aortic valve structure and function
leading to the current understanding of the cells of the heart valve and their
4

influence on disease progression, followed by a review of current replacement
options. Finally, we highlight necessary requirements for growth of viable tissue
for aortic heart valve replacement.
Heart & Valve Physiology: Structure and Function
During normal operation, the four unidirectional valves of the human heart
regulate the one-way flow of blood through the circulatory system (heart, lungs,
and body). Based upon structure, function, and location within the heart, valves
are classified as atrioventricular or semilunar (Figure 1). Atrioventricular valves
prevent the backflow of blood from the left (mitral/bicuspid valve) and right
(tricuspid valve) ventricles into the atria. Semilunar valves control the flow of
blood leaving the heart from the left and the right ventricles into the aortic and
pulmonary arteries, respectively. [11,12] All heart valves contain similar
constituent tissues, but the most obvious differences between valve types are 1)
the presence of chordae tendineae which allow for the attachment of
atrioventricular valves to the papillary muscles of the heart wall and 2) the
cusped tri-leaflet structure of semilunar valves with an unbound/free edge (Figure
2).
As a semilunar valve, the three leaflets of the AV attach in a parabolic profile
between the base of the aortic artery and outflow of left ventricle (Figure 3 &
Figure 4). This crown shaped structure is what is known as the valve annulus,
while the entire region of attachment is known as the aortic root. The aortic root
can be characterized by a bulb shaped fibrous structure made partially of smooth
5

muscle tissue (ventricular region) and mostly of the fibro-elastic walls of the aorta
(Figure 3). The valve can also be further distinguished by several anatomical
systems: the three valve leaflets/cusps, lanula (commissures or overlapping
leaflets allowing for proper closure/coaptation), and cavities in the aortic wall
(aortic sinuses) that allow for the correct flow profile through the valve and
redirecting of blood flow to the coronary arteries (Figure 4). It should be clearly
noted that the aortic root and valve annulus both cross the anatomical region that
distinguishes the left ventricle from the aortic artery (see ventriculo-aortic
junction, Figure 3). This is of particular importance due to the difference in
material properties presented by these two types of tissues. Anderson RH et al.
gives a complete review of this region for further distinction. [13] See Figure 4 for
an anatomical dissection of the AV and portions of the left ventricle.
Valve Cycle
The proper function of the AV relies on the ability of the valve leaflets to
continually withstand the cyclic forces of the pumping heart with minimal
obstruction to flow. The heart cycles approximately 70 times per minute, in a
resting adult, corresponding to a blood flow rate of 5 liters per minute.3 [14]
During this period, the pumping of the heart can be classified by two distinct
phases, diastolic & systolic ( Figure 5).
Before freshly oxygenated blood can be ejected through the aortic valve, to
the rest of the body, it first flows into the left ventricle from the atria (ventricular
3

0.07 L [stroke volume] * 70 beats/min = 4.9 L/min
6

filling). This takes place during the diastolic phase of the cardiac cycle, while the
aortic valve is in an interlocked/closed position with 40% coaptation (overlap) of
leaflet surfaces (lunula). [15] In this position the valve leaflets are pulled taut by
the valve annulus to prevent collapse into the ventricle (prolapse) under back
pressure from blood in the aortic artery. [16]
From the closed position, the cycling of the aortic valve can be divided into
three phases: opening, quasi-steady state, and decelerated/reversed flow,
comprising 15%, 55%, and 30%, respectively, of the systolic cycle of the heart.
[17] The opening phase can be distinguished by isovolumic contraction of the
aortic artery which pulls the leaflets apart to create a small (stellate) orifice before
flow through the valve begins. As blood is ejected from the left ventricle, the
separation of the valve leaflets quickly changes from a stellate shape to
triangular, then circular, as seen in Figure 5. [14]
During the steady state phase, the valve leaflets are thrown open in alignment
with the aortic wall and the flow of blood (Figure 4). As a result of fluid flow
behind the leaflets and through the sides of the aortic sinus (Figure 4B), a small
vortex is formed by the leaflet free edge creating a stagnation point along the
sinus ridge (Figure 4A). This balance is maintained throughout the quasi-steady
state phase. [17]
Finally, through deceleration of fluid flow in the aorta, backflow and pressure
within the sinus overcomes that on the ventricle side of the valve and forces
closure of the valve. As fluid begins to flow behind the valve leaflets, vortices in
7

the left and right sinus cavities funnel oxygenated blood into the coronary arteries
for delivery to the heart muscles. [17] The end of the valve cycle is marked by a
return of the valve leaflets to a closed position in order to separate the aorta from
the left ventricle and allow for a drop in ventriclar pressure resulting in filling and
completion of the cycle.
Heart Valve Microstructure
Due to the thinness of valve leaflet tissue (<1mm) there is no need for
vasculature within the adult or fetal valve leaflets. [18,19,20,21] The thinness of
the tissue allows for easy diffusion and nutrient transport through hemodynamic
convection in and out of the valve leaflets. [18] However, the aortic root does
contain some vasculature in order to provide proper nutrient transport in this
region. [22] Some groups have also shown an influx of vasculature in thicker
valves and some species of animals. [18,19]
Aortic valve leaflets are composed of three distinct (stratified) tissue layers,
fibrosa, spongiosa, and ventricularis. Variations in the composition and
arrangement of the extracellular matrix (ECM) of each layer impart distinct
characteristics suited to cope with the forces placed on that portion of the valve
during daily operation (Figure 6).
The fibrosa is primarily composed of transverse/circumferentially aligned, load
bearing collagen-I, II, & III [23] fibrils that extend into the aortic root to allow for
proper load distribution. [24] By transmitting the forces along the leaflet into the
aortic wall, this arrangement prevents the valve from collapsing (prolapse) into
8

the ventricle during closing, under the back pressure of blood in the aortic
sinuses. [25] However, fiber bundles will crimp axially to allow the valve to bend
during opening (Figure 6B). [26]
Complementing the fibrosa is the ventricularis, named by its location within
the ventricle of the heart. The ventricularis largely contains elastin which allows
for closing of the valve by elastic recoil of the fibers. [27] As opposed to
transversally aligned collagen, elastin fibers are radially aligned to allow for
stretch during the opening and quasi steady-state phases and contraction under
reduced flow. [28]
Sandwiched between these two layers is the spongiosa, largely consisting of
glycosaminoglycans (GAGs) (chondroitin sulfate, dermatan sulfate, and
hyaluronan) as well as other proteoglycans. This layer provides for lubrication
between the fibrosa and ventricularis during movement of the valve (shearing),
resists compression and the shock of closing, and provides flexibility. [29,30]
Recently identified, the spongiosa also contains a network of loosely connected
fibrous proteins attaching the rigid collagen fibrils of the fibrosa with the recoiling
elastin fibers of the ventricularis: however, there are some variations in structure
throughout different regions of the spongiosa (Figure 7). These fibers help to
direct the controlled buckling of the fibrosa layer and allow for return of collagen
and elastin fibers to their original state once the external forces of blood flow
have been reduced. [27,31] Furthermore, the increased spongiosa of the

9

coaptation surfaces of the valve likely play a role in dampening vibrations during
valve closing.
Valve Formation
Valvulogenesis
During human development, when static diffusion is no longer sufficient for
nutrient and waste transport in the growing embryo, the cardiovascular system is
the first organ system to form. [32] At this stage the early heart contains
endocardial and myocardial tissues separated by cardiac jelly. Chamber
formation in the heart is initiated by heart looping and is typically observed from 6
4/7 – 7 5/7 weeks in humans (estimated gestational age, EGA). [33] See Figure 8
for a diagram of heart looping. Simultaneously, valves development begins with
swelling of mesenchymal tissue, endocardial cushions, into the lumen (cavity) of
the primitive heart tube. Primarily cardiac jelly, the swellings are composed of
hyaluronan-rich GAGs secreted by the myocardium. [32,33,34] Although the
valves of the heart are not recognizable until week 8 (atrioventricular and
semilunar), the beginning of valvulogenesis can be identified at week 7 1/7 for
semilunar valves. Semilunar valve formation is identified by the creation of the
aorticpulmonary septum and dividing of the aortic and pulmonary arteries. At
week 7 3/7 ventricular valves begin formation with the creation of the
atrioventricular junction. As such, early valve leaflets are prolongations of
endocardial cushion material (Figure 9). [21] While the atrioventricular valves
originate from cushions in the atrioventricular canal (AVC) semilunar valves are
10

derived from cushion formations in the outflow tract (OFT). [23,32,34,35,36,37]
Even at this early stage the endocardial cushions work to provide for directional
flow through the heart tube. [32]
Endothelial to Mesenchymal Transition (EndoMT)
During valve development, endothelial cells lining the inside of the heart,
change phenotype to a mesenchymal lineage to form valvular interstitial cells
(VICs), during endothelial-to-mesenchymal transition (EndoMT),4 and invasion of
the cardiac jelly. To replenish these cells during later stages in adults, circulating
endothelial and mesenchymal precursors from the bone marrow have been
shown to undergo EndoMT. [39,40]
EndoMT begins with the secretion of growth factors by myocardial cells into
the cardiac jelly that activate the cells of the endocardium to undergo transition.
Most markedly, these are composed of members of the transforming growth
factor-beta (TGF- β) family, TGF- β1 [41] and bone morphogenic protein (BMP) 2
& 4, [42,43,44] assisted by increased Wnt signaling. [36,45,46] In this stage,
activated endocardial cells down regulate cell-cell contacts (e-cadherin) and
adhesion ligands to detach from the endothelial lumen and infiltrate the cardiac
jelly, meanwhile activating Has2 and hyaluronic acid (HA) synthesis. [47] This
4

Not to be confused with epithelial to mesenchymal transition, describing
a number of transition states that occur in the developing fetus. Endothelial to
mesenchymal transition is a specific transition state involving the differentiated
cells lining the interior of the heart. Also to be differentiated from endocardial to
mesenchymal transition which is part of the atrioventricular valve formation and
shows infiltration of differentiated epicardial cells from the surrounding heart
tissue. [38]
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transformation from an endothelial phenotype to a mesenchymal phenotype is
characterized by expression of alpha–smooth muscle actin (α-SMA). [48]
Accompanying this shift is cardiac jelly remodeling through breakdown by matrix
metalloproteinases (MMPs) and deposition of collagen and proteoglycans to
replace the hyaluronan matrix. [23] However, it is not until postnatal stages that
the elastin fibers are laid down, suggesting the necessity for mechanical
activation of this transition. [49] Tao G., et al. gives an in-depth review of this
process. [45] A noticeable difference between atrioventricular and semilunar
valve formation includes: 1) the delamination of atrioventricular valves from the
heart wall at early stages of heart formation, and 2) the excavation of semilunar
valves to form the unique cusped structure after aorticpulmonary septum
formation (Figure 9)
Heart Valve Cell Types
The adult aortic heart valve is composed of two main cell types, valvular
endothelial cells (VECs) at the blood contacting surfaces and valvular interstitial
cells (VICs) within. VECs, as with other cardiac endothelial cells, are responsible
for creation of a non-thrombogenic (non-clotting) valve surface. Meanwhile, VICs
are responsible for maintaining homeostasis by actively degrading and
remodeling the ECM within the valve. [45]
Valvular Endothelial Cells (VECs)
VECs are identified by a polygonal morphology amongst individual cells, but
adopt a cobblestone morphology when forming a complete cell sheet.[46] While
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the outer most layer of the AV is composed of a single layer of VECs, it is
proposed that they are not actively responsible for matrix deposition, and thus,
and are only peripheral to tissue formation. However, VECs have been shown to
be highly responsive to shear stress due to blood flow in the aortic artery. While
other cardiac cells are aligned parallel to the flow of blood, VECs align
themselves circumferentially across the surfaces of the valve, though the reason
for this arrangement is currently unknown. [50,51]
By monitoring shear stress VECs express many factors including caspase-3,
nitrous oxide (NO), tumor necrosis factor-α, and bone morphogenetic factor-4.
[52,53,54] As such, VECs are believed to help regulate the homeostasis of the
AV by signaling to VICs within the valve. [32] However, recent studies into the
heterogeneity of this cell population suggest a link between VEC location and
molecular signaling that may affect disease progression. [55]
Valvular Interstitial Cells (VICs)
As the primary matrix depositing cell line within the AV, VICs are present in all
layers: fibrosa, spongiosa, and ventricularis. VICs have been shown to have a
higher level of protein turnover coupled with a higher rate of proliferation as
compared to many other cell types, consistent with their role in repair. [56] VICs
express many characteristics similar to both smooth muscle (myoblasts) and
ECM supporting fibroblasts. Furthermore, VICs are often further sub-divided into
different sub-populations based on phenotypic expression. Phenotypic variation
among VICs is known to be a normal function of healthy valves but many factors
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have recently been identified that facilitate the transition of the VICs from one
phenotype to another. Currently, VICs are thought to contain five subpopulations: (embryonic progenitor, adult progenitor (pVIC), quiescent (qVIC),
activated (aVIC), and osteoblastic (obVIC)) (Figure 10). [57]
VIC Phenotypes
Embryonic Progenitor VICS
Early in valve formation, endothelial cells (VECs) in the valve region undergo
EndoMT by infiltrating the cardiac jelly to form VICs. [37] Signaled by TGF- β,
BMP 2&4, and increased Wnt, VECs increase proliferation and motility by
degrading cell-cell contacts and expressing matrix metalloproteinases (MMPs).
They are also controlled by Notch [58,59] and vascular endothelial growth factor
(VEGF), [37] which signal endothelial cell population to proliferate and invade the
endocardial cushion to begin remodeling the early heart valve. Embryonic
progenitor VICs are only present in the developing valve while all other types can
co-exist in a single valve. [60] The majority of VICs come from the endocardial
cushions and are derived from VECs as a result of EndoMT, however, recent
lineage tracking suggests that neural crest derived cells also contribute to VIC
lineage after the formation of the aortic and pulmonary arteries by infiltration of
the aorticpulmonary septum (Figure 8c). [61]
Quiescent VICs (qVICs)
In healthy adult valves, quiescent VICs are the predominate phenotype
present with little, if any, cellular proliferation occuring after birth. Thus VICs only
become activated (aVICs) upon damage or disease. [49,62] Characterized as
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fibroblast-like with a cobblestone morphology, qVICs express vimentin and low
levels of aSMA. [57] qVICs are also thought to regulate low levels of ECM
turnover that inhibits angiogenesis important to maintaining a thin, pliable valve
by preventing vascularization. [63]
Activated VICs (aVICs)
Characterized as smooth muscle-like with an elongated, spindle-shaped
morphology, [57] activated VICs (aVICs) are associated with higher rates of ECM
turnover, proliferation, contraction, and motility. aVICS are generally
characterized by expression of vimentin and increases in alpha-smooth muscle
actin (αSMA), as well as proteolytic enzymes for matrix remodeling. [64] qVICs
are proposed to become activated to regulate the repair and replacement of
tissue within the valve. aVICs are therefore thought to be responsible for healing
damage or disease through repair of tissues. After completion of remodeling,
aVICs are deactivated and return to a quiescent state or undergo apoptosis. [65]
When VIC dysregulation or abnormal ECM production occurs, conversion to an
osteoblastic-like phenotype results in pathological fibrosis and calcification of the
valve. [66,67]
Osteoblastic VICs (obVICs)
While all VIC phenotypes are present in diseased valves, osteoblastic VICs
(obVICs) are primarily implicated in escalating symptoms of disease. In vivo,
obVICs are not observed until later stages of disease marked by the
development of cartilaginous and late stage calcific nodules and, under severe
circumstances, mature lamellar bone. [68,69] Accompanying nodule formation is
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the onset of apoptosis and necrosis within and around calcific nodules. [70] In
vitro, obVICs are observed to adopt round/rhomboidal morphology with a welldefined cytoskeleton, similar to osteoblastic progenitor or mesenchymal cells.
ObVICs have been shown to express the osteoblastic markers alkaline
phosphatase (ALP) [69,71], osteocalcin [72,73,74,75], transforming growth
factor-beta 1 (TGF-b1) [67,73,76], and osteopontin [74,75,77] and subsequent
calcium uptake to begin formation of calcified tissue. [57,78]
In culture, obVICs will spontaneously form multicellular aggregates that
subsequently develop into calcified nodules, providing an in vitro model for aortic
stenosis. [79] To study the transition between the aVIC and obVIC states, in vitro
studies require the addition of specific cytokines (bone morphogenetic protein-2
and 4 and transforming growth factor-β1), organic calcium (ascorbic acid, βglycerol phosphate), and apoptotic inducers (dexamethasone). [80] However,
recent studies have shown that these signaling factors may not produce a
complete osteoblastic transition in VICs which leads to the conclusion that this
phenotype is not a true conversion to a bone cell. [71] Representative images of
qVIC, aVIC, and obVIC phenotypes are shown in Figure 10.
Progenitor VICs (pVICs)
Progenitor VICs (pVICs), the least well-defined VIC population, can account
for as much as 10% of VICs and have markers associated with bone marrow
derived mesenchymal stem cells. [9] This population of VICs is believed to
consist of a heterogeneous population of progenitor cells that can infiltrate and
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replenish VIC populations within the valve. While investigations into identifying
pVICs are still underway, circulating mesenchymal progenitor cells in the blood
have shown to attach and infiltrate into valve leaflets to replenish cells in the
adult valve. [34] It has been hypothesized that these cells are associated with
valve disease and the differentiation into obVICs. However, no conclusive data
is currently available.
In order to overcome the immune response to foreign replacements,
autologous cell sources for tissue engineered valves are currently being
investigated, [39,40] but further characterization and stimulation of such cells
needs to be conducted. Bone marrow is commonly known as a source of
progenitors for red blood cells, platelets, and other cells of the hematopoietic
lineage but also contains cells that meet the criteria for stem cells in other
tissues. Mesenchymal stem cells (MSCs) derived from bone marrow have
already been shown to form functional cardiomyocytes and vascular structures,
while forming a myofibroblast-like phenotype expressing α-SMA and vimentin,
with no expression of LDL receptors, desmin, CD31 and CD14. MSCs can be
obtained through extraction from the iliac crest of the pelvic bone, from adipose
tissue, or a number of other sources; which make them valuable for their ability to
be derived under less invasive techniques. MSCs have also shown the ability to
form a functional heart valve structure, under pulsatile flow, with comparable
mechanical properties to native tissue. [81,82,83,84,85]
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Valve Pathogenesis: Disease & Dysfunction
Disease can be divided into three distinct groups: congenital defects, damage
or age-related failure, and infection. Signs of disease or dysfunction are usually
identified by stenosis (resistance to forward flow) or regurgitation (reversed flow
due to incomplete closure of the valve) leading to valve overload and reduced
pumping efficiency by the heart. [8,86,87,88] As a result, increased ventricular
compensation leads to thickening of the heart walls. [14] A malfunctioning aortic
valve increases the likelihood of death related to a cardiovascular disease by
50% without replacement. Most patients are not expected to survive more than
two years after the onset of symptoms [89,90], a life expectancy lower than
certain metastatic cancers. [7]
Congenital Defects
Congenital defects result from any number of hereditable disorders that cause
dysfunction of the heart or valve, ultimately resulting in valve failure. Many are
associated with increased strain on the heart and deposition of tissue, or a result
from irregular cellular signaling that have far reaching implications. Defective
valvulogenesis often leads to lifelong complications due to impaired cardiac
function. [32] Most notably, bicuspid aortic valve disease (BAVD) is the most
common congenital heart valve disease, occurring in 1% to 2% of the population.
A combination of factors, including genetic susceptibility, abnormal mechanical
forces, and environmental risk likely contributes to the pathobiology and early
onset of symptoms. [91] BAVD contributes to 50% of aortic stenoses and
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associates with structural abnormalities of the aortic wall such as aortic
aneurysm and aortic dissection. BAVD likely results from the disruption of the
Notch pathway during development of valves resulting in the lack of leaflet
division which leads to stenosis in adults. [53]
One of the most common genetic disorders of the aortic valve includes
Marfan’s syndrome. Marfan’s syndrome is a connective tissue disorder caused
by mutations in fibrillin-1, resulting in cardiovascular, musculoskeletal, and ocular
malformations. The most striking manifestation involves a disproportionate
increase in bone growth that causes malformations of the digits, limbs, and
chest. In the cardiovascular system, manifestations include progressive aortic
root enlargement and abnormally thick and elongated valve leaflets. [92] It is
proposed that, while fibrillin-1 is responsible for binding of several factors
including the latent TGF-b1 binding protein, the absence of a functional
microfibrils to sequester the large latent complex leads to activation of TGF-b1.
[93] Therefore, TGF-b1 signaling results in an inappropriate production of matrix
proteins and metalloproteinases, valve inflammation, elastic fiber calcification,
and structural collapse of the aortic valve or aortic aneurysm. [92]
Aortic Valve Disease
Most cases of aortic valve disease result from ectopic bone formation in the
leaflets. [4,70,94] This is often the result of a thickening of the AV which prevents
proper opening due to increases in stiffness. The pathological response to this
type of bone formation is characterized by accumulation of VICs associated with
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inflammatory cells, neovascularization, increased matrix deposition, and
eventually fibrosis and calcification (Figure 11). [57] Markedly, the incidence of
sclerosis on the aortic side of the valve (fibrosa) is shown to correspond with
sites of increased mechanical stress. [95,96,97] In cases where valve stress is
increased, such as bicuspid aortic valve, the likelihood of calcification is also
increased. [91] While valve disease pathogenesis is strongly correlated with VIC
activation, VEC dysfunction and denudation of the valve (loss of VEC layer) are
also strongly associated with valve failure. [45] Research into the interplay
between these systems still needs to be expanded.
In a European Heart Survey, which included 4,910 patients in more than 25
countries, aortic stenosis was the most frequent lesion, accounting for 43% of all
patients who had valvular disease. [94] As part of the overall strain in the
cardiovascular system, a stenosed valve causes a considerable drop in blood
flow to the heart muscles. This stems from the failure to open properly during
quasi-steady state flow and the formation of a low-pressure region within the
aortic sinus leading to reduced flow in the coronary arteries which feed the heart
muscles (Figure 4). Flow within the coronary arteries of a stenosed valve has
been shown to be reduced to 20% that of normal flow (from 51.0 cm/s to 8.6
cm/s). [17]
Stiffening of the AV can also disrupt leaflet coaptation, allowing for blood flow
back into the ventricle known as regurgitation. However, the most common cause
of aortic regurgitation in industrialized countries results from the degeneration of
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the aortic valve and root. [98] This leads to ventricular volume overload and
reduced pumping efficiency in the heart.
Aortic valve disease is directly linked to 15,000 patient deaths per year in the
United States. While this is a relatively low figure considering that ~30% of adults
over 65 years old suffer from early stages of valve failure, [99] valve disease
results in >100,000 heart valve surgeries per year at an approximate cost of $14
billion. [7,32] Treatment of AV disease by pharmaceuticals is still in early stages
and has had limited success. [9] Therefore, replacement of the heart valve with
either a synthetic or decellularized biological valve is often necessary.
Aortic Valve Replacements
Bioprosthetic Valves
Common replacement options for the aortic valve utilize porcine or bovine
(xenograft) or human (allograft) tissue5 (Figure 12). As tissue replacement
options, the use of allograft valves is desirable over xenograft, however, lack of
viable human donors leads to the more common use of animal valves.
In order to prepare the tissue for transplantation, cryopreservation of allograft
tissue often results in easy removal of cells while maintaining the ECM. Most
importantly, the non-thrombogenic valve surface is preserved. [100,101] As the
most biocompatible replacement this is often the treatment of choice for pediatric

5

Due to the singularity of the aortic heart valve, no autograph option is
available.
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patients. However, due to partial transplantation of foreign and cellular debris the
risk of disease transmission with cryopreserved allografts is often increased over
other replacement options. [100]
As an alternative, decellularization using detergents is a common treatment
for biological valve tissue but long-term valve durability can be severely reduced
by processing. Decellularization is necessary in xenograft replacements in order
to avoid complications of valve rejection due to immune response to antigen
presentation on the surface of cells. In the decellularization process, damage to
the tissue itself occurs through break down of ECM by the detergents used for
cell removal. Remaining tissue is chemically cross-linked to inhibit autolysis and
enhance mechanical stability. As such, decellularized valves have shown to be
stiffer radially and less stiff circumferentially than native valves. [102] Because
cellular maintenance of the valve is required for the constant remodeling and
regeneration of tissue, and damage to ECM is incurred through processing,
removal of cells within an allograft or xenograft transplant can be crippling to the
overall function of the valve.
Attempts to re-populate decellularized tissue in order to overcome these
issues have been unsuccessful due to damage to ECM components resulting in
irregular cell behavior upon repopulation. [103] Valve endocarditis is also a
common issue for replacement valves. Due to irregularities on the surface of
replacement valves, irregular blood flow often allows for bacterial attachment and
growth resulting in infection. Xenografts are more susceptible to valve
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endocarditis than mechanical vales due to damage to tissues during
decellularization. [104]
Structural failure of a biologic valves results in either patient death or
reoperation. While strongly age dependent, biological replacements have a
limited functional lifetime of ~10-15 years. However, with decreased patient age
and increases in activity level, the functional lifetime of the valve can be
decreased to less than five years. [101,105] These complications make biological
valves an attractive option for the elderly but less suitable for children or young
adults. [15] Less than 1% failure has been shown to occur within 5 years of
replacement, with this number growing to 20-30% within 10 years. However,
between 12-15 years >50% of patients will experience prosthesis associated
problems requiring replacement. [104,106,107,108,109,110,111] Therefore, end
of life use of biological valves, in adults older than 65, is more common than
younger patients.
Mechanical Valves
Mechanical heart valve replacements are an alternative to biological valves.
However, non-physiological surfaces and flow abnormalities can cause
hemolysis (cell rupture) and thrombosis (clotting). [112,113] As a result,
mechanical valves are often coated with pyrolytic carbon to increase lifetime and
limit thrombosis, but patients are still required to maintain an anticoagulant
regimen for the remainder of their lifetime, as well as immune suppressants.
[86,114,115,116] Such anticoagulation therapies are problematic due to thinning
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of the blood and potentially serious hemorrhagic complications. Mechanical
valves can also lead to valve endocarditis, though not as often as biological
valves.
Need for Alternatives
While the current gold standards, biological and mechanical replacements
have several limitations that need to be addressed. Frequent failure by structural
damage and calcification of biological replacements limits the functional lifetime
to less than 20 years. [117] Similarly, mechanical valves create the need for longterm anticoagulation therapies to reduce thromboembolic complications, but
simultaneously increase bleeding risks for patients. [35] The failure of all current
replacements to grow, repair, and remodel limits the usefulness of current
options for pediatric patients. As such, these complications have spurred
research into developing tissue engineering solutions to produce living valves
capable of recapitulating the healthy structure and function of the aortic valve.
Conclusions and Future Directions
Tissue Engineered Heart Valves (TEHV)
The primary goal of tissue engineering is to construct tissues from cellular
components which imitate the characteristics of the native tissue and provide
mechanical function, durability, adequate heamodynamic behavior, absence of
immunogenic/inflammatory behavior, and mature ECM. [118] In other words, the
goal of tissue engineering is to create a living and dynamic valve, with structure,
function, and homeostatic mechanisms as close as possible to those of the
24

natural valve. [35] In order to produce a viable tissue engineered heart valve
(TEHV) several factors are considered necessary for tissue integration and
growth. 1) A TEHV scaffold material should be >90% porous, with an
interconnected pore network to allow for proper nutrient distribution and waste
removal from the material and cell surroundings. [119] 2) A scaffold material
must be biocompatible, producing a non-thrombogenic, cell favorable surface
chemistry. 3) In order to provide proper function and signaling to cells, the
scaffold must match the mechanical properties of native tissue and retain the
natural repair and regeneration potential. [120] 4) To allow for effective ECM
turnover, the scaffold material must be biodegradable at a similar rate to tissue
production by the native cell population. 5) To allow for control over cell signaling
cues, fabrication must be reproducible. [121]
Cellular Behavior
The current status of research in aortic heart valve regeneration is focused on
the development of natural and synthetic polymer scaffolds to support cell health
and tissue deposition. However, there is an incomplete understanding of how to
induce VICs to produce tissue, while preventing disease progression and
calcification. Research into cellular behavior has begun to show variations in
cellular response caused by several different factors including soluble growth
factors in media, chemical functionality, and mechanics of the underlying
substrate. [72,73,122,123] The current challenge remains in identifying and
controlling biological, chemical, and mechanical factors that have an effect on
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ECM formation and cellular wellbeing. [124] Only after further investigation into
cellular behavior and signaling are we likely to be able to produce viable TEHV
alternatives.
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Figure 1. Diagram of a cross-section of the human heart (anterior view). The shaded region
indicates the plane of dissection. Within can be seen the four chambers and corresponding
valves, right atria (RA, tricuspid valve), right ventricle (RV, pulmonary valve), left atria (LA, mitral
valve), and left ventricle (LV, aortic valve). The dashed lines indicate the flow of blood through
the heart, entering in a de-oxygenated state (blue) in the RA, and leaving though the aorta after
passing through the lungs to be oxygenated (red).
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Figure 2. Diagram of anatomical cross-section of atrioventricular (AV) and semilunar (SL) heart
valves, shaded areas indicate plane of dissection. Major differences between AV and SL valves
include the presence of chordae tendineae in AV valves, binding the valve to papillary muscles
of the heart wall, and the cusped structure of SL valves with an unbound, free edge.
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Figure 3. A) Diagram of bisected aortic root, showing semilunar attachment of the valvular
leaflets, with corresponding aortic and ventricular tissues. B) Diagram of the aortic root
spanning entire range of leaflet attachment. The attachments of the valvular leaflets, shown in
red, extend through the entire length of the root, from the sinutubular junction (end of aortic
sinus region), in blue, to the virtual basal ring (base of leaflet attachment), shown in green. The
crown-like attachments of the leaflets cross the anatomic ventriculo-aortic junction, shown in
yellow. Modified from [13].
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Figure 4. A. Cross-section of flow profile within the aortic valve (AV) and aortic sinuses during
systolic flow in the opening, quasi-steady state, and deceleration phases. S, indicates the
stagnation point during quasi-steady state flow, between valve leaflet and aortic artery. B.
Diagram of intact AV (left) and dissection (right), when cut between posterior/non-coronary (N)
and right coronary (R) valve leaflet, of aortic valve and left ventricle of heart (posterior view); (L)
indicates left coronary valve leaflet.
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Figure5. Heart chambers pressure diagram (Wiggers diagram) showing aortic pressure (blue),
atrial pressure (green), and ventricular pressure (red), with corresponding aortic valve (AV)
opening geometries. The mitral valve (atrioventricular) closes at the beginning of the systolic
cycle, and isovolumic contraction (IVC) allows for the pumping of blood from the ventricles into
the arteries. IVC begins by pulling apart the valve leaflets of the AV, forming a stellate orifice. As
ejection of blood from the ventricle forces blood through the AV the orifice quickly changes to
triangular and then circular, during maximum ejection. During the diastolic cycle, buildup of
backpressure in the AV forces valve closure, freshly oxygenated blood refills the atria and the
blood vessels contract to further displace blood into the deep tissues. Isovolumic relaxation
(IVR) allows for the re-filling of the ventricle while the mitral valve is open. Modified from [14]
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Figure 6. A) Diagram of a single valve leaflet in the closed and B) open position depicting internal
movement of extracellular matrix (ECM) proteins of valve layers. C) Movat’s pentachrome
staining of aortic valve cross-section. D) Diagram of dissected aortic valve leaflet removed from
aortic root with labeled anatomical markers. Modified from [27].
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Figure 7. Diagram of interconnecting fibers (gray) found in the matrix of the spongiosa (white) of
the aortic valve. A) Fiber connectivity varies between different regions of the valve. B) The
greatest connectivity is found in the coaptation and hinge regions, D) as compared to the linear
structure of the belly region. These fibers allow for interconnectivity between collagen and
elastin fibers in opposing fibrosa and ventricularis layers, respectively. C) Opposing regions are
primarily composed of hyaluronin rich glycomainoglycans. [27,31]
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Figure 8. Development of the human heart during the first eight weeks, and the formation of the
heart chambers in a process known as heart looping. A) Initially, all venous blood flows from the
tail to the head, however B) rotation and decent of the central domain results in the process
known as heart looping. C) Development of the atrioventricular junction and aortic pulmonary
septum result in the beginning of valve formation through the creation of endocardial cushions
(yellow & light blue). The fusion of tail and head (white dot) result in the characteristic four
chambered heart structure observed at later stages of development. Cross-sections of fused
heart show aortic and pulmonary artery twisting and the development of atrioventricular valves.
E) Cross section of the human heart after tissue re-organization and complete formation of four
chambers. Modified from [125].
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Figure 9. Diagram of the general stages of atrioventricular (top) and semilunar (bottom) valve
development (valvulogenesis). Early secretion of glycosaminoglycans results in endocardial
cushion formation. Following endothelial to mesenchymal transition, endothelial cells infiltrate
the cardiac jelly and begin to remodel the tissue. In atrioventricular valves this results in
delamination if the tissue from the heart wall. In semilunar valves excavation of the cushion and
deposition of circumferentially aligned collagen results in the formation of semilunar cusps with
an unbound free edge. Modified from [32]
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Figure 10. Diagram of valvular interstitial cell phenotype & morphology. The adult heart valve is
primarily composed of quiescent VICs which serve to monitor valve environment and provide a
low level of protein turnover to prevent revascularization. Activated VICs are responsible for
valve formation and tissue repair. As a highly proliferative cell type, aVICs adopt an elongated
spindle shape morphology. For as yet unknown reasons aVICs can become osteoblastic,
adopting and irregular spread morphology and cytoskeleton formation result in in contractile
nodule and calcium deposition.
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Figure 11. Diagram of A) healthy and B) diseased (calcified) aortic valves. The healthy aortic
valve contains three thin and compliant valve leaflets. As a result of increased tissue deposition
calcification, the diseased valve begins to stiffen, obstructing blood flow through the valve.
Diseased valve used with permission, CDC: Public Health image Library. [126]
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Figure 12. A) Decellularized biological aortic valve before implantation (Medtronic, Mosaicâ),
which undergoes calcification after removal due to tissue degradation and lack of viable cells to
repair damage. B) A synthetic valve (Saint Jude Medical, RegentTM Heart Valve) replacement
before implantation, primarily composed of plastic and metal materials, mechanical valves
result in increased blood lysis, clotting, and increased stroke risk.
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Table 1. Top 10 leading causes of death; United States, 2007 and 2008. Information originally
from [1].
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Table 2. 2009 Estimated Inpatient Cardiovascular Operations and National Health Costs and
Utilization Project Statistic. Modified from [2].

Procedure

ICD-9-CM Procedure Codes

Total vascular and cardiac surgery and
procedures §

Mean
Hospital
Charges, $

Estimated Procedures (thousands)
Age, Y
Male Female
< 15
15 - 44
45 - 64

³ 65

Sex

All

$66,703

7,453

4,154

3,299

252

715

2600

3886

36.1-36.3

$124,404

416

305

111

-

14

162

240

00.66, 36.06, 36.07

$60,309

605

400

205

-

29

255

321

37.21-37.23

$36,905

1,072

622

449

5?

80

450

537

Pacemakers

37.7, 37.8, 00.50, 00.053

$61,015

397

193

204

4?

18

47

328

Implantable defibrilators

37.94-37.99, 00.51, 00.54

$134,904

116

86

30

2?

8?

43

65

38.12

$32,689

93

52

41

-

-

21

72

35.1, 35.2, 35.99

$171,270

139

81

58

3?

12

34

89

37.5

$540,125

Cardiac Revascularization (Bypass) ¥
Percutaneous Coronoary Intervention
(PCI, non-surgical)
Cardiac catherterization

Edarterectomy
Valves
Heart Transplantaion

Angioplasty
36.0, 00.66
1,133
745
388
55
471
608
§ Totals include procedures not shown here. ? Estimate should be used with caution because it may be unrelliable or does not meet standards of reliability or precision.
¥ Because ³1 procedusre codes are required to describe the specific bypass procedure performed, it is impossible from these (mixed) data to determine the average number
of grafts per patient.
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Chapter 2
Introduction and Specific Aims

Valvular Heart Disease
Cardiovascular disease (CVD) is the primary cause of death in industrialized
countries, responsible for 1,600 deaths daily in the United States—1 death every
51 seconds. [1, 2] Comprised of several conditions, CVD is correlated with the
obstruction of normal circulation, preventing the distribution of oxygenated blood.
As the sixth leading cause of death, valvular heart disease (VHD) is also linked
with more prevalent forms of cardiovascular failure through obstruction of blood
flow through the valve and increased overall strain on the heart. [3] An estimated
one in eight persons over the age of 75 has at least moderate VHD, [1] with more
than 5 million Americans diagnosed each year. [4]
Aortic Valve Disease (AVD)
Resulting from infections, valve degeneration, or genetic disorders, aortic
valve disease (AVD) is the result of improper valve function leading to loss of
blood flow efficiency. As such, AVD contributes to ventricular enlargement and
hypertension and increases the likelihood of death, by 50%, if not replaced. [2-6]
Most patients are not expected to survive more than two years after the onset of
symptoms, [7, 8] a life expectancy lower than certain metastatic cancers. [5] As
such, VHD represents a significant health risk worldwide.
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The leading cause of AVD is valve stenosis. This type of ectopic bone
formation is characterized by a marked accumulation of valvular interstitial cells,
inflammatory cells, vascularization, increased matrix deposition, fibrosis, and
calcification (Chapter 1, Figure 11). [6, 7, 9, 10] Several factors, including age,
family history, diet, and body mass increase the risk of developing AVD. During
stenosis, stiffening of the valve obstructs the flow of blood out of the ventricle,
reducing pumping efficiency and increasing the work required by the heart. [11]
Stiffening of the aortic valve (AV) can also disrupt leaflet overlap (coaptation),
allowing for blood flow back into the ventricle known as regurgitation. Both
conditions can result in the development of irregular blood flow around the valve,
and reduced blood pressure. This is particularly important due to the placement
of the coronary arteries in the aortic sinuses which provide the heart with
oxygenated blood. Improper blood flow and pressure gradients caused by AVD
disrupts the flow of blood to the heart muscles further increasing cardiovascular
stress.
Despite its prevalence, the exact mechanisms for the development of AVD
remain unclear. Due to the difficulty in early diagnosis and a lack of laboratory
models to study disease progression, research currently focuses on determining
the mechanisms responsible for valve cell behavior. One leading explanation for
AVD is long term wear associated with hypertension, high blood pressure, or
inflammation, which increases valve stress leading to tissue breakdown. [12, 13]
In response, primary valvular interstitial cells (VICs) activate to repair the valve,
54

but persistent inflammation, repeated breakdown, and increased scar tissue
formation result in thickening of the valve. [13] This process of thickening, or
fibrosis, alters the valve microenvironment which affects neighboring VICs and
causes extracellular matrix (ECM) changes leading to AVD. [12]
Aortic Valve Structure
The AV is comprised of three valve leaflets less than 1 mm thick. [14, 15]
Despite the thinness of the valve, there are three distinct (stratified) tissue layers;
fibrosa, spongiosa, and ventricularis. [3, 5, 16-18] Variations in the composition
and arrangement of the structural tissues of each layer impart distinct
characteristics suited to cope with the forces placed on that portion of the valve
during daily operation.
The fibrosa is primarily composed of transverse/circumferentially aligned, load
bearing collagen fibrils that extend into the aortic root to allow for load transfer
into the aortic wall. [19, 20] Complementing the fibrosa is the ventricularis,
named for its location on the ventricular side of the valve. The ventricularis
largely contains elastin to allow for elastic recoil and return of the valve to a
closed position. [21] Sandwiched between these two layers is the spongiosa,
largely consisting of glycosaminoglycans (GAGs) and other proteoglycans. This
layer provides shear dampening between the fibrosa and ventricularis during
valve opening, resists compression and the shock of closing, and provides
flexibility. [22, 23]
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AVD Treatments
The current gold-standard for the treatment of AVD is replacement of the
diseased valve using either biological or synthetic valve alternatives (Chapter 1,
Figure 12). Biological valves are derived from xenograft, porcine or bovine, tissue
which has been shaped, decellularized to prevent immune response, and
crosslinked to create a valve with similar biomechanical behavior to that of the
native valve. [24] However, due to the decellularization process tissue
degradation and calcification often occurs in biological valve reducing their
functional lifetime to within 5-20 years following surgery dependent on the level of
a patient’s physical activity. [25, 26] Alternatively, synthetic valves composed of
non-biological materials are designed to mimic valve function while avoiding the
foreign body response. Similarly, the synthetic materials and complex flow
profiles found in synthetic valves create thrombogenic surfaces which can cause
blood lysis, clotting, and increased stroke risk. [26] To counteract clot formation,
patients must use anticoagulants for their remainder of their life.
Given the lack of cell infiltration for tissue growth and repair over time,
decellularized biological and synthetic valve replacements provide only limited
treatment options which are fraught with immunosuppressant requirements and
revision surgery as patients age. Tissue engineered heart valve (TEHV)
replacements, which integrate into the native tissue, utilize the body’s self-repair
mechanisms to maintain scaffold fitness, and grow over time are highly sought
after as an alternative valve replacement option. However, in order to realize
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TEHV replacements, a better understanding of valvular interstitial cell (VIC)
behavior and disease development needs to be established.
Valvular Interstitial Cells (VICs)
VICs are the primary matrix depositing cell line in the aortic valve. [10] As a
myofibroblastic cell type, VICs express many characteristics similar to both
smooth muscle myoblasts and ECM supporting fibroblasts. However, VICs are
often further sub-divided into different sub-populations based on phenotypic
expression. Phenotypic variation among VICs is known to be a normal function of
healthy valves but many factors have recently been identified to facilitate the
transition of the VICs from one phenotype to another.
VICs contain three main sub-populations: quiescent (qVIC), activated (aVIC),
and osteoblastic (obVIC). [10] Quiescent VICs are the predominant phenotype
present in a healthy adult valve. Characterized as fibroblast-like with cobblestone
morphology, qVICs express vimentin and low levels of alpha-smooth muscle
actin (αSMA). [10] qVIC are also thought to regulate low levels of ECM turnover
believed to inhibit angiogenesis, maintaining a thin, pliable valve by preventing
vascularization. [27] Characterized as smooth muscle-like with an elongated
morphology, [10] activated VICs are associated with higher rates of ECM
turnover, proliferation, contraction, and motility. aVICs are characterized by the
formation of contractile stress fibers and increased expression of αSMA, as well
as other contractile proteins and proteolytic enzymes required for matrix
remodeling. [28] After completion of remodeling, aVICs are deactivated and
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return to a quiescent state or undergo apoptosis. [29] When VIC dysregulation or
abnormal ECM production occurs, conversion to an osteoblastic-like phenotype
results in pathological fibrosis and calcification of the valve. [30, 31]
While all VIC phenotypes are present in diseased valves, osteoblastic VICs
are primarily implicated in escalating symptoms of disease. In vivo and in vitro,
obVICs will spontaneously form multi-cellular aggregates that subsequently
develop into calcified nodules. [32] Accompanying nodule formation is the onset
of apoptosis and necrosis within and around clusters. [33] obVICs adopt
round/rhomboidal morphology with a well-defined cytoskeleton, similar to
osteoblastic progenitor or mesenchymal cells. Subsequent calcium uptake leads
to the formation of calcified tissue. [10] To study the transition between the aVIC
and obVIC states, in vitro studies require the addition of specific cytokines (bone
morphogenetic protein-2 and 4 and transforming growth factor-β1), organic
calcium (ascorbic acid, β-glycerol phosphate), as well apoptotic inducers
(dexamethasone). [9] However, these signaling factors alone may not result in
complete osteoblastic transition in VICs, which suggests that this phenotype is
not a true conversion to an osteoblastic/bone cell. [29]
One interesting aspect of VICs that remains less explored is the
heterogeneity as observed in vitro. VICs reside throughout the aortic valve,
among the three stratified tissue layers. However, due to very different ECM
production, it is likely these cells have different functions within each valve layer.
Yet most studies isolate the entire population of VICs to use for experimentation
58

without further separation. At the current time the separation of these
subpopulations represents a significant challenge as no surface markers identify
differences in VIC phenotype. If 1) VICs could be separated into subpopulations
with distinct differences in phenotype and 2) unique surface markers could be
identified for each subpopulation, then VICs could be more easily sorted
immediately after extraction and used to study VIC behavior and growth of
TEHVs.
Microenvironmental Cues
Effective understanding of complex cellular structures for the study of valve
disease requires the control of physical and chemical properties of the
surrounding microenvironment. The conditions in the immediate cell vicinity have
a direct effect on behavior and phenotypic expression. Physical, chemical, and
biological control of cell microenvironment are of crucial importance for the ability
to direct and study cell behavior. Current cell culture techniques utilize plastic
culture flasks made from plasma-treated, tissue culture polystyrene (TCPS).
TCPS is used as a cell culture platform because it is a disposable, synthetic
material which can be easily molded while retaining excellent optical properties.
As a hydrophobic polymer polystyrene is not well suited for cell adhesion, but
plasma oxidization imparts a negative charge to the TCPS surface shown to
allow for greater cell attachment and proliferation. [34, 35] However, after
reaching confluence on TCPS, VICs spontaneously contract and form calcific
nodules. [36] This suggest that TCPS alone may trigger obVIC formation in vitro.
59

In order to provide for a more physiological relevant culture hydrogel materials
and ECM proteins have been used to decrease the stiffness of culture surfaces.
[37-39] Chapters 6-7 will describe the development of a synthetic modifiable
hydrogel environment for the study of VICs in 3D culture.
However, stiffness alone does not control phenotypic behavior. Just as TCPS
can be altered through use of plasma oxidation, several other surface treatments
can be used to alter the cell culture surface in order to control protein deposition,
cellular binding, and growth behavior. [40-45] Of specific interest in the growth
and behavior of VICs is the large amount of negatively-charged hyaluronic acid
present during valve formation and cell migration. [46, 47] We hypothesize that
negatively charged environments may give rise to aVIC formation.
Alkanethiol Self-Assembled Monolayers
In order to investigate the effects of surface chemistry on VIC phenotype and
initiation of VHD, alkanethiol self-assembled monolayers (SAMs) of wfunctionalized alkanethiolates on gold can be used as model substrates with
uniform chemistry. The chemisorption of thiols to gold and the hydrophobic
interactions of alkane chains results in stable, ordered, and well-packed
monolayers. [23, 42-45, 48-50] As such, SAMs offer well-defined models for
systematically investigating phenotypic change directed by surface chemistry.
Alkanethiol SAMs with differing chemistries have been shown to alter
mammalian cell phenotype. Protein deposition, cell adhesion, and integrin
signaling are all affected by substrate chemistry. [40-45] It is proposed that SAMs
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alter the affinity, structure, and function of ECM proteins at the cell-material
interface. Distinct differences in protein adlayers on SAMs alter cellular binding
and regulate the presence or absence of specific integrin binding subunits and
cell-adhesion plaques. As a result of integrin binding and clustering in focal
adhesions, cytoskeletal re-arrangement and signaling cascades alter phenotype.
[13, 39, 42, 45, 48] Specifically, it has been shown that cell culture surfaces can
result in distinct differences in integrin expression and correspond with increased
focal adhesion, cytoskeletal rearrangement, and distinct morphologies, which
correlate with observed changes in cell phenotype. [40-45]
The effect of alkanethiol SAM chemistry on VIC phenotype is investigated in
Chapters 3-5. Initially, changes in phenotype were assessed through use of
SAMs in order to identify distinctly different signaling pathways for healthy and
disease behavior caused by surface chemistry. We then assessed and
characterized differences in protein binding and integrin signaling to identify
possible signaling pathways responsible for heart valve disease progression.
In order to translate the effects of tissue microenvironmental cues from twodimensional surfaces to three-dimensional tissue scaffolds, synthetic polymers
are typically utilized for their well-defined behavior and ability to be easily
modified. Previous work investigating VIC behavior in 3D systems utilizes
hydrophilic polymers which can be degraded for novel tissue secretion and
matrix remodeling. [51-53] By incorporating degradable functional groups into
polyethylene glycol scaffolds using alternative synthesis techniques we have
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developed an improved modifiable hydrogel for investigating VIC phenotype in
three-dimensional systems. The degradable hydrogel, oligo ((polyethylene) glycol
fumarate) (OPF), has a number of advantages over other scaffolds because it
degrades though ester hydrolysis, is easily tailored to alter stiffness, and has
multiple sites per molecule that can be functionalized to alter the molecular
structure. This work is described in Chapter 6. The modification and cell
encapsulation of VICs in OPF with adhesive peptide sequences is investigated in
Chapter 7.
Summary
Valvular calcification, a cell mediated-process, results in significant morbidity
and mortality world-wide. In the US alone, valvular heart disease (VHD) is
estimated to affect 2.5% of the population with a disproportionate impact on an
increasing elderly populous. [2, 5] It is well understood that the primary driver for
valvular calcification is the differentiation of valvular interstitial cells (VICs) into an
osteoblastic-like phenotype. [9, 54] However, the factors leading to the onset of
osteoblastic-like VICs (obVICs) and resulting calcification are not fully understood
and a more complete characterization of VIC differentiation and phenotypic
change is required before treatment of valve disease or growth of TEHVs can be
realized. By investigating the microenvironmental cues at the cell-material
interface we can begin isolating the effects of protein deposition and cell
adhesion that may be responsible for VIC differentiation and disease
development. Utilizing synthetic materials, we can then transfer this behavior into
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a more-relevant 3D tissue engineered environment for use as a disease model
and the development of TEHV replacements.
Overall Objective
The objective of this work is to investigate in vitro VIC differentiation and
calcified tissue formation in order to identify signaling pathways resulting in
disease progression. Specifically, w-functionalized alkanethiol SAMs are used to
investigate the effects of surface chemistry on VIC behavior and initiation of
disease. Understanding the isolated effects of surface chemistry on VIC behavior
will in turn allow for the intelligent design of scaffolds for tissue regeneration and
development of disease models for therapeutic testing.
Specific Aims
In the course of this work the following specific aims were investigated:

Specific Aim 1: Identify VIC phenotypic behavior on well-defined chemically
functionalized surfaces (Chapters 3-5).
To determine the effect of material surface chemistry on VIC phenotype, VICs
were grown on alkanethiol SAMs. Four physiologically relevant functional
groups [CH3 (hydrophobic), OH (hydrophilic), COOH (COO-, negative at
physiological pH), and NH2 (NH3+, positive at physiological pH)] were used
to determine the effects of substrate hydrophobicity and charge on VIC
phenotypic behavior. VIC viability and proliferation, morphology, genetic
markers α-smooth muscle actin (αSMA), and osteocalcin (OCN), as well as
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calcified nodule formation were used as markers of VIC phenotype. Additional
research identified of phenotypic sub-populations of VICs from native heart
valve tissue.
Specific Aim 2: Characterize extracellular matrix protein affinity and integrin
signaling using chemically functionalized surfaces (Chapter 5).
To understand the effects of cell phenotype and interaction with selfassembled monolayer surfaces, we assessed the deposition of common
extracellular matrix proteins [fibronectin, laminin, collagen, and fetal bovine
serum/bovine serum albumin] on self-assembled monolayers using surface
plasmon resonance (SPR). Additionally, protein ad-layer morphology on
SAMs was determined using atomic force microscopy (AFM). Finally, to
determine the mechanisms of phenotypic progression in VICs, we
investigated integrin expression on SAMs during attachment (12hrs) and after
5 days using antibody labeling and flow cytometry detection.
Specific Aim 3: Develop a modifiable 3D hydrogel system to elucidate the effects
of microenvironmental cues on VIC behavior (Chapter 6-7).
To study the effects of charged environments and material stiffness on the
growth and behavior of valvular interstitial cells we developed a novel
synthesis technique for the formation of oligo(poly (ethylene glycol)) fumarate
(OPF). Utilizing alkanethiol click chemistry, we functionalized OPF with
pendant functional groups in order to investigate the phenotypes of VICs in
three-dimensional environments. Resulting hydrogels were characterized
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using nuclear magnetic resonance (NMR), gel permeation chromatography
(GPC), differential scanning calorimetry (DSC), nanoindentation, and cell
viability.
Broader Impacts
By determining VIC phenotypic behavior as a result of surface chemistry, we
have begun to define signaling pathways, initiation, and control of phenotypic
changes in VICs. By determining the protein affinity of common extracellular
matrix proteins involved in binding of integrins as well as the expression of their
integrin binding partners by VICs, we began to elucidate the cellular-material
signaling cascades responsible for healthy or disease progression in vitro.
Finally, through the development and functionalization of 3D hydrogels we
translated studies into physiologically relevant tissue culture platforms. Overall,
the work outlined here resulted in a more complete understanding of VIC
behavior and the development of both tissue engineered scaffolds as well as in
vivo drug targets for valvular heart disease.
Contributions
The chapters of this dissertation were developed from research done in
Elizabeth L. Hedberg-Dirk’s (Herdberg-Dirk EL) laboratory in the Center for
Biomedical Engineering at the University of New Mexico.
Chapters 1-2 were written by Matthew Nicholas Rush (Rush MN) with minor
revisions and edits by Dirk lab members (Christian Denny/Denny C and Kent
Edward Coombs/Coombs KE). Chapter 1 was originally intended as an
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educational reference for new lab members on the structure and function of the
aortic valve. Continued revisions and expansion has resulted in preparation of
the manuscript for open access publication.
Chapter 3 was primarily written by Rush MN with help in gathering and
analyzing data by Coombs KE. This manuscript was revised and submitted for
publication in Acta Biomaterialia in 2015.
Chapter 4 was equally developed by Rush MN and Coombs KE as a result of
findings from chapter 3. Isolation of cell subpopulations was achieved by Rush
MN & Coombs KE with continued experiments led by Coombs KE with shared
analysis and interpretation. The manuscript text was primarily compiled by
Coombs KE with significant revisions and edits by Rush MN.
Chapter 5 was almost exclusively conducted by Rush MN with help by
Coombs KE in integrin experimental development and execution. Continued work
on integrin blocking and assessment of VIC phenotype will be conducted by
Derek Montoya and existing members of the Dirk lab.
Chapter 6 was initially developed by Rush MN in combination with HedbergDirk EL and Kirsten N Cicotte, and aid by Shawn Dirk. With successful
application for NSF funding (Hedberg-Dirk, NSF CBET 13151947) OPF synthesis
became the primary priority of Coombs KE with training and advisement by Rush
MN. OPF synthesis was conducted by Coombs KE and David Santistevan with
analysis conducted by Rush MN at the University of New Mexico and the Center
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for Integrated Nanotechnologies. Analysis of results and paper conceptualization
was shared among group with execution by Rush MN.
Chapter 7, functionalization of OPF, was previously developed by Rush MN.
However, Coombs KE was primarily responsible for experiments and expansion
of OPF functionalization. The manuscript was drafted by Coombs KE with
revisions by Rush MN and edits to be finalized with future work by members of
the Hedberg-Dirk lab.
Each successive chapter (1,3-7) is formatted for publication and therefore is
meant to stand on its own as a primary article. Chapters 2 & 8 were written by
Rush MN in order to explain the results and significance of the results described
in this dissertation.
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Abstract
The primary driver for valvular calcification is the differentiation of valvular
interstitial cells (VICs) into diseased phenotype. However, the factors leading to
the onset of osteoblastic-like VICs (obVICs) and resulting calcification are not
fully understood. This study isolates the effect of substrate surface chemistry on
in vitro VIC differentiation and calcified tissue formation. Using w-functionalized
alkanethiol self-assembled monolayers (SAMs) on gold [CH3 (hydrophobic), OH
(hydrophilic), COOH (COO-, negative at physiological pH), and NH2 (NH3+,
positive at physiological pH)], we have demonstrated that surface chemistry
modulates VIC phenotype and calcified tissue deposition independent of
osteoblastic-inducing media additives. Over seven days VICs exhibited surfacedependent differences in cell proliferation (COO- = NH3+> OH > CH3),
morphology, and osteoblastic potential. Both NH3+and CH3-terminated SAMs
promoted calcified tissue formation while COO--terminated SAMs showed no
calcification. VICs on NH3+-SAMs exhibited the most osteoblastic phenotypic
markers through robust nodule formation, up-regulated osteocalcin and α-smooth
muscle actin expression, and adoption of a round/rhomboid morphology
indicative of osteoblastic differentiation. With the slowest proliferation, VICs on
CH3-SAMs promoted calcified aggregate formation through cell detachment and
increased cell death indicative of dystrophic calcification. Furthermore, induction
of calcified tissue deposition on NH3+ and CH3-SAMs was distinctly different than
that of media induced osteoblastic VICs. These results demonstrate that
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substrate surface chemistry alters VIC behavior and plays an important role in
calcified tissue formation. In addition, we have identified two novel methods of
calcified VIC induction in vitro. Further study of these environments may yield
new models for in vitro testing of therapeutics for calcified valve stenosis,
although additional studies need to be conducted to correlate results to in vivo
models.
Introduction
Valvular heart disease (VHD) is estimated to affect 2.5% of the US population
with a disproportionate impact on an increasing elderly community. [1, 2] Derived
from infections, valve degeneration, or genetic disorders, VHD can manifest as
regurgitation or stenosis of the valve. As a result of obstructed blood flow, valve
stenosis generates transvavlular gradients that triggers compensatory ventricular
hypertension, leading to increased risk for other cardiovascular disorders. [1-3]
As such, VHD represents a significant health risk worldwide. Furthermore, there
will continue to be rises in the prevalence of VHD as the elderly population grows
due to advances in medical technology. [1-5]
The leading cause of VHD is valve stenosis, which is characterized by valve
thickening, increased protein deposition, and eventual calcification. [3, 4, 6] The
primary driver for valvular calcification is the differentiation of valvular interstitial
cells (VICs) into a disease inducing phenotype. [6, 7] However, the factors
leading to the onset of VIC differentiation and resulting calcification are not fully
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understood and a more complete characterization of VIC differentiation and
phenotypic change is required before treatment of valve disease can be realized.
As the predominant cell type within the valve, VICs are responsible for valve
formation, remodeling, and tissue homeostasis. VICs are a heterogeneous
population that undergo phenotypic change regulated by environmental factors.
VICs have been shown to alter phenotype in response to soluble factors, [8-11]
substrate stiffness, [6, 8, 12-15] and surrounding extracellular matrix proteins. [8,
10, 11, 16-21] Although phenotypic change is a dynamic event, literature tends to
compartmentalize VIC function in order to clarify and separate the underlying
causes. [22]
VICs are commonly characterized by their quiescent (qVIC), activated (aVIC),
and disease phenotypes. In a normal adult valve, qVICs are thought to preserve
physiological structure and function while maintaining a low level of matrix
synthesis and degradation inhibiting angiogenesis. [22] Following injury or
abnormal hemodynamic/mechanical stress, VICs become activated (aVICs,
myofibroblastic) and are associated with increased extracellular matrix secretion
and expression of various biological markers including a-smooth muscle actin (aSMA), matrix metalloproteinases, and transforming growth factor-β. [22, 23]
Activated VICs exhibit increased contraction, prominent stress fiber formation,
increased proliferation, and migration. [22] In vitro, aVICs display an elongated
morphology and form orthogonal patterns of overgrowth resembling hills and
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valleys.[6] Upon completion of remodeling or wound healing, most aVICs are
eliminated by apoptosis or reversion to qVICs.[24]
When VIC dysregulation or abnormal extracellular matrix production occurs,
conversion to diseased phenotypes results in pathological fibrosis and
calcification of the valve.[10, 24] The mechanisms of VICs tissue calcification
have been intensely study and currently two processes have been proposed. [5,
25-27] Dystrophic calcification is a passive degenerative process characterized
by early cell injury and deposition of calcium associated with tissue damage and
necrotic cells. [10, 25, 26] Alternatively, osteogenic calcification (ossification) is
an active process involving bone and cartilage development, marked by the
expression of various osteogenic markers. [7, 25, 26, 28] In vitro, VICs
undergoing osteogenesis, osteoblastic-like VICs (obVICs), are characterized by a
round/rhomboid morphology followed by the formation of three-dimensional
calcified nodules. It is important to note, that these two processes are not
mutually exclusive as a common activator of tissue calcification, TGF-β, has
been shown to lead to cellular apoptosis as well as nodule formation. [10]
However, different processes may arise due to variations in signaling in the
cellular microenvironment. Forced obVIC differentiation in vitro is commonly
achieved by adding soluble signaling factors (β-glycerophosphate, ascorbic acid,
and dexamethasone) to media. However, spontaneous in vitro nodule formation
in media lacking osteoblastic inducing additives, [8] as well as calcification of

78

decellularized biological valves in vivo, suggests calcification may be mediated
by additional physical cues. [29]
To understand how surface chemistry correlates to VIC behavior and initiation
of valvular disease, we used alkanethiol self-assembled monolayers (SAMs) of
w-functionalized alkanethiolates on gold as model substrates with uniform
chemistry. The chemisorption of thiols to gold and the hydrophobic interactions of
alkane chains results in stable, ordered, and well-packed monolayers (Figure 1).
[30] As such, SAMs offer well-defined models for systematically investigating
phenotypic change directed by surface chemistry. Four physiologically relevant
functional groups were used to assess the effects of substrate hydrophobicity
and charge on VIC phenotypic behavior. Due to the negatively charged
environment present during valvulogenesis through increased hyaluronic acid
expression, it was hypothesized that anionic functional groups would result in
VIC activation and tissue production. [31, 32]
Materials and Methods
Reagents and Chemicals
All chemicals were purchased from Sigma-Aldrich chemicals unless otherwise
noted. All cell culture media and reagents were purchased from Thermo Fisher
Scientific, unless otherwise noted.
Fabrication of Self Assembled Monolayers
Gold-coated round 15 mm glass cover slips (26021, Ted Pella Inc.) were
used as substrates for self-assembled monolayer (SAMs) formation. Coverslips
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were etched for 30 minutes prior to gold deposition in Piranha solution [70% (v/v)
concentrated H2SO4, 30% industrial grade H2O2 (KMG Chemicals)] rinsed with
diH2O, and blown dry with N2. Gold coating was conducted by sequential electroevaporation of optically transparent films of chromium, adhesion layer (2 nm;
High Vacuum Evaporator Systems), followed by gold (30 nm, 99.99% purity;
Plasmaterials). Metal deposition was accomplished at 2 nm/s using a
Thermionics VE-90 vacuum Evaporation System (TLI Enterprises) with chamber
pressures at or below 1 x 10-5 Torr. Freshly prepared gold substrates were
immersed in 1mM ethanolic alkanethiol solutions [1-dodecanthiol (47-136-4); 11mercapto-1-undecanol (447528-16); 11-mercaptoundecanioc acid (450561-5G);
11-amino-1-undecanethiol, hydrochloride 1N NaOH (A423, Dojindo
Laboratories)] and SAMs were allowed to assemble for 12 hours.[30, 33] Etched
cover glass and gold-coated controls were incubated alongside SAMs in absolute
ethanol. Before use or characterization, samples were cleaned of unbound thiols
in absolute ethanol and dried with N2. In order to obtain desired charge on COOH
(COO-) and NH2 (NH3+) surfaces, samples were rinsed in 1N basic (NaOH; EMD)
and acidic (HCl; EMD) ethanol solutions, respective of charge group, blown dry
with N2 and then cleaned. [34]
Contact Angle Measurements
Static contact angles and images were evaluated using the sessile drop
technique on a Model 100-00-115 Advanced goniometer (ramé-hart Inc.).
Briefly, 5 μL of ultrapure water was pipetted onto sample surface and the contact
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angles were measured immediately after drop formation to minimize the effect of
dynamic surface wetting and evaporation. Contact angle measurements between
the water droplet and the sample surface were determined using DROPimage
Standard software (ramé-hart).
X-Ray Photoelectron Spectroscopy (XPS)
XPS survey and high resolution spectra were obtained using Axis Ultra
spectrometer (Kratos Analytical Ltd.) with a monochromatic Al K(α) (1486.6 eV)
source at 225W. High-resolution spectra of carbon and oxygen were obtained for
three areas for each sample at 30˚ and 90˚ take-off angles. Electron pass energy
of 20 eV was used to analyze the regions of interest and curve fitting was
performed on each spectral region to calculate atomic percentages. Base
pressure was less than 5 x 10-9 Torr. Charge compensation was accomplished
using low energy electrons. Linear background was used for elemental
quantification of C1s and O1s spectra. Quantification utilized sensitivity factors
provided by the manufacturer. All the spectra were charge referenced to Au at 84
eV. Curve fitting was carried out using individual peaks of constrained width,
position, and 70% Gaussian/ 30% Lorentzian line shape.
Atomic Force Microscopy
Scanning was performed at 2.50 µm/s (0.25 Hz) using a super sharp silicon
probe (SSS-NCH, r > 5nm, Nanoworld) on an MFP3D-BIO (Asylum Research).
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Ellipsometry
Freshly prepared samples were analyzed for film thickness using a Nanofilms
EP3 optical ellipsometer @ 532nm (Accurion). Samples were collected at an
incident angle of 70˚ for three areas on three different samples. The layer
thickness was calculated using an index of refraction n = 1.52. [35, 36]
Primary Cell Extraction & Characterization
VICs were obtained through primary cell extraction from recently excised pig
hearts (Hormel Foods Corp.) shipped overnight on ice. Aortic heart valves
leaflets were removed and washed in 25 mL Dulbecco’s phosphate buffered
solution (DPBS) containing 2% (v/v) penicillin/streptomycin (P/S, Life
Technologies). Three hearts (9 leaflets) were combined in 25 mL collagenase
solution [12,500 units collagenase (LS004174, Worthington Biochemical Grp.) in
50 mL Media 199 (Hyclone, SH30253.01)] filtered through 22 µm Steriflip unit
(Millipore) and incubated at 37°C for 15 min with gentle agitation. Both sides of
leaflets were scraped and rinsed in DPBS. Leaflets were then incubated with 25
mL fresh collagenase solution at 37°c for 60 min with gentle agitation. Leaflets
were vortexed for 2 min to break free loosely attached cells. Supernatant was
collected and filtered through 100 µm cell strainer (BD Falcon). To remove
valvular endothelial cells (VECs), cell solutions were incubated with 50 µL of
magnetic beads labeled with CD31 antibody (Dynabead CD31, Life
Technologies) at 4°C for 30 minutes with occasional mixing. Dynabeads were
removed by magnetic separation. VICs were then placed in a new conical tube
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and centrifuged. Supernatant was removed and cells were re-suspended in VIC
media [Media 199 (Hyclone), 10% FBS, 1% P/S, & 1% Fungizone]. Cells were
seeded in T75 flasks (collagenase sample), and remaining leaflet material was
diced up and plated into 6-well plates (Corning), 1 leaflet/well, to allow remaining
VICs to migrate from leaflet (explant sample).
VICs were incubated (37°C, 5% CO2, ~90% RH) and grown for 7-10 days,
with media changes every other day. Cell supernatant was removed from T75
flasks after 2 days of attachment. Heart valve leaflets were removed from well
plates after 3 days. Cells were grown to 70% confluence and enzymatically
detached from surface with 2 mL of .25% (w/v) trypsin (Life Technologies).
Collagenase and explant samples were combined in M199 media with 10% FBS
(v/v) and 10% DMSO (EMD), and cryogenically frozen until use. VICs were
seeded on SAMs between passages 3-4.
Cell Growth & Viability
Before seeding on substrates, VICs were thawed and grown till 80%
confluence, to ensure cell viability. For all experiments, substrates were
equilibrated with complete growth media [Medium 199, 10% fetal bovine serum,
1% penicillin/streptomycin, 1% fungizone] prior to cell seeding at 21,500
cells/cm2. Media was replaced after 12 hours to remove unbound cells
(attachment) and changed every two days. Osteoblastic controls were grown in
OB media [Media 199, 10% fetal bovine serum, 10mM β-glycerophosphate, 2
mM ascorbic acid, & 10-7M dexamethasone] [6] after initial 12-hour attachment.
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Substrates were rinsed prior to testing. Cell attachment and proliferation was
assessed after 12 hours, and at 3, 5, & 7 days using MTT calorimetric assay (301010K, ATCC) according to manufacturer’s instructions.
VIC viability was further investigated using AlexaFluor 488 Annexin V/Dead
cell apoptosis kit (V13241, Life Technologies) according to manufacturer’s
instructions. Briefly, at 12 hrs and 5 and 7 days, culture media was removed and
retained for apoptotic/dead cell concentrations while attached cells were
enzymatically removed from surfaces. Cells were centrifuged, supernatant
removed, and cell pellet re-suspended in 1x annexin binding buffer. Necrotic
controls were achieved by incubating with 70% (v/v) ethanol. Apoptotic controls
were achieved by leaving cultures at room temperature overnight. All samples
were incubated with 100 µL staining solution [5 µL Annexin V and 1 µL propidium
iodide @ 100µg/mL in 1x annexin binding buffer] for 15 minutes. Samples were
read on Accuri C6 flow cytometer (BD Bio.).
Calcium Content
After 5 and 7 days, calcium deposition was visualized by incubating cells with
the anthriquinone dye alizarin red S (ARS), forming a complex via chelation.
Briefly, culture medium was aspirated and cells were rinsed 3x with DPBS
followed by fixation using 10% formalin for 1 hour. After fixation, 100 µl of 40 mM
ARS staining solution (pH 4.1) was added to each well and incubated for a
minimum of 30 minutes in the dark at room temperature. [6] Upon completion the
ARS solution was aspirated and the wells were rinsed 3x with diH20 then PBS in
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order to ensure removal of non-specific ARS stain. Samples were imaged under
brightfield with phase contrast 10x magnification objectives (Eclipse TS1000).
Calcified tissue and nodule diameter was determined using Image J (NIH).
Gene Expression
All reagents for gene expression were purchased from Life Technologies
unless otherwise noted. mRNA was extracted from cell samples using RNAeasy
plus micro kit (Qiagen 74034) with gDNA removal, according to manufacturer’s
instructions. Total mRNA content was analyzed using Nanodrop UV/Vis
Spectrometer (Model 2000c, Thermo Fisher Sci.) and reverse transcription
carried out using GoScript reverse transcriptase system (Promega). Gene
expression of αSMA/ACTA (Ss04245588_m1), osteocalcin/BGLAP
(Ss03373655_s1), collagen I-α2 (Ss03375690_U1), and elastin (EMLIN: Custom
Primer#AJLJIR9) were analyzed using TaqMan Gene Expression master mix,
according to manufacturers specifications, and measured on a StepOne Real
Time-PCR (Applied Bio). Data was collected and analyzed using StepOne
software v2.2.2. All samples were compared to GAPDH (Ss03374854_g1)
endogenous controls.
Immunocytochemical (ICC) Staining
Cells were fixed with 10% formalin for one hour and washed twice with DPBS.
Cells were then permeabilized with 0.01% (v/v) Tween20 in DPBS (PSBT) for 15
min followed by reactive ion removal using 10% (m/v) sodium azide and 10µM
H2O2 in PBST. Samples were incubated with primary antibodies (αSMA, ab7817)
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diluted 1:75 in a 3% (w/v) BSA solution for 90 minutes. Primary antibodies were
removed and samples washed twice with PBST followed by secondary
antibodies goat anti-mouse AlexaFluor 488 (A11001, Invitrogen) 1:400 in DPBS
incubation for 90 minutes. Cells were counter stained with DAPI in DPBS
(1:1000, Invitrogen) for 5 minutes. Samples were mounted (Fluoromount, F468025ML) on glass slides and sealed with clear nail polish. Samples were imaged on
a Zeiss LSM 510 META microscope with 40x oil 1.3 NA objective.
Statistical Analysis
All results were analyzed using one-way analysis of variance followed by
Tukey-Kramer post hoc analysis with Sidak correction for multiple comparisons
and a 95% confidence interval (p < 0.05). All analyses were done using Prism 6
software (GraphPad).
Results
Surface Characterization of Self-Assembled Monolayers
Self-assembled monolayers expressing four different functional groups (CH3,
OH, COO-, NH3+) were used as model surfaces to assess the effect of substrate
chemistry on VIC phenotype. These four chemistries exhibit different degrees of
wettability and charge. CH3-SAMs are non-polar and relatively hydrophobic,
whereas, OH, COO-, and NH3+ are relatively hydrophilic. At physiological pH
(7.4) partially ionized COOH and NH2 SAMs present negative or positive
charges, respectively (COO- and NH3+).[34, 35] Gold-coated and uncoated glass
were run as negative control substrates. Results from all experiments performed
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showed no statistical difference between the gold (Au) and glass controls.
Therefore, only Au data will be included here. As current methods of osteoblastic
differentiation utilize supplemented media, obVIC-media induced positive control
samples on glass were used. All surface treatments and controls were
characterized prior to VIC studies.
Static water contact angles of SAMs measured by goniometry are
summarized in Figure 1. Measured values are in agreement with those reported
in literature. [33, 37] X-ray photoelectron spectroscopy analysis of surface
chemistry agrees with theoretical percentages (Supplemental Figure I).
Ellipsometric measurements of SAMs indicate monolayer formation, with
confirmation by atomic force microscopy (Supplemental Figure II and Table 1).
[34, 35]
Proliferation and Cellular Density of VICs
Initial differences in the number of attached cells were observed within the
first 12 hours (Supplemental Figure III). CH3-SAMs resulted in significantly lower
attachment (53% of attachment average) as compared to all other treatments
when seeded at 21,500 cells/cm2. Results reflect literature showing decreased
cell adhesion to hydrophobic surfaces. [37-39] In order to provide uniform
seeding density all subsequent experiments were seeded at 43,000 cells/cm2 on
CH3-SAMs and 21,500 cells/cm2 on all other surfaces ensuring no significant
difference in initial cell density between treatments (Figure 2).
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Proliferation of VICs was assessed over seven days, demonstrating variations
in growth rate due to substrate chemistry. A lack of initial proliferation on CH3 and
OH-SAMs resulted in a significantly lower cell concentration at day 3. Over the
same time, VICs on glass induced with OB media demonstrated the greatest
proliferation rate and significantly higher cell concentration. All other treatments
(Au, COO-, and NH3+) resulted in a moderate initial proliferation (Figure 2).
Differences in proliferation rate continued through 5 days (Figure 2). During this
time, COO--SAMs promoted the greatest proliferation rate. After 7 days in
culture, however, all treatments except CH3-SAMs resulted in VIC confluence
inhibiting further proliferation (Figure 3).
Morphological Variation Between Surfaces
Upon attachment (12 hrs), VICs adopted a characteristic elongated
morphology on all treatments with the exception of CH3-SAMs, which exhibited
cellular aggregates and areas of increased cellular density with large cell-free
regions (Figure 3). On CH3, OH, and osteoblastic-induced samples a small
subset of VICs maintained a spherical morphology but remained anchored after
media changes (Figure 3).
By day 3 VICs on all surfaces exhibited an elongated morphology (Figure 3).
However, between days 3 and 5, significant morphological differences amongst
treatments emerged. Individual VICs in OB media adopted a round/rhomboid
morphology and spread to fill the entire growth area. Similar round/rhomboid VIC
morphology was exhibited by NH3+, CH3, and OH-SAMs to varying degrees
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(Figure 3, Supplemental Figure IV-V). VICs on COO--SAMs and Au maintained
elongated morphology through 5 days.
By day 7 VICs on Au, OH, and COO--SAMs adopted highly aligned cellular
confluent cultures, generally exhibited by aVICs, [6, 22] while VICs in OB media
and on NH3+-SAMs tended to adopt a round/rhomboid morphology with nonlinear/spread confluent cultures (Figure 3). As the only surface not to reach
confluence, VICs on CH3-SAMs adopted a round morphology in lower density
regions, and formed clustered aggregates in higher density areas. The tendency
for cellular aggregates on CH3-SAMs to partially detach from the surface led to
the formation of sheeted aggregates semi-suspended in culture media (cell
sheets). Cell sheets were typically bound by a single edge resulting in the cell
sheet folding back upon itself (Supplemental Figure VI).
Development of Calcified Nodules
At confluence (day 7), cells on all treatments except COO--SAMs and
osteoblastic culture exhibited some degree of calcified tissue formation (Figures
3 and 4). On CH3-SAMs early cellular clustering resulted in the formation of large
cellular aggregates (221 ± 123 µm). On Au and OH-SAMs, small spherical
nodules were observed infrequently and the nodules were typically small (30-60
µm), indicative of recent formation. Distinct from all other treatments, VICs grown
on NH3+-SAMs exhibited nodule formation by day 5, which increased in size (115
± 40 µm) and frequency by day 7 (Figure 3 and Table 1). VICs grown in OB
media exhibited no nodule formation through 7 days, consistent with the
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observation that nodules typically appear between 14 and 21 days under
supplemental media conditions (without TGF-β). [6, 8, 40] Small nodules were
observed on OB cultures when cultured out to 14 days (Supplemental Figure
VII).
Nodule formation is typically accompanied by apoptosis and deposition of
Ca2+. In order to determine calcium deposition and apoptosis/necrosis, samples
were stained with alizarin red S and imaged using bright field microscopy, or
evaluated by flow cytometry using annexin V and propidium iodide. After 7 days,
VICs grown on COO--SAMs were the only cells to lack nodule formation or
calcium staining (Figure 4). On Au and OH-SAMs VICs exhibited few small
alizarin red S stained nodules, while VICs on CH3-SAMs exhibited calcium within
cellular aggregates with no distinct boundary. OB media induced VICs exhibit
some cellular alizarin red S staining, but no aggregate nodular structures were
observed. NH3+-SAMs, however, developed tightly bound, spherical calcium
nodules with significant alizarin red S staining (Figure 4, arrows). When
apoptosis was assessed at day 7, VICs exhibited equivalent levels of apoptosis
on all treatments (Figure 5a). Overall cell death, staining positive for annexin V
and propidium iodide, was statistically elevated on CH3-SAMs (Figure 5b).
Genetic Analysis of Phenotypic Markers
In order to determine phenotypic expression of VICs, samples were tested for
common genetic markers. The development of contractile α-SMA cytoskeletal
filaments is an accepted indicator of activation. [22, 41] At 3 and 5 days VICs
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grown on NH3+-SAMs and OB media exhibited a significant up-regulation of αSMA mRNA expression compared to other treatments (Figure 6A). Similar upregulation was observed in VICs stained for α-SMA using immunocytochemical
techniques (Supplemental Figure V). Osteocalcin (OCN), a late-stage marker of
OB differentiation [6, 22] that typically accompanies the onset of nodule formation
was tested at 5 and 7 days of culture. By day 7, VICs grown on NH3+-SAMs
showed significant increase in OCN mRNA expression over all other treatments,
including media induced obVICs (Figure 6B). In order to assess tissue
production, collagen I and elastin mRNA expression were quantified at 3 and 5
days (Figure 7). After 3 days, collagen is up regulated on NH3+-SAMs and media
induced osteoblastic controls. Elevated collagen expression was also observed
on CH3-SAMs, but results were not statistically different from Au controls. By day
5, all SAMs treatments are significantly lower than Au controls. Elastin
expression is elevated on NH3+ surfaces at day 5, accompanying nodule
formation.
Discussion
Many factors influencing VIC phenotype have been studied in the hope of
understanding calcified nodule formation and controlling in vitro culture for
healthy tissue production. [6, 8-11, 17-21] Previous research investigating the
effect of distinct protein adlayers on VIC phenotype has attempted to control the
cellular binding environment through adsorption and presentation of specific
proteins onto tissue culture polystyrene. [6, 8-11, 17-21] However, the non91

homogeneous surface of tissue culture substrates causes random deposition of
proteins with uncontrolled orientations, [8, 42] resulting in conflicting results in
literature. [18, 20]
Alkanetiolate Self-Assembled Monolayers
The uniform SAMs surface chemistry allows for controlled protein deposition
and orientation, producing distinct and reproducible culture surfaces for
understanding cell behavior in different microenvironments. [37, 38, 42, 43] In
previous work, it has been observed that proteins in culture adsorb at a faster
rate than cell attachment, and dictate cell-surface interactions. [38, 44]
Specifically the adsorption of proteins to hydrophobic/hydrophilic and charged
surfaces has shown that specific extracellular matrix proteins bind in a surface
dependent manner, with variability in their tertiary structure, resulting in variation
in available cellular attachment domains. [37-39, 43, 45]
Media-Induced Osteoblastic VICs
As a positive control VICs were grown in OB media on glass. Observed
increases in proliferation rate and cell spreading resulting in confluent cell sheets
is similar to results reported in literature. [6] While calcification never occurred in
OB media cultures within the seven days examined in this study, cultures were
taken out to 14 days to confirm nodule formation in our controls. Previous
research indicates nodule formation occurs between 14-21 days in low-density
(<25,000 cells/cm2) cultures following the development of αSMA stress fibers,
cellular detachment, and contraction. [6, 9, 40] For this reason αSMA is
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considered necessary for osteoblastic differentiation, suggesting that qVICs must
go through activation to result in obVICs and tissue calcification. [9, 23] However,
our results on CH3-SAMs suggest a direct transition through well-defined stress
fiber formation (quiescent à activated à osteoblastic) is not always necessary
for the development of calcified tissues, similar to previous observations of
dystrophic calcification caused by increased cell death. [10]
Non-activated VIC Calcium Deposition on CH3-SAMs
As hydrophobic CH3-SAMs have been shown to irreversibly adsorb and
denature proteins resulting in loss of cellular binding domains, CH3-SAMs provide
a look into changes in VIC phenotype that result from low cell adhesion. [38, 39,
44] The slow proliferation, cellular aggregation, and formation of loosely adhered
cell sheets suggest minimal interaction between the VICs and CH3-SAMs. As
such, the early aggregate behavior of VICs is likely the result of cell-cell adhesion
to compensate for a lack of cell-surface adhesions.
Previous experiments have shown the release of mechanical tension on VICs
also leads to increased apoptosis and in vitro calcification. [6, 7, 46, 47]
Increased αSMA expression typically accompanies nodule formation, thus,
calcification on hydrophobic surfaces without elevated αSMA expression
suggests that VIC detachment may result in calcification without the need for
αSMA-mediated contraction. [9, 23] Higher Ca2+ deposition under hydrophobic
conditions are therefore likely related to the high cell necrosis levels observed
through classical dystrophic mechanisms of cell death resulting in release of
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intracellular calcium and aggregation under this condition. Previous results by
Jain B. et al. have shown that tissue calcification in vitro does not require cellular
contraction and spherical nodule formation to induce apoptosis and calcium
deposition. [6, 10] As such, inhibition of cell adhesion and possibly altered
integrin and cell-cell signaling may explain the triggering event for increased cell
death and Ca2+ deposition under these experimental conditions. [6, 48] Further
studies are needed to determine if this observed behavior is exemplary of in vivo
disease development.
Osteoblastic VIC Differentiation on NH3+-SAMs
With increased proliferation, elongated morphology, and increased αSMA
expression over other functionalized SAMs, VICs grown on NH3+ surfaces exhibit
early myofibroblastic behavior. With the onset of a round/rhomboid morphology,
robust nodule formation, and OCN expression NH3+-SAMs undergo a clear
transition from an aVIC to obVIC phenotype between days 3 and 5. The
expression of OCN, a late stage osteoblastic marker, and the early appearance
of calcified nodules suggests an accelerated transition between activated and
osteoblastic phenotypes on cationic surfaces. Such behavior correlates with the
observed osteoblastic differentiation of pre-osteoblastic cells on NH3+ surfaces.
[39] Compared to the soluble factors used in OB media induction, the rapid
obVICs differentiation on NH3+-SAMs is controlled by cell-surface interactions, as
no media additives are present. As no calcium deposition and gene expression in
osteoblastic culture were observed during this same period, the accelerated
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obVIC behavior is likely the result of a novel signaling pathway in VICs induced
by cell-material interactions specific to protein adsorption on NH3+ surfaces.
NH3+-SAMs have been shown to preferentially adsorb greater amounts
collagen and fibronectin than other hydrophilic groups (COO- and OH). [43]
However, currently literature on the influence of collagen and fibronectin on VIC
nodule formation is conflicting. [10, 18-20] Such behavior may be the result of
different treatments of extracellular matrix proteins in these studies. Interestingly,
NH3+-surfaces also resulted in a significant up-regulation of elastin expression
over all other surfaces, which seems to correspond with development of nodules
in culture at day 5. As fibronectin is required for microfibril formation onto which
elastin is deposited, the early availability of fibronectin on NH3+-SAMs may be at
least partially responsible for increased rate of nodule formation by VICs. [49, 50]
Delayed Growth on OH-SAMs
Previous research has demonstrated decreased protein adhesion on OHSAMs, and thus, lower levels of binding domains available for cell attachment
and proliferation. [36, 37, 45, 51] In this study VICs have shown limited
attachment and proliferation over the first 3 days, but do not undergo significant
apoptosis (Figure 5). No significant increase in collagen or elastin mRNA
expression was observed up to 3 days in culture. However, collagen expression
increased through 5 days. The increased cell spreading and proliferation of VICs
on OH-SAMs suggests secretion of ECM proteins by VICs on these surfaces is
sufficient to maintain viability and recover cellular functions. Lack of OCN
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expression and adoption of an elongated morphology forming highly aligned
cultures suggests OH-SAMs serve to maintain the aVIC phenotype. However, as
VICs on OH-SAMs eventually lead to nodule formation at high cell densities, OH
substrates may not be ideal for VIC expansion in vitro.
Non-Osteoblastic Activation of VICs on COO--SAMs
The activation of VICs on COO--SAMs characterized by rapid proliferation
and maintenance of an elongated, myofibroblastic morphology at confluence
indicates COO--SAMs are a favorable substrate for cell amplification. While
confluent VIC cultures tend to undergo rapid conversion to obVICs, [8, 10, 40]
COO--SAMs do not exhibit such behavior, suggesting the negative charged
environment plays a role in preventing osteoblastic differentiation of VICs. [18,
39, 43] Proliferation without confluent nodule formation supports the hypothesis
for activation of VICs on negatively charged substrates similar to hyaluronic-acid
rich valvulogenesis. [31] However, the lack of increased αSMA expression and
protein (collagen or elastin), suggests secondary signaling may be required for
healthy tissue production.
Cell-Material Phenotypic Signaling
It has been suggested that VICs in osteoblastic media do not become true
osteoblasts due to a lack of osteoblastic expressed gene markers. This has led
to the support of dystrophic calcification mechanisms in VICs. [52] In this study
osteocalcin expression and an osteoblastic morphology, suggest VIC phenotype
on NH3+ SAMs may be more related to an osteogenic differentiation rather than
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dystrophic mechanisms. This is likely due to changes in integrin expression and
focal adhesion formation resulting in up-regulation of an osteoblastic phenotype.
Previous research has shown NH3+-SAMs expose more α5β1integrin binding
domains, causing differentiation of pre-osteoblastic cell (MC3T3-E1) to
osteoblasts. [39] Similar results using VICs and primary osteoblasts also indicate
the necessity of α5β1 integrin binding in calcified nodule formation and
osteoblastic gene expression. [18, 53]
Conversely, it has been observed that COO- surfaces allow for greater
binding availability of αvβ3, and reduced mineralization by MC3T3s, which was
reversed when β3 binding was inhibited. [39] Furthermore, increased αvβ3
integrin expression in MC3T3s show increased proliferation but a downregulation of osteocalcin and other osteoblastic markers similar to VICs on COO-SAMs. [54] Although some correlations to integrins in research have been
presented here, a more complete explanation of integrin expression and
phenotype needs to be conducted to better understand the importance and
influence of specific cell-material interactions on VIC phenotype. Once these are
better understood a correlation between in vitro and in vivo conditions can be
sought.
Experimental Limitations
It is well understood that self-assembled monolayers allow for the control of
surface chemistry for investigating the effects on cell behavior. However, the use
of gold-bound alkanethiolate SAMs on glass do present some experimental
97

difficulties for comparison with in vivo tissue development, primarily though the
use of stiff substrates [55] and two-dimensional environments. It has previously
been observed that VIC growth on stiffer matrixes results in greater differentiation
towards myofibroblastic and calcifying phenotypes. [6] However, this is also a
limitation to standard methods of in vitro expansion of VICs on TCPS.
It is also well understood that variations in fetal bovine serum (FBS) can result
in altered cell-behavior. [56] As batch-to-batch variations in FBS result in
differences in protein constituents, the results of this work were collected utilizing
a single lot of FBS to control growth environment. To accommodate for such
changes, surfaces can be pre-incubated with specific proteins for creation of a
more-homogeneous environment. However, even surfaces treated for single
protein interactions can become attenuated upon addition of FBS as higher
affinity proteins dissociate the adhered proteins before cell attachment. [38, 43,
57] As such when attempting to control cell-surface interactions it becomes
important to characterize protein adlayers or utilize well-defined surfaces such as
SAMs, which help to guide protein adsorption. [43, 58]
Furthermore, species-specific differences do exist between VICs in culture.
These differences do lead to greater susceptibility of porcine VICs to develop
calcified nodules in vitro. However, due to limited availability of human VICs and
the tissue specific similarities between human and porcine heart tissue, porcine
VICs remain the predominant cell type in literature used to investigate the
development of valve stenosis. [59, 60]
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Conclusions
Although VIC activation and proliferation can result in calcified nodule
formation in confluent cultures, tissue mineralization is likely the result of several
distinct mechanisms in vitro. Through variations in surface chemistry we have
identified an osteoblastic-inhibiting environment (COO-), and surfaces which
possess characteristics of dystrophic calcification (CH3) and osteogenic
differentiation/calcification (NH3+). The rapid nodule formation by VICs on NH3+SAMs may provide an accelerated in vitro model of heart valve disease, although
additional studies remain to verify that our results resemble material mediated
VIC differentiation in aortic valve disease in vivo. While cell-signaling cascades
will be the subject of future investigations, these results establish surfacedependent effects on VIC phenotypic behavior. Using SAMs to study VIC
behavior should also prove to be clinically relevant in guiding the selection of
biomaterials for heart valve implants and tissue engineering scaffolds. Overall
these results establish the importance of surface chemistry on VIC phenotypic
behavior and establish SAMs as model surfaces for studying in vitro VIC
differentiation.
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Figures

Figure 1. A) Schematic of alkanethiol self-assembled monolayer (SAM) on gold (Au, 30nm)
coated glass with chromium (Cr, 2nm) adhesion layer. B) Air-water-surface contact angles
determined using the sessile drop goniometry (ultrapure H2O in air).
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Figure 2. Valvular interstitial cell (VIC) proliferation on monolayer surfaces as compared to bare
glass/osteoblastic (OB) and gold controls (dashed lines). Initial inhibition of VIC growth (1-3
days) is exhibited by OH and CH3-SAMs with significant lower cell concentration, while
osteoblastic (OB) controls are significantly greater than other treatments. Between 3 and 5 days,
VICs on OH-SAMs begin proliferation while CH3-SAMs result in significantly lower cell
concentration throughout the experiment. By day 5, COO--SAMs have significantly higher cell
concentrations than any other treatment. Between five and seven days in culture all samples,
except CH3-SAMs, reach confluence. *p < 0.05, n = 6.
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Figure 3. Bright field (phase contrast) representative images of cell morphology on varying
surfaces chemistry compared to gold (Au) and osteoblastic controls over seven days of growth.
Day 5 and 7, insets show morphology and relative size of nodules formed in culture, COO-
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surfaces did not show any nodule formation over the course of this study. Further images can be
found in online data supplement. Scale = 50 µm, inset images same scale.

Figure 4. Representative images of alizarin red S calcium staining after seven days of growth.
Arrows indicate distinct calcium-stained nodules. Scale = 50µm
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Figure 5. Measurement of valvular interstitial cell A) apoptosis and B) overall cell death after
seven days. CH3-SAMs result in significant increase of dead cells over all other treatments. Cell
death assessed through measurement of annexin V activity (apoptosis) and propidium iodide
infiltration (dead). *p < 0.05, n = 6.
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Figure 6. A) α-smooth muscle actin (αSMA) and B) osteocalcin (OCN) gene expression (mRNA) by
valvular interstitial cells (VICs) at later stages of growth on functionalized surfaces. Initial
expression of αSMA visualized through immunocytochemical staining (data not shown) is
reduced by day 5 on most surfaces except NH3+-SAMs and osteoblastic controls, which have a
significantly higher in αSMA expression. NH3+-SAMs also express significant increases in OCN
expression (a late stage osteoblastic marker observed in between days 14 & 21 in osteoblast-like
VICs) as early as day 7. *p < 0.05, n = 6.
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Figure 7. A) Collagen-I and B) Elastin genetic expression (mRNA) by valvular interstitial cells
(VICs) at three and five days of growth on functionalized surfaces. After 3 days, collagen is up
regulated on NH3+-SAMs and media induced osteoblastic controls. Elevated collagen expression
was also observed on CH3-SAMs, but results were not statistically different from Au controls.
Collagen expression is significantly greater in all treatments between days 3 and 5. By day 5, all
SAMs treatments are significantly lower than Au controls. * Indicates a statistically significant
difference (p < 0.05) between treatments and Au controls and † indicates significant differences
among SAMs treatments, n = 4.
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Tables
Table 1. Calcified tissue/nodule diameter after 7 days.

Average Nodule Diameter
Treatment

(μm)

Au

60.5 ± 27.0

CH3 †

221 ± 123*

OH

29.8 ± 10.9

COO-

-

NH3+ ‡

115 ± 39.8*

OB

-

(-) No nodules observed during culture
†

Highly irregular cellular aggregates, no distinct boundary

‡

Tightly bound, spherical calcium nodules
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Supplemental Figures

Figure I. A) XPS detail spectra and B) chemical composition for ω-functionalized alkanethiol selfassembled monolayers. The lack of oxygen on CH3-SAMs, increased C-OH peak at 287.0 eV on
OH-SAMs, further increases in O (COOH at 289.4 eV) on COOH-SAMs, and presence of nitrogen
(C-N at 285.4 eV) on NH2-SAMs all agree with monolayer formation, as well as theoretical
values.
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Figure II. Surface topography obtained through atomic force microscopy (AFM) of functionalized
SAMs compared to Au controls. Images show monolayer formation with minimal variation in
height. 20 µm Scan size.
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Figure III. Valvular interstitial cell (VIC) density upon attachment (12 hrs) on varying surface
functionalities, as compared to bare glass/osteoblastic (OB) and gold controls. A) Statistically
significant lower VIC attachment observed on CH3 SAMs when seeded (t=12 hr) at 21,500
cells/cm2 as compared to other functional groups and controls. B) Uniform seeding density
achieved when seeded with 43,000 cells/cm2 on CH3-SAMs and 21,500 cells/cm2 on all other
surfaces.
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Figure IV. Representative images of VIC morphology on SAMs and control surfaces after 5 days
in culture. Variations in individual morphology amongst VICs on SAMs are represented within
populations. Scale = 50 µm
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Figure V. Representative images of immunofluorescent stained α-smooth muscle actin
cytoskeletal protein (green) with Dapi stained nuclei (blue) in VICs after five (top) and seven
(bottom) days. Scale = 50 µm.
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Figure VI. Representative images of cellular aggregation and detachment (cell sheet formation)
on CH3-SAMs after 7 days in culture. Images show several stages of aggregates formed,
beginning with detachment of VICs on edges of sheet (A-C), during media changes, and eventual
folding/condensing of cell sheet onto remaining cells in culture (D-F). Scale = 50 µm
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OB – Day 14

Figure VII. Representative images of cellular aggregation/nodules in osteoblastic culture after 14
days of growth. Scale = 50 µm
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Supplemental Tables
Table 1. Air-water-surface Contact Angle Measurements and Thickness of CH3, OH, COO-, and
NH3+-SAMs
COO-

NH3+

CH3

OH

Contact Angle (˚)

105.9 ± 0.9

14.9 ± 1.5

31.8 ± 2.9

46.6 ± 4.9

Thickness (nm)

1.66 ± 0.02

1.43 ± 0.05

2.21 ± 0.05

1.61 ± 0.36
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Abstract
Valvular interstitial cells (VICs) are a heterogeneous population of
myofibroblastic cells isolated from the aortic heart valve. Previously, separating
VICs into different subpopulations has been difficult in vitro due to a lack of
unique markers. We have developed a simple adhesion-based detachment
technique that isolates more adherent and less adherent subpopulations of VICs
based on their ability attach to tissue culture polystyrene. Characterization of
these subpopulations shows that the more adherent VIC subpopulation exhibits
an osteoblastic-like (OB) phenotype expressing increased alpha smooth muscle
actin (αSMA), osteocalcin (OCN), and transforming growth factor beta 1 (TGFβ1). Additionally, the more adherent subpopulation proliferates slower and has a
rhomboidal morphology similar to that of osteoblastic medium induced VICs. In
comparison less adherent VICs proliferate significantly faster, have a spindle
shaped morphology, and express no OB markers. Three different integrins were
investigated as possible surface markers of VIC differentiation; alpha-V beta-3
(αVβ3), alpha-V beta-5 (αVβ5), and alpha-2 beta-1 (α2β1). With the highest
expression in more adherent VICs, αVβ3 correlates with increased osteoblastic
phenotype and may be applicable in sorting VIC subpopulations directly from the
dissected aortic valve. This work highlights the heterogeneity of recently excised
VICs and identifies relevant subpopulations in the valve for the to study valve
health and disease.
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Introduction
Aortic valve disease (AVD) results in stenosis and calcification of the valve,
increasing the strain on the heart due to obstructed blood flow , and mortality
without replacement (1, 2). Valvular interstitial cells (VICs), the primary
population of the heart valve, are responsible for altered extra-cellular matrix
(ECM) and the formation of calcific nodules that result in thickening and loss of
flexibility of the valve leaflets and, ultimately, AVD (3). VICs are dispersed
throughout the major three layers of the aortic valve; fibrosa, spongiosa, and
ventricularis. However, the first site of calcification is in the fibrosa (4). This
suggests that conditions in the fibrosa allow VICs to undergo osteoblastic
differentiation and create nodules. Despite this observation, isolating
subpopulations of VICs is an essential but largely overlooked process in the in
vitro study of AVD.
In general, VICs are removed and treated as a homogenous group
characterized as having a highly plastic phenotype with the ability to differentiate
into activated/myofribroblastic, osteoblastic-like, progenitor, and quiescent
phenotypes (5-9). Within diseased valves, the two most commonly observed
phenotypes are activated/myofibroblastic (aVICs) and osteoblastic (OB VICs)
(Table 1). aVICs are characterized by their rapid proliferation and secretion of
ECM while OB VICs form calcific nodules with the expression of bone-specific
genes, including, osteopontin, and alkaline phosphatase. It is, however, unclear if
multiple phenotypes in vitro are reflective of in vivo VIC population phenotypes,
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or if culture conditions allow a subpopulation of VICs to dominate culture. To
answer this question, we have used attachment ability to differentiate between
specific subpopulations of VICs.
In prior studies, distinct VIC morphologic and phenotypic subpopulations have
been demonstrated conversion to osteoblastic (OB) phentoypes (10-12). For
example, a mesenchymal progenitor cell population isolated from VICs resulted
in differentiation into osteogenic, adipogenic, chondrogenic, or myofibrogenic
lineages using media induction (10). Other, progenitor cell subpopulations, were
isolated using the cell surface marker ABCG2+ and fluorescent activated cell
sorting. This small (~5%) ABCG2+ VIC subpopulation showed increased
secretion of calcified extracellular matrix over ABCG2- populations when cultured
in osteoblastic induction medium (11). Taken together these results suggest the
existence of VIC subpopulations which are predisposed toward distinct
phenotypes depending on the chemical environment in which they are exposed.
Currently, osteogenic medium induction is the most commonly used method
to direct the osteoblastic-like (OB) VIC phenotype (10, 11, 13-15). However, this
technique does not recapitulate disease development conditions in vivo (16, 17).
Chronic buildup of extracellular matrix (ECM) causes valve stiffening due to a
small population of OB VICs (16, 18). It seems more likely, therefore, that a small
OB-prone subpopulation of VICs exists natively within the valve and cause
disease later in life. In order to confirm his a method to isolate, separate, or
identify an OB prone VIC subpopulation within the valve is required. To address
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this need we have demonstrated a straightforward method for directly isolating
VIC subpopulations for the study of VIC disease progression and healthy
subpopulation for heart valve tissue engineering.
A subset of VICs that take longer to detach from TCPS during passaging has
been previously observed (12). This early work concluded that increased
adhesion strength correlates with expression of αSMA and served as a maker for
a myofibroblastic phenotype. Recently, however, αSMA has been associated
with both aVIC and OB VIC phenotypes (9, 19-21).
Based upon previous work showing increased αSMA expression along with
distinct morphological changes in osteoblastic culture, we hypothesize that more
adherent VICs give rise toan osteoblastic phenotype. As such, additional
osteoblastic markers were evaluated, specifically, osteocalcin (OCN) which has
been observed in OB VICs (19, 21), and transforming growth factor beta 1 (TGFβ1) which is upregulated in AVD (16, 19, 22, 23).
To reliably separate these subpopulations directly from the valve, phenotypespecific cell surface markers based on previous observations correlating integrin
expression levels to changes in the phenotype of other cells were examined (3,
24-26). α2β1, a collagen 1 binding integrin, was investigated to assess collagen 1
expression known to fragment during aortic valve disease (16, 27). We also
measured integrins αVβ3 and αVβ5 known to increase during osteoblastic
induction, but rare in native VICs (16, 25, 26, 28-30). By characterizing
populations of VICs within the valve, and their innate disease potential we may
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be able to model the progression of native VICs to an osteoblastic phenotype
that contributes to AVD.
Material and Methods
Cell Culture
VICs were extracted from porcine aortic heart valves as previously described
(31). Briefly, freshly excised pig hearts were shipped overnight, on ice (Hormel).
Aortic valve leaflets were dissected and treated with collagenase II (15 min at
37°C, 2,500 units/mL, Worthington) and scraped to remove valvar endothelial
cells (VECs). Leaflets were then incubated in fresh collagenase (1 hour at 37˚C)
to release the valvular interstitial cells. Remaining tissue was removed through
filtration (70 µm, Corning) and the cell suspension spun down (2000 rpm, 5 min).
The cell pellet was re-suspended in growth media [199 EBSS Hyclone media
supplemented with 10% fetal bovine serum (FBS) (Hyclone), 1%
penicillin/streptavidin (Hyclone), and 1% fungizone (Hyclone)]. The cell
suspension was treated with CD31+ Dynabeads (30 minutes at 4˚C,
ThermoFisher Scientific) to remove residual VECs. VICs were plated onto TCPS
and cultured under normal conditions at 37˚C with 5% CO2 in growth media.
These cells were considered to be passage 0. At ~80% confluence, cells were
sorted using differential attachment protocol.
Differential Detachment Protocol and Kinetic Study
P0 VICs were grown to 80% confluence, washed in Dulbecco’s phosphate
buffer saline (DPBS) without calcium or magnesium, and treated with 2 mL of
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dilute trypsin EDTA (0.025% DPBS, Gibco). After two minutes of incubation at
37˚C, the solution and lifted cells were collected. New dilute trypsin solution was
added to the flask and incubated for an additional two minutes at 37 °C and
solution and released cells were collected. Additional dilute trypsin treatment
steps were repeated until all cells were detached from the flask as determined by
optical microscopy. The cell number of cells in each fraction was counted using a
Z2 Beckman Coulter Counter to determine the total number of cells. The first
25% of cells to detach (less adherent), and the last 25% of cells to detach (more
adherent) were kept. Less adherent and more adherent VICs were reseeded,
separately, in growth medium becoming passage 1 cells (P1). During subsequent
passages, the dilute trypsin method was repeated, while re-seeding only the 1st
25% of VICs to detach from the less adherent cell population and the last 25% of
VICs to detach from the more adherent population. During the third passage, the
number of cells removed with each fraction was plotted to determine population
detachment time. Subsequent passages were done using a normal trypsin
concentration (0.25%). A small proportion of the P0 VICs did not undergo the
differential attachment protocol and were passaged using normal trypsin
concentration to generate the heterogeneous and OB VIC cell populations.
Osteoblastic induced cells were cultured using 199 EBSS Hyclone media
supplemented with 10% FBS, 10-8 M dexamethasone (Sigma-Aldrich), 10 mM ßglycerolphosphate (Sigma-Aldrich), and 2mM ascorbic acid (Sigma-Aldrich)
exchanged 12 hours after seeding.
130

Growth Curve
In order to determine doubling times of VICs subpopulations were determined
all cell types were seeded at 25,000 cells/cm2 in a 6-well TCPS plates with
growth media. OB VIC induction media was added to OB VICs 12 hours after
seeding. Media was changed every 2 days. At each time point 3-5 wells of
growing VICs were trypsinized and counted on a Z2 Beckman Coulter Counter.
Doubling times was calculated as the slope of the exponential growth region of
each curve.
Gene Expression
Heterogeneous, more adherent, and less adherent VIC genetic expression
was examined after three days of culture on P4 cells. VIC mRNA was extracted
using RNeasy Plus Micro Kit (Qiagen) according to manufacturers instructions,
and RNA concentration determined using a NanoDrop 2000C. mRNA was
converted to cDNA using two-step RT PCR GoScript Reverse Transcription Kit
(Promega). Genetic expression of alpha smooth muscle actin (αSMA)
(Ss04245588_m1), osteocalcin (OCN) (Ss03373655_s1), transforming growth
factor beta 1 (TGF-β1) (Ss03382325_u1), Collagen 1 (Ss03375690_u1), elastin
(AJLJIR9), and the endogenous control glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (Ss03374854_g1) was analyzed using Taqman probes
and Taqman gene expression master mix, according to manufacturer’s
instructions and quantified using a Step-One RT PCR System (Applied
Biosystems).
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Integrin Expression
Heterogeneous, more adherent, and less adherent VICs were grown for 3
days and treated with 5mM EDTA in DPBS to facilitate detachment followed by
gentle scraping. Collected cells were pelleted and re-suspended at ~500,000
cell/ml in ice cold phosphate-buffered saline (PBS), 1% BSA, and 0.02% sodium
azide. Cells were then labeled with 3 µL/ml of the following antibodies (ab): αVβ5Alexa 647 MS (Novus, FAB2528R), αVβ3-FITC mouse (Sigma-Aldrich,
MAB1976F), α2β1 mouse (Sigma-Aldrich, MAB1998Z), mouse IgG1 κ -FITC
(Biolegend, 400110), mouse IgG1, κ- Alexa 647 (Biolegend, 400130), and mouse
IgG1 κ (Biolegend, 401402) for 30 min at 4°C. The secondary ab Alexa 488 goat
anti-mouse (Life Technologies A11017) 1.5 µL/mL was added to samples stained
with primary α2β1 Ms, mouse (BALB/c) IgG1, or IgG1 κ primary ab’s and
incubated for another 20 min on ice. All samples were kept on ice until read on
the Attune NXT Flow cytometer. Antibody specific immunoglobulin controls have
been subtracted from the reported integrin expression values.
Statistics
All results were analyzed using one-way ANOVA and two-tailed t-tests to
determine significance at a 95% confidence interval (p < 0.05). All analyses were
done using GraphPad Prism 7 software.
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Results
VIC Subpopulation Isolation and Growth
Two subpopulations of VICs (more adherent and less adherent) were isolated
through differential adhesion to TCPS (Fig 1). Once separated (>P3), less
adherent VICs exhibited a faster time of detachment than more adherent VICs,
with 90% of each subpopulation detaching within 8 and 14 minutes, respectively
(Fig 2). Distinct morphologies were also observed in culture with less adherent
VICs having an elongated morphology compared to more adherent VICs which
had an irregular cuboidal morphology (Fig 3). Heterogeneous VICs displayed a
combination of both morphologies. Growth curves highlighted the doubling time
of less adherent VICs (30.7 ± 2.5 hr, mean ± SD) as well as OB media-induced
VICs (20.3 ± 5.4 hr) to be significantly faster than those of more the adherent
(21.4 ± 4.0 hr) and heterogeneous VIC populations (25.2 ± 3.4 hr) (Fig 4,p ≤ 0.05
n=3).
VIC Phenotype
To test for differences in VIC phenotype between subpopulations, mRNA
expression of cytoskeletal αSMA, signaling factors OCN and TGF-β1, and
extracellular matrix proteins collagen 1, and elastin were measured after three
days of culture. The expression of αSMA and OCN was the highest among more
adherent VICs, compared to all other groups (Fig 5). TGF-β1 expression was
greater in more adherent VICs when compared to less adherent VICs, but not
heterogeneous. And collagen expression was similar between all cell
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subpopulations, while elastin expression was significantly higher in more
adherent cells when compared to heterogeneous but not less adherent VICs (Fig
5).
Subpopulation Surface Markers
To identify surface markers for the different subpopulations of VICs, integrin
expression was determined through use of integrin specific antibodies (α2β1,
αVβ3, and αVβ5) and flow cytometry detection (Fig 6). Values are expressed as
the median fluorescence intensity above non-specific immunoglobulin controls.
The collagen specific integrin α2β1 was significantly lower in less adherent VICs
compared to other subpopulations. The RGD specific integrin αVβ3 was
significantly higher in more adherent VICs compared to heterogeneous VICs and
was undetectable in the less adherent subpopulation. And αVβ5 (RGD) was
significantly higher in heterogeneous VICs but was not statistically different
between more adherent and less adherent VICs subpopulations.
Discussion
VICs are a heterogeneous population of cells arising from the fibrosa,
spongiosa, and ventricularis layers of the aortic valve. Given the differences in
function, each layer has a distinct ECM environment and mechanical properties
(32). However, previous research has shown that differences in surface
chemistry and mechanical properties can alter VIC phenotype (19, 21).
Therefore, primary extracted VICs were hypothesized to express differences in
phenotype and disease potential. In previous studies, VICs induced to an OB
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phenotype, using exogenous signaling factors, exhibit a rhomboidal morphology
with increased cytoskeletal actin and a marked increase in proliferation (20, 21,
23). Furthermore, in vitro, VICs exhibit variations in morphology caused by
differences in adhesion and cytoskeletal structure (12). Knowing that cell
spreading and cytoskeletal filaments require greater focal adhesion, we
hypothesized that a more adherent VIC population would express increased OB
genetic markers and greater proliferation rate than less adherent VICs (19, 23).
However, separating VICs to study the behaviors of subpopulations has been
difficult due to a lack of unique markers to distinguish between subpopulations.
Using a differential detachment method, two distinct subpopulations of VICs with
differing levels of adhesion to TCPS were isolated. Less adherent and more
adherent VIC subpopulations were tested for differences in morphology,
proliferation rate, gene expression, and integrin expression.
After three consecutive passages using dilute trypsin treatments, separate
subpopulations of VICs were successfully obtained which had a marked
difference in adhesion (Fig 2), morphology (Fig 3), and proliferation rate (Fig 4).
This behavior is explained by differences in focal adhesion formation and cell
spreading, resulting in a more robust cytoskeleton and greater contact with the
surface.
The cytoskeletal protein αSMA has historically been the primary marker used
to identify activated/myofibroblastic VICs. (26) However, more recently αSMA
has been shown to be upregulated in osteoblastic VICs both in vitro and in vivo
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with a marked difference in stress-fiber formation (16, 19, 21, 23). In this study
αSMA expression was significantly higher in more adherent VICs and is
associated with a cuboidal VIC morphology (12). The late stage marker for
osteoblastic differentiation, osteocalcin, was similarly upregulated in more
adherent VICs which corresponds with increased expression among previous
studies (19, 21). Furthermore, TGF-β1 expression, upregulated in stenotic valves
and commonly added to VIC osteoblastic induction media, was upregulated in
the more adherent subpopulation (16, 33, 34). As such, the isolation of a more
adherent VIC subpopulation has been achieved through differential adhesion and
exhibits significantly greater osteoblastic signaling factors and morphology. This
suggests that the faster proliferating, less adherent VICs may be necessary for
VIC proliferation and heart valve repair, however, the long term behaviors of the
slow growing, more adherent VICs eventually lead to valve fibrosis and
calcification.
Surprisingly, a difference in ECM protein expression was also observed
between less and more adherent VICs. Collagen and elastin are the most
common ECM proteins present within heart valves (8, 27, 35-37). With aging and
disease collagen content can become elevated. Furthermore, ex vivo studies
indicate VICs undergo OB differentiation when valvular collagen begins to
degrade (16, 27, 38). Although no significant differences in collagen I expression
were detected between subpopulations (Fig 5), the less adherent VIC
subpopulation expressed less α2β1 (Fig 6), the primary integrin binding partner
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for collagen I. Because collagen I expression increases and existing fibers
fragment during AVD, binding and activation of α2β1 may be related to AV
disease progression (16, 27). As less adherent VICs seem to maintain healthy
growth behavior in vitro, increased α2β1 expression could be a marker of an
osteoblastic VIC subpopulation when used to isolate primary cells.
Elastin has a more intricate role in the control of heart valve health.
Elastin/fibrillin microfibrils normally sequester TGFβ as it is released with the
latency associate peptide (LAP)inhibiting biological activity without significant cell
binding and contraction (39, 40). Increased elastin expression has previously
been correlated with VIC OB differentiation caused by changes in stiffness and
surface chemistry, independent of OB differentiation media (19, 21). In this study,
the highest levels of elastin were similarly observed in the more adherent VIC
subpopulation, with an OB-like phenotype (Fig 5). We hypothesize that early
elastin expression and the development of a contractile cytoskeletal in vitro leads
to increased TGF-β1 signaling. As a result, increased TGF-β1 expression is
upregulated in more adherent VICs, corresponding with greater αSMA
contraction and osteoblastic differentiation.
Previously, αVβ3 expression in VIC literature has been considered an
activated phenotype that express αSMA and increased spreading in hydrogels
(26). As an RGD binding unit, αVβ3 is commonly associated with fibronectin,
shown to increase during AVD (16, 28). With the highest αVβ3 expression in more
adherent VICs with significant osteoblastic behavior, αVβ3 should be more closely
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related with an osteoblastic VIC phenotype (3, 26). αVβ3 has also been shown to
bind to osteopontin (OPN) which is similarly upregulated during AVD. In
conclusion, αVβ3 may be an integrin surface marker that identifies the
osteoblastic prone VIC subpopulation within the AV.
It is important to note that primary cultures of heterogeneous VICs did not
always fall directly between more adherent and less adherent VICs in growth
behavior and genetic expression. Such behavior is likely due to the influence that
different VIC subpopulations have on each other. With similar expression of
αSMA and osteocalcin to less adherent VICs, greater collagen and α2β1
expression, and lower elastin and αVβ5 expression than either VIC
subpopulations, heterogeneous VICs show a distinctive phenotype of their own.
This behavior may be caused by the dominating proliferation of the less adherent
population which interact with more adherent VICs to deposit higher amounts of
collagen during AVD. Alternatively, there is a possibility further subpopulations of
VICs remain to be identified.
In summary, this work highlights the heterogeneity of recently excised VICs
and identifies relevant subpopulations in the valve for the study of valve health
and disease. The more adherent VIC subpopulation isolated exhibited increased
expression of αSMA, OCN, and TGF-β1 suggesting that strongly adhered VICs
are an osteoblastic VIC phenotype. It is important to note that such behaviors
were achieved through simple differential detachment methods, without using OB
induction media. Furthermore, doubling times show that the more adherent
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subpopulation of VICs proliferate at a slower rate than less adherent cells,
contradicting the current hypothesis that OB VICs proliferate more quickly than
activated VICs (23). Integrins αVβ3 and α2β1 were also found to be upregulated in
the more adherent subpopulation and therefore may be surface markers to
separate VIC subpopulations using fluorescence activated cell sorting. Overall,
these results demonstrate a simple method to isolate a proliferative healthy
subpopulation from an osteoblastic subpopulation within heterogeneous VIC
culture.
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Figures and Tables
Table 1. VIC Phenotype Marker Summary
Marker
VIC Phenotype
Alpha smooth
Activated
muscle actin*
Osteoblastic?

First Found
Extracted from
Valves1,2,3
In vitro systems4,5

Citations
1
Mulholland GL 1996
2
Rabkin E. 2001
3
Lui 2007
4
Rush MN 2015
5
Coombs KE 2016

6
Human calcified
Srivatsa SS 1997
6
7
valves and vascular
Giachelli CM 2003
smooth muscle cells7
8
Osteopontin
Osteoblastic
Human and canine
Mohler 1999
6,8
calcified valves and 9Giachelli CM 2003
vascular smooth
muscle cells9
10
Alkaline
Osteoblastic
Human calcified
Rajamannan N.M.
10
Phosphatase
aortic valves and in
2003
11
vitro culture11
Monzack M.S. 2011
12
TGF-β1
Osteoblastic
Human calcified
Jian B. 2003
13
aortic valve
Walker G.A. 2004
cusps5,12,13
*Originally a marker for activated/myofibroblastic VICs it has now be detected in high levels
in osteoblastic VICs. List is not exhaustive.

Osteocalcin

Osteoblastic
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Figure 1. Schematic of dilute (0.025%) trypsin cell detachment procedure.
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Figure 2. Detachment profile of more adherent and less adherent VIC subpopulations isolated
during the third passage (P3) using sequential exposure to dilute (0.025%) trypsin. 90% of less
adherent VICs are removed from the flask after 8 min (4 dilute trypsin treatments) while for
more adherent VICs it take 14 minutes (7 trypsin treatments).
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Figure 3. Optical microscopy after 3 days of growth shows the representative morphologies of
different VIC subpopulations, with a rhomboidal morphology of more adherent VICs in
comparison to less adherent VICs which have an elongated spindle like morphology.
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Figure 4. Doubling times in hours of heterogeneous, osteoblastic media induced, less adherent
and more adherent VICs. OB and less adherent VICs grew significantly faster than more
adherent VICs (p≤ 0.05*).
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Figure 5. Genetic expression of αSMA, OCN, TGF-β1, collagen 1, and elastin normalized to the
heterogeneous control population. A) More adherent VICs have significantly higher αSMA than
all other subpopulations. B) OCN is upregulated in more adherent VICs. C) TGF-B1 is significantly
higher in more adherent compared to less adherent VICs. D) No difference is seen in collagen
expression. E) Heterogeneous VICs have significantly less elastin than other subpopulations (p≤
0.05*).
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Figure 6. Flow cytometry results of A) αVβ3 integrin b) αVβ5 and c) α2β1 expression in the three
VICs subpopulations at day 3. A) Heterogeneous VICs have significantly less αVβ5 than more and
less adherent VICs (*p ≤ 0.05). B) More adherent VICs have significantly higher levels of αVβ3
than other VIC subpopulations. C) α2β1 is significantly lower in less adherent VICs.
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Abstract
Extracellular matrix (ECM) proteins such as fibronectin, laminin, and collagen
dictate cell adhesion, spreading, and growth factor signaling. Understanding their
adsorption properties on cell culture surfaces can be important in characterizing
cell behavior in vitro. Using w-functionalized alkanethiol self-assembled
monolayers (SAMs) on gold [CH3 (hydrophobic), OH (hydrophilic), COOH (COO-,
negative at physiological pH), and NH2 (NH3+, positive at physiological pH)], we
have investigated the effect of surface chemistry on protein adlayers in an
attempt to understand cellular differentiation. Using surface plasmon resonance
and atomic force microscopy, we characterized the quantity and organization of
ECM common adhesive and non-adhesive proteins. Valvular interstitial cell
spreading and focal adhesion formation on SAMs was compared with previous
findings of phenotypic variation as a result of surface chemistry. Results indicate
that hydrophobic surfaces support significant protein deposition, but high levels
of bovine serum albumin deposition and protein denaturation prevent significant
cell adhesion and thus eliminates focal adhesion formation. Conversely,
significant quantities of adhesive proteins fibronectin and collagen deposition
result in good cell adhesion and spreading on gold and glass surfaces. Through
the expression of fibronectin specific integrins αVβ5 and αVβ3, osteoblastic
adhesion and differentiation of VICs is likely regulated through fibronectin binding
along with reduced binding of non-adhesive bovine serum albumin. This work
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highlights the importance of surface chemistry on protein structure and function
resulting in heart valve cellular differentiation.
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Introduction
Biomaterial surface chemistry modulates in vitro and in vivo cellular response,
including adhesion, survival, and expression of differentiated phenotypes.[1-4]
These cell-material interactions regulate the cell response to implanted devices,
biological integration of biomaterials and tissue engineering constructs, and can
control fomration of healthy and diseased tissue. Consequently, protein affinity
and structure as a result of material properties have garnered much attention
over the last decade in an attempt to better understand the cell-material interface
and cellular behavior.[2, 3, 5-8]
Various materials have been used to study the adsorption of proteins,
however, significant changes in mechanical and chemical properties, as well as
topography make it difficult to examine the dominating effect of each in
controlling cell-material interactions. Alkanethiol self-assembled monolayers
create well-defined, close-packed monolayer surfaces allowing for easy
modification of solid materials to investigate the interaction of biomolecule
adsorption and activity.[2, 3, 5, 6, 9] In addition, the chemisorption of thiols at
room temperature allows for simple in situ surface modification providing a
flexible platform for studying biological response.[10]
Prior research has focused on the use of SAMs for the immobilization of
enzymes or antibodies for the development of bioassays,[11, 12] the deposition
of plasma proteins from media,[10, 13] and investigation of the effects of charge
and surface hydrophobicity on cell behavior.[1-3, 8] Previously we have identified
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changes in heart valve, valvular interstitial cell (VIC) phenotype and disease
progression through growth on chemically modified SAMs.[1] The effects of
biomaterial surface properties on cellular responses is attributable to materialdependent differences in adsorbed protein species, concentration and/or
biological activity. Nonetheless, the molecular mechanisms modulating these
substrate-dependent, complex higher-order cellular activities remain poorly
understood.[3]
Proteins adsorb rapidly upon surface-blood contact when materials are
implanted. It has been suggested that protein adsorption, as one of the first
occurrences, may influence outcomes by mediating the recruitment of specific
cells, which in turn affect further events at the implant site.[10] As the primary
mechanism for cellular interaction with its surrounding environment, integrins
present on the cell surface serve to both anchor cells to the surrounding
extracellular matrix as well as provide growth factor signaling that regulates gene
expression. As such, integrins play an important role in cell behavior during
differentiation and tissue deposition. It is believed that the progression of VICs to
an osteoblastic phenotype may be at least partially regulated by this behavior.[4,
14, 15]
In the present study we have used SAMs to investigate the affinity and
conformation of common extracellular-matrix proteins as a result of surface
chemistry. SAMs were characterized using contact angle measurements, x-ray
photoelectron spectroscopy, and atomic force microscopy to confirm successful
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monolayer functionalization of surfaces. In addition, cell adhesion through
integrin expression and focal adhesion formation was assessed to determine
differences in ECM binding associated with phenotypic change. It is our
hypothesis that specific surface chemistries result in deposition of differing
amounts of proteins present in media, thereby altering the cellular adhesion
through focal adhesion plaque formation.
Materials and Methods
Reagents and Chemicals
All chemicals were purchased from Sigma-Aldrich chemicals unless otherwise
noted. All proteins, cell culture media, and reagents were purchased from
Thermo Fisher Scientific, unless otherwise noted.
Self-Assembled Monolayers
Fabrication of self-assembled monolayers was done according to previously
published procedures.[1] Briefly, round 15 mm glass cover slips (26021, Ted
Pella Inc.) were etched for 30 minutes in Piranha solution [70% (v/v)
concentrated H2SO4, 30% industrial grade H2O2] rinsed with diH2O, and blown
dry with N2. Gold coating was conducted by sequential electro-evaporation (2
nm/s, ≤ 1 x 10-5 Torr. Thermionics VE-90 vacuum Evaporation System; TLI
Enterprises) of optically transparent films of chromium (2 nm; High Vacuum
Evaporator Systems) and gold (50 nm, 99.99% purity; Plasmaterials). Freshly
prepared gold substrates were immersed in 1mM ethanolic alkanethiol solutions
[1-dodecanthiol (47-136-4); 11-mercapto-1-undecanol (447528-16); 11157

mercaptoundecanioc acid (450561-5G); 11-amino-1-undecanethiol,
hydrochloride (A423, Dojindo Laboratories)] and SAMs were allowed to
assemble for 12 hours. Etched cover glass and gold-coated controls were
incubated alongside SAMs in absolute ethanol. Before use or characterization,
samples were cleaned of unbound thiols in absolute ethanol and dried with N2.
In order to assess protein conformation without the counfounding effects of
underlying gold surface roughness smooth, self-assembled monolayers were
fabricated according to previously published techniques.[11, 16] Briefly,
muscovite mica sheets (Z01875, SPI Supplies) were freshly cleaved and 150 nm
of gold was deposited (2 nm/s, ≤ 1 x 10-5 Torr) using electro-evaporation. After
removal from the evaporation chamber, gold films were stored in ambient
conditions. Atomically flat films were prepared by cutting gold-coated mica into
1cm2 sections followed by adhesion of gold sheet to glass slides using lowviscosity thermal set epoxy (Epo-Tek 377, Epoxy Technology). Epoxy was set at
150 ˚C for one hour, then mica/gold/glass samples were allowed to cool to room
temperature. Detachment of the mica sheet was accomplished by incubation of
samples in tetrahydrofuran under ambient conditions for 10 minutes. Immediately
thereafter the freshly cleaved gold surface was rinsed in ethanol and incubated in
1mM ethanolic thiol solutions. Before use SAMs were rinsed in ethanol and
blown dry with N2.
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Contact Angle Measurements
Static contact angles were evaluated using the sessile drop technique on a
Model 100-00-115 Advanced goniometer (ramé-hart Inc.). Briefly, 5 μL of
ultrapure water was pipetted onto sample surface and the contact angle between
the water droplet and the sample surface were determined using First Ten
Angstroms V2 software.
X-Ray Photoelectron Spectroscopy (XPS)
Elemental compositions of the surfaces were determined by XPS using a
Kratos AXIS Supra with a monochromatic Al Kα (1486.7 eV, 75 W) source ≥ 5 ·
10-9 Torr. In general, three spots on each sample were analyzed, and analysis
locations were 300 x 700 microns elliptically. Survey spectra were recorded at
160 eV pass energy with 1.0 eV step sizes and 100 millisecond dwell times. High
resolution scans were performed with 20 eV pass energy, 50 meV step sizes,
and 200-600 millisecond dwell times depending on the signal of the core line of
interest. Charge neutralization was provided from low energy electrons from a
filament above the sample. Data was processed using CasaXPS (Casa Software
Ltd.) using the built-in Kratos relative sensitivity factors for quantification.
Protein Solutions
Proteins solutions were prepared by dissolving 1 µg/mL fibronectin (FN, R&D
Systems 1030-FN), Collagen (Col, Sigma-Aldrich C9791), Laminin (LN, Corning
354232), and bovine serum albumin (BSA, Sigma-Alrich 0547) in phosphate
buffered saline (PBS) adjusted to pH 7.4. Solutions were warmed to 37 ˚C for
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increased solubility and recapitulation of physiologic conditions. Fetal bovine
serum (FBS, Gibco) was suspended in PBS in a concentration of 10% in order to
recapitulate cell growth media.
Surface Plasmon Resonance
Protein adlayer thickness was assessed using a surface plasmon resonance
(SPR) model BI-2000 (Biosensing Instrument) on 50 nm gold and alkanethiol
SAMs.[17] Proper refractive index matching between the prepared slide and the
prism was achieved with a glycerol silica solution. A 80 µL flow cell was fitted
over the sample using a silicone gasket. This flow cell was attached, via
poly(ethyl ether ketone) (PEEK) tubing and fittings, to a syringe pump (New Era
Pump Systems). Compounds were injected at a flow rate of 50 µL/min. After a
steady baseline of PBS buffer was observed, protein solutions were injected from
the sample loop. Following protein deposition PBS was injected to remove nonspecific protein binding and correct for a baseline shift due to variations in
refractive index. The SPR detector was confirmed to be linear in response to
changes in refractive index using sucrose solutions previously characterized
using a DR6200-TF refractometer (Kruss).[17, 18]
Protein Adlayers
Atomically smooth SAMs were incubated in protein solutions for 12 hours at
37 ˚C, 5% CO2, and > 95% RH in order to simulate cell culture conditions. Before
imaging, samples were rinsed with DI water to prevent salt crystallization and air
dried.
160

Atomic Force Microscopy
SAMs surface topography and protein adlayer morphology was assessed
using an MFP3D-BIO atomic force microscope (Asylum Research). Samples
were characterized using silicon cantilevers (AC240TS, r > 7nm, Olympus)
scanned at 1 µm/s (0.4 Hz) over a 1µm area. Samples were plane fit and root
mean square (RMS) surface roughness was calculated using asylum MFP3D
software (V120804+1230).
Cell Culture
VICs were extracted from porcine aortic heart valves using previously
published methods.[1] For all experiments, substrates were equilibrated with
complete growth media [Medium 199, 10% fetal bovine serum, 1%
penicillin/streptomycin, 1% fungizone] prior to cell seeding at 21,500 cells/cm2.
Media was replaced after 12 hours to remove unbound cells (attachment) and
changed every two days. Osteoblastic controls were grown in OB media [Media
199, 10% fetal bovine serum, 10mM β-glycerophosphate, 2 mM ascorbic acid, &
10-7M dexamethasone] after initial 12-hour attachment.
Immunocytochemical (ICC) Staining
In order to characterize cell adhesion and spreading on SAMs, VICs were
stained using actin cytoskeleton focal adhesion staining kit (FAK 100, EMD
Millipore) according to manufacturer’s instructions. Briefly, after five days of
culture, cells were fixed with 10% formalin for one hour and washed twice with
DPBS. Cells were then permeabilized with 0.01% (v/v) Tween20 in DPBS
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(PSBT) for 15 min followed by reactive ion removal using 10% (m/v) sodium
azide and 10µM H2O2 in PBST. Samples were incubated with primary antibodies
(rhodamine/phalloidin, Ms anti-vinculin) diluted 1:75 in a 3% (w/v) BSA solution
for 60 minutes. Primary antibodies were removed and samples washed twice
with PBST followed by secondary antibody goat anti-mouse AlexaFluor 488
(A11001, Invitrogen) 1:100 in DPBS incubation for 60 minutes. Samples were
mounted (Fluoromount, F468) on glass slides and sealed with clear nail polish.
Samples were imaged on an Olympus IX81 confocal microscope with 40x air 1.3
NA objective.
Integrin Expression
VICs were grown for 12 hours (attachment) and 5 days on SAMs and treated
with 5mM EDTA in DPBS to facilitate detachment followed by gentle scraping.
Collected cells were pelleted and re-suspended at ~500,000 cell/ml in ice cold
phosphate-buffered saline (PBS), 1% BSA, and 0.02% sodium azide. Cells were
then labeled with 1:100 dilution of antibodies (ab): αVβ5-Alexa 647 MS (Novus,
FAB2528R), αVβ3-FITC mouse (Sigma-Aldrich, MAB1976F), α2β1 mouse (SigmaAldrich, MAB1998Z), mouse IgG1 κ -FITC (Biolegend, 400110), mouse IgG1, κAlexa 647 (Biolegend, 400130), and mouse IgG1 κ (Biolegend, 401402) for 30
min at 4°C. The secondary ab Alexa 488 goat anti-mouse (Life Technologies
A11017) was added to samples stained with primary α2β1 Ms, mouse (BALB/c)
IgG1, or IgG1 κ primary ab’s and incubated for another 20 min on ice. All
samples were kept on ice until measured using an Attune NXT Flow cytometer.
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Unstained cells were used to gate cell population using forward and side
scattering. Gated cell population was analyzed for fluorescence intensity and
antibody specific immunoglobulin controls were subtracted from the reported
integrin expression mean fluorescence intensity values.
Statistical Analysis
All results were analyzed using one-way ANOVA and two-tailed t-tests to
determine significance at a 95% confidence interval (p < 0.05). All analyses were
done using GraphPad Prism 7 software.
Results
Surface Characterization of Self-Assembled Monolayers
Self-assembled monolayers (SAMs) expressing four different functional
groups (CH3, OH, COO-, NH3+) were used as model surfaces to assess the effect
of substrate chemistry on protein affinity and conformation, as well as VIC
adhesion and integrin expression. These four chemistries exhibit different
degrees of wettability and charge. CH3-SAMs are non-polar and relatively
hydrophobic, whereas, OH, COO-, and NH3+ are hydrophilic. At physiological pH
(7.4) partially ionized COOH and NH2 SAMs present negative or positive
charges, respectively (COO- and NH3+).[19] Static water contact angle and x-ray
photoelectron spectroscopy (Supplemental Table 1-2) indicate no difference
between fabrication techniques and agree with previous reported values.[1, 19]
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Protein Deposition
Differences between chemically modified surfaces resulted in variations in the
quantity of proteins adhered using surface plasmon resonance (SPR) detection.
CH3-SAMs resulted in significantly greater deposition of all proteins as compared
to other treatments. Results reflect literature indicating large amounts of nonspecific adhesion to hydrophobic surfaces, Table 1, Figures 1-4.[11] In
comparison hydrophilic OH-SAMs exhibited little protein deposition. Positively
charged NH3+-SAMs exhibited little collagen (COL) or bovine serum albumin
(BSA) deposition, with similar levels of fibronectin (FN) and laminin (LN) to gold.
Negatively charged COO--SAMs exhibited significantly increased levels of LN
and the second highest levels of FN along with significant BSA affinity.
Protein Conformation
Along with adlayer thickness, protein conformation was also assessed
through use of mica-transferred gold SAMs and atomic force microscopy, see
Figures 1-5. When assessed for fibronectin (FN) deposition, CH3-SAMs and
COO--SAMs exhibit a globular monolayer formation indicative of denatured
fibronectin proteins.[5] In comparison, gold, glass, and N3+-SAMs exhibited
monolayer formation of more functional FN protein. The morphology of FN on
OH-SAMs shows patches of FN with uncertain functionality. See Figure 1 for FN
morphology.
When assessed for collagen (COL) deposition, CH3-SAMs exhibited
significant globular protein conformation, as compared to the loosely connected
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network of fibrillar proteins on gold surfaces. COO--SAMs also exhibited some
COL fibril formation, at a reduced level to gold. In comparison, glass, OH-SAMs,
and N3+-SAMs exhibited little COL deposition. See Figure 2 for COL morphology.
When assessed for laminin (LN), COO--SAMs, CH3-SAMs, and glass
exhibited significant LN deposition, with drastically different protein conformations
between hydrophilic and hydrophobic surfaces. Gold, OH-SAM, and N3+-SAMs
exhibited some LN deposition with questionable functionality. See Figure 3 for LN
morphology.
In order to assess the effects of surface chemistry on non-adhesive cell
culture components, bovine serum albumin (BSA) was utilized. BSA is present at
significant levels in fetal bovine serum (FBS) a common supplement in cell
culture media and blood plasma.[20-22] In conjunction with the significant
amount of BSA adhered to CH3-SAMs, there was a layer of BSA present when
visualized using AFM. Furthermore, this layer exhibited distinct structure with
random punctuated circular areas which correspond to uncovered SAMs. The
diameter of the circular regions was 10-50 nm with a layer height of 3-4 nm
indicative of monolayer formation.[11] Similar monolayer structure was observed
on COO--SAMs with near monolayer formation on glass. Gold and N3+-SAMs
showed some BSA deposition, however, OH-SAMs exhibited distinctive
denaturing of the SAMs monolayer surface to form sequestered holes which
allowed for aggregate BSA deposition. See Figure 4 for BSA morphology.
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In order to compare individual protein structure and deposition with cellculture media, FBS, containing a concoction of proteins, was also incubated with
SAMs. With the deposition of FBS, similar punctuated monolayer formation on
CH3-SAMs was observed. Furthermore, the base monolayer seems to prevent
further protein deposition on CH3-SAMs. In comparison, gold and COO--SAMs,
which exhibited increased deposition of BSA as well as distinct conformation of
other proteins resulted in significant protein adlayers. Glass, OH, and NH3+-SAMs
all experienced protein deposition from FBS, with no distinctive characteristics to
protein morphology.
Cytoskeleton Differences in Focal Adhesion Formation
In order to assess previously observed changes in cell adhesion and
spreading on SAMs, valvular interstitial cells were grown for five days and
stained for phalloidin, a stabilizing agent in actin cytoskeletal filaments, and
vinculin, an anchoring component of the cytoskeleton with focal adhesion
plaques and cell-cell junctons.[23] As was previously observed, maintenance of
an elongated spindle-shape morphology indicative of a healthy, activated VIC
phenotype was observed on gold, OH, and COO--SAMs, with some focal
adhesion formation. In comparison, CH3-SAMs exhibited little cell spreading and
resulted in aggregate cell sheet formation with increased cell-cell junction and
little cytoskeletal spreading. VIC growth on NH3+-SAMs and glass/osteoblastic
conditions resulted in the adoption of rhomboidal/spread morphology with
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significant focal adhesion formation and cytoskeletal filaments.[1] See Figure 6
for cytoskeletal staining of VICs.
Integrin Expression
As a primary component of focal adhesion plaques, transmembrane integrin
proteins serve to attach and transmit microenvironmental signals through protein
binding and aggregation. It has previously been shown that surface chemistry
can alter the expression of integrins through growth on SAMs.[2, 3, 8] VIC
integrin expression during initial attachment (12 hours) and sustained growth on
SAMs showed similar differences to surface chemistry. Upon attachment,
positively charged NH3+-SAMs and glass/osteoblastic surface exhibited upregulation of RGD/FN binding integrins αVβ3 and αVβ5 as well as COL binding
α2β1. Increased αVβ3 and α2β1 expression was also observed through attachment
to gold surfaces. In comparison, growth over five days resulted in decreased
integrin expression on all surfaces as a result of stable cell binding and
monolayer formation. However, significantly greater αVβ3, αVβ5, and α2β1
expression was maintained on gold surface, as well as αVβ5 and α2β1 on
glass/osteoblastic surfaces. See Figure 7-8 for integrin expression.
Discussion
Uniform SAM surface chemistry allows for controlled protein deposition and
orientation, producing distinct culture surfaces for understanding cell behavior in
different microenvironments.[2, 5, 24, 25] It has been observed that proteins in
culture adsorb at a faster rate than cell attachment and dictate cell-surface
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interactions.[25, 26] Specifically the adsorption of proteins to
hydrophobic/hydrophilic and charged surfaces has shown that specific
extracellular matrix proteins bind in a surface dependent manner, with variability
in their tertiary structure, resulting in variation in available cellular attachment
domains.[2, 3, 5, 8, 25]
We have previously shown that heart valve, valvular interstitial cells (VICs) do
not adhere well to hydrophobic surfaces, resulting in aggregate cell sheet
formation, apoptosis, and dystrophic calcium deposition.[1] Similarly, VICs exhibit
slow proliferation and spreading on OH-SAMs, but eventually recover and exhibit
an elongated myofibroblastic phenotype. Significantly, VICs grown on NH3+SAMs resulted in increased adhesion, spreading, and differentiation to an
osteoblastic phenotype resulting in ectopic bone formation. Such behavior
typically requires the addition of soluble growth factors through osteoblastic
media and extended culture in order to achieve the same level of osteoblastic
differentiation. In comparison, COO--SAMs resulted in robust proliferation of VICs
with maintenance of an elongated spindle-shaped morphology and a lack of
contact induced calcified nodule formation on rigid surfaces, indicative of a
healthy, activated phenotype. These results led us to further examine the
adsorption of cell-adhesive and non-adhesive proteins to SAMs carrying different
functional groups. In conjunction, we investigated the expression of ECM specific
integrin binding subunits by VICs grown on SAMs along with changes in cell
spreading and focal adhesion formation.
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Non-adhesive Protein Deposition Controls Cell Adhesion to CH3-SAMs
Variations in protein affinity and conformation on hydrophobic CH3-SAMs
correlates well with the lack of cell adhesion and integrin expression observed on
these surfaces. While significant levels of all proteins were present on CH3-SAMs
the non-functional structure and deposition of non-adhesive BSA, individually,
and as a result of FBS incubation, results in a lack of significant cell-adhesive
domains for VIC attachment and spreading. Similar behavior has been observed
in other cell types.[2, 6, 7, 25] This behavior likely results in forced cell-cell
junctions to maintain cell viability, but the lack of cell adhesive domains ultimately
results in cell-sheet contraction and formation of calcified, apoptotic cell
aggregates in culture.[1]
Lack of Protein Deposition Limits Cell Adhesion to OH-SAMs
In comparison, the lack of significant protein deposition on OH-SAMs and
disruption of the monolayer structure by BSA results in a lack of effective cell
binding and inhibited initial growth. It is likely, however, that the continued
secretion of protein allows for eventual recovery of VICs in order to effectively
adhere and grow. Integrin expression on OH-SAMs was not investigated in this
study due to the lack of significant previous finding and denaturing of the
monolayer surface by BSA, indicating an ineffective cell culture environment for
VICs.
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Multifactorial Activation of VICs on COO--SAMs
With increased deposition of adhesive FN and LN, as well as significant BSA
and large aggregate structures formed though incubation with FBS, it is uncertain
what effect COO--SAMs may have on VIC growth and behavior. The lack of
significant integrin FN and COL expression may indicate that functional binding
to such proteins is affected in complete growth media, given the presence of
BSA. However, the adhesion and proliferation of VICs to COO--SAMs as well as
lack of osteoblastic phenotype indicates that a negatively charged environment
may be beneficial for VIC expansion and growth. It is likely that the presence of
BSA, or other ECM adhesive proteins may be responsible for the rapid
proliferation and lack of osteoblastic behavior due to a lack of significant focal
adhesion formation and cytoskeletal re-arrangement.
Functional FN and Col Protein Deposition Controls VIC behavior on Gold
Used as a control surface, gold substrates exhibit effective adhesion and
proliferation of VICs in culture. Although Au surfaces remain less hydrophilic than
charged or OH-SAMs, they exhibit significant protein deposition which results in
a favorable growth environment. Although significant BSA deposition is observed
on gold, effective deposition of FN and COL resulted in increased integrin
expression (αVβ5, αVβ3, & α2β1). One primary difference between gold and
osteoblastic treatments (NH3+-SAMs and osteoblastic media) was the lack of
significant αVβ5 integrin expression upon attachment. As αVβ5 has been shown to
colocalize differently than other RGD binding subunits within focal adhesions
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(e.g. αVβ3)[27] and has been associated with increased fibrotic behavior in
VICs,[28] the lack of initial αVβ5 integrin expression may correlate with a lack of
robust osteoblastic differentiation on gold surfaces.
FN Binding Controls Osteoblastic VIC behavior on NH3+-SAMs
While no single protein exhibited strong affinity for NH3+-SAMs a lack of nonadhesive BSA and presence of FN, as well as the increased expression of αVβ5
and αVβ3 upon attachment indicate FN affinity may play an important role in early
osteoblastic differentiation in VICs.[2, 3, 8] While no significant fibrillar COL was
observed on NH3+-SAMs the expression of α2β1 upon attachment indicates some
functional collagen may be present for cell adhesion. Furthermore, the lack of
non-adhesive BSA likely contributes to the increased expression of integrins and
focal adhesion formation. Decreased integrin expression at day 5, corresponds
with the rapid and robust differentiation of VICS to an osteoblastic phenotype
along with the development of contractile calcified nodules. This further suggest
that increased expression of other integrins may occur after or during
osteoblastic transition, all of which may be mediate by initial early adhesion, focal
adhesion formation, and cytoskeletal signaling. Interestingly, NH3+-surfaces also
resulted in a significant up-regulation of elastin expression in VICs, which seems
to correspond with development of nodules in culture at day 5.[1] As fibronectin is
required for microfibril formation onto which elastin is deposited, the early
availability of fibronectin on NH3+-SAMs may be at least partially responsible for
increased rate of nodule formation by VICs.[29, 30]
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Media-Induced Osteoblastic VICs
Osteoblastic media induction, the current gold standard for forced
differentiation of VICs relies on the exposure of cells to corticosteroids
(dexamethasone) and the upregulation of a number of signaling factors that are
hard to differentiate from surface mediated cell-signaling.[31] Interestingly,
similarities exist in protein conformation, FN, COL, and FBS on NH3+-SAMs.
Furthermore, significant upregulation of αVβ5, αVβ3, & α2β1 by osteoblastic VICs
corresponds with similar expression by VICs on NH3+-SAMs. Such behavior
indicates some level of shared signaling resulting in an osteoblastic phenotype
on NH3+-SAMs and glass with osteoblastic media.
Experimental Limitations and Future Work
The current work focused on the use of SPR for quantification of protein
adlayers. Due to the need for plasmon generating surface treatments glass was
unable to be characterized for protein adlayer quantity. While used primarily as a
positive control for osteoblastic differentiation in VICs, future studies investigating
the quantity of adhesive ECM proteins to glass would provide further
understanding of the dominating effects of surface chemistry of soluble growth
factor signaling in VICs.
While the deposition and control of proteins by surface chemistry is a
significant factor in cell-material signaling, the complexity of cell-adhesion,
protein secretion, and ECM re-arrangement can alter initial behaviors in
controlled cell environments. While this work has identified the expression of
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particular integrins which may be responsible in the differentiation potential of
VICs, further studies should be conducted to block or knock-down integrin
binding in order to determine if integrin presence can be overcome through a
reduced signaling by a lack of proteins present on SAMs. Completion of these
studies should provide for stronger correlation between observed osteoblastic
differentiation of VICs on NH3+-SAMs as a result of integrin binding and signaling
or identify other signaling factors.[28, 32]
Finally, it is well understood that self-assembled monolayers allow for the
control of surface chemistry for investigating the effects on cell behavior.
However, the use of gold-bound alkanethiolate SAMs on glass present some
experimental difficulties for comparison with in vivo tissue development, primarily
through the use of stiff substrates[33] and two-dimensional environments. It has
previously been observed that VIC growth on stiffer matrixes results in greater
differentiation towards myofibroblastic and calcifying phenotypes.[31, 34] In order
to correlate observed cell behavior of VICs on 2D monolayer surfaces with
physiologically relevant 3D environments, similar charged and/or adhesive
peptide-functionalized soft polymer systems should be investigated.
Conclusions
For many years calcified aortic valve stenosis has been viewed as a
degenerative process marked by thickening of the valve and deposition of
ectopic bone. However, growing evidence has proven tissue calcification to be
mediated by active transition of valvular interstitial cells into an active calcium
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depositing phenotype.[35] While mechanisms that control this process have not
been fully identified, it is believed that the surrounding cellular microenvironment
plays a critical role in triggering the changes observed in VICs in combination
with the onset of valve disease. Through the deposition of proteins on alkanethiol
SAMs surfaces we have identified distinct differences in protein affinity and
conformation which correlate with integrin expression and focal adhesion
formation. Changes in VIC morphology and cytoskeletal proteins have been used
to characterize a differentiation of VICs to and osteoblastic phenotype. By
correlating observed osteoblastic behavior on chemically modified surfaces with
fibronectin presence and increased αVβ5 and αVβ3 expression, we have begun to
identify possible signaling mechanisms which initiate VIC differentiation and
regulate disease progression with implications for protein adlayer deposition and
VIC culture.
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Figures

Figure 1. A) Fibronectin (FN) surface coverage as determined using SPR. B) Representative
images of adsorbed FN on SAMs surfaces. **FN deposition on CH3-SAMs significantly greater
than all treatments except COO--SAMs. **FN deposition on OH-SAMs significantly lower than all
treatments except NH3+-SAMs. (n=4, p<0.05)
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Figure 2. A) Collagen (COL) surface coverage as determined using SPR. B) Representative images
of adsorbed COL on SAMs surfaces. *COL deposition significantly different than all treatments.
(n=4, p<0.05)
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Figure 3. A) Laminin (LN) surface coverage as determined using SPR. B) Representative images of
adsorbed LN on SAMs surfaces. *LN deposition significantly different than all treatments. (n=4,
p<0.05)
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Figure 4. A) Bovine serum albumin (BSA) in surface coverage as determined using SPR. B)
Representative images of adsorbed BSA on SAMs surfaces. *BSA deposition significantly
different than all treatments. (n=4, p<0.05)
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Figure 5. Representative images of adsorbed fetal bovine serum on SAMs surfaces. Glass, CH3,
OH, & NH2 images, as well as Au & COOH inset scaled to 5 nm. Au & COOH images scaled to 25
nm for increased clarity of larger particles.
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Figure 6. Representative images of immunocytochemical staining (Red-actin/phalloidin, GreenVinculin/focal adhesions) after five days of VIC growth on SAMs. Arrows indicate distinct focal
adhesion formations. Scale = 50µm
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Figure 7. Flow cytometry results of integrin expression A) αVβ5 b) αVβ3 and c) α2β1 in VICs
attached to SAMs, 12 hours. A) VICs grown on osteoblastic surfaces exhibited greater αVβ5
expression than all other treatments (**NH2 > CH3 & COOH). B) VICs grown on gold, osteoblastic,
and NH2 SAMs exhibited statistically different αVβ3 expression. C) VICs expressed the highest
level of α2β1 integrins following the trend Au>OB>NH2>CH3=COOH.*p < 0.05, n = 4.
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Figure 8. Flow cytometry results of integrin expression A) αVβ5 b) αVβ3 and c) α2β1 in VICs after 5
days of growth. A) VICs grown on SAMs surfaces exhibited lower αVβ5 expression than gold and
osteoblastic controls. B) VICs grown on gold exhibited greater αVβ3 expression, while NH3+-SAMs
exhibited lower integrin expression than all other treatments. C) VICs expressed the highest
level of α2β1 integrins in gold and osteoblastic controls.*p < 0.05, n = 4.
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Tables
Table 1. Protein surface coverage quantified using surface plasmon resonance (SPR).

Surface Coverage (ng/mm2)

Treatment

FN

Col

LN

BSA

Au

5.25 ± 0.40

1.30 ± 0.32

2.49 ± 0.24

1.49 ± 0.08*

CH3

8.50 ± 0.37

7.80 ± 0.36*

9.05 ± 0.44*

4.45 ± 0.14*

OH

3.33 ± 0.50

1.00 ± 0.07

2.21 ± 0.14

0.35 ± 0.02

COO-

7.11 ± 1.20

1.15 ± 0.14

4.85 ± 0.33*

1.86 ± 0.07*

NH3+

4.52 ± 0.57

0.40 ± 0.08*

2.75 ± 0.23

0.39 ± 0.07

* Significantly different than all other groups, (p<0.05)
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SAMs Surface Characterization
Table 1. Static water contact angle of atomically smooth SAMs and glass prior to protein
deposition.
Treatment

Contact Angle (degrees)

Au

73.9 ± 1.2

CH3

100.7 ± 2.0

OH

16.5 ± 2.1

COOH

36.3 ± 0.1

NH2

49.2 ± 1.1

Glass

29.3 ± 2.2
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Table 2. X-ray photoelectron spectroscopy (XPS) chemical composition for ω-functionalized
alkanethiol self-assembled monolayers.

Theoretical

Glass
Au
CH3
OH
COOH
NH2

Actual

Substrate

Glass
Au
CH3
OH
COOH
NH2

Au 4f
100.00
53.85
53.85
51.85
53.85
Au 4f
71.61
61.34
59.85
57.67
40.09

C 1s
46.15
42.31
40.74
42.31
C 1s
14.63
25.92
37.83
36.59
36.13
51.31

Cl 2p
Cl 2p
0.30
0.08
0.00
0.00
0.63
0.56

N 1s
3.85
N 1s
1.01
0.00
0.00
0.00
0.00
1.80
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Atomic Concentration [%]
O 1s
72.13
0.00
3.85
7.41
0.00
O 1s
60.72
1.74
0.00
2.35
5.57
4.99

Si 2s
26.23
-

Al 2p
1.64

K 2p
-

Ti 2p
-

Si 2s
21.72
0.65
0.83
1.21
0.00
1.26

Al 2p
0.87

K 2p
0.33

Ti 2p
0.42

Figure 1. Representative images gold coated surface topography using thermal evaporation
(left) and mica transfer (right). The root mean square (RMS) surface roughness of thermal
evaporated gold (612.7 ± 12.4 pm) was significantly greater than mica transfer (237.7 ± 31.7
pm). Scale = 250µm
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Figure 2. Representative images atomically smooth gold, piranha cleaned glass, and selfassembled monolayer surface topography. All surfaces exhibited RMS roughness less than 300
pm. Scale = 250µm
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Table 2. Root mean square (RMS) surface roughness of atomically smooth SAMs and glass prior
to protein deposition

Root Mean Square
Treatment

Surface Roughness (pm)

Au

237.7 ± 31.7

CH3

269.4 ± 9.5

OH

298.1 ± 42.4

COOH

308.0 ± 86.5

NH2

226.7 ± 16.5

Glass

242.8 ± 108.6

No Significant difference between groups (p<0.05)
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Figure 3. Root mean square (RMS) surface roughness of thermal evaporated gold was
significantly greater than all mica coated SAMs surfaces and glass. (n=4, p<0.05)
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Upregulation and genetic expression of the ECM protein Elastin has also
been observed in VIC culture. In order to compare Elastin expression and
behavior on SAMs 1mg/mL of Elastin (ELN, Molecular Probes 101636) was
incubated and imaged using AFM on atomically smooth SAMs.

Figure 4. Representative images of adsorbed elastin on SAMs surfaces.

196

Chapter 6

Nitrogen Sparge Synthesis and Characterization of
Oligo(Poly(Ethylene Glycol) Fumarate) Macromer
Matthew N. Rush1,2,3, Kent E. Coombs1,4, Kirsten N. Cicotte1,5, David Santistevan1, Quan M.
Huynh1,5, Chester K. Simocko3, and Elizabeth L. Hedberg-Dirk1,2,5,6*.

1

Center for Biomedical Engineering, University of New Mexico, Albuquerque, NM. 2Nanoscience

and Microsystems Engineering Graduate Program, University of New Mexico, Albuquerque, NM.
3

Center for Integrated Nanotechnologies, Sandia National Laboratories/Los Alamos National

Laboratory, Albuquerque, NM, USA. 4Biomedical Sciences Graduate Program, University of New
Mexico, Albuquerque, NM, USA. 5Biomedical Engineering Graduate Program, University of New
Mexico, Albuquerque, NM, USA. 6Department of Chemical and Biological Engineering, University
of New Mexico, Albuquerque, NM, USA.

To be Submitted: Tissue Engineering

197

Abstract
The macromolecule oligo(poly(ethylene glycol) fumarate) (OPF) exhibits
promising attributes for creating 3D hydrogel environments to study cell behavior,
deliver therapeutics, and serve as a degradable, non-fouling scaffold. However,
previous synthesis techniques were time consuming, contained salt
contaminants, and generated significant waste. These issues have been
overcome with an alternative, one-pot approach utilizing inert gas sparging
methods. Departing from previous synthetic schemes requiring acid scavengers,
sparging removes HCl byproducts in situ thereby eliminating significant filtration
and post processing steps while allowing a more uniform product. Characterized
by nuclear magnetic resonance, gel permeation chromatography, and differential
scanning calorimetry nitrogen sparge synthesis yields the same OPF product as
traditional triethylamine synthesis methods with greater polymer length.
Furthermore, nitrogen-sparged OPF (N2-OPF) readily crosslinks using either UV
initiator or thermal initiator methods with or without the addition of short chain
diacrylate units, which allows for greater tunability in the material properties of
the resulting hydrogels with little to no cytotoxicity. Overall, sparge synthesis
provides a better polymer product for hydrogel material studies, while maintaining
degradable hydrogel characteristics.

Keywords: oligo(poly(ethylene glycol) fumarate), OPF, polyethylene glycol,
polymers, hydrogel
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Introduction
Oligo(poly(ethylene glycol) fumarate) (OPF) has been extensively
investigated as a biodegradable hydrogel for use in tissue engineered scaffolds
and drug delivery. (1-13) The step-growth polymerization of polyethylene glycol
(PEG) and fumaryl chloride produces a linear polyester with hydrochloric acid
byproducts. The resulting oligomer consists of a repeating scheme of PEG and
fumarate which chemically crosslinks utilizing unsaturated double bonds into a
non-fouling hydrogel, Figure 1. The ability of OPF to undergo hydrolytic
degradation through ester hydrolysis gives OPF greater utility over previous PEG
diacrylate hydrogels. (14-17) Additionally, the physical properties of OPF can be
easily tailored by changing the PEG precursor length. (1, 18) Due to the
presence of unsaturated double bonds, modification of the oligomer backbone
can also be achieved prior to or during crosslinking with the incorporation of short
chain polymers. (4, 10) Overall, these factors make OPF a desirable synthetic
polymer for multiple applications.
Originally developed by Jo, et al., the OPF synthesis procedure has not been
significantly modified since its inception. (1, 2, 19) However, several groups have
reported issues with removal of secondary reaction byproducts affecting
crosslinking efficiency and cell viability. (20-22) In order to trap hydrochloric acid,
groups have used acid scavengers such as triethylamine, potassium carbonate,
and sodium hydroxide. (16, 23-28) However, batch-to-batch inconsistencies in
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polymer product are common due to inefficient removal of insoluble hydrochloric
acid-acid scavenger salts. (22)
Common in waste treatment and manufacturing procedures, sparging is a fast
and efficient method which can be easily introduced into the process
environment. (29-33) By bubbling a chemically inert gas such as nitrogen, argon,
or helium through a liquid, sparging allows for the removal of low boiling-point
solutes in real time, without post-processing steps. (32, 33) Furthermore, the
introduction of compressed gas into the system serves as a heat sink,
maintaining the low temperatures required for efficient step-growth
polycondensation. (34) Through the introduction of gas sparging, we have
developed a one-pot, straight-forward, and improved method for the production
of OPF while simultaneously eliminating the complications of acid removal,
cooling, filtration and post-processing, and working with peroxide forming
chemicals.
Materials and Methods
Reagents and Chemicals
Polyethylene glycol (PEG, Mn 4600), fumaryl chloride (FuCl), ascorbic acid
(AA), Irgacure 2959, trimethylamine (TEA), polyethylene glycol diacrylate
(PEGDA, Mn 575), deuterated chloroform (CDCl3), and tetrahydrofuran (THF)
were purchased from Sigma-Aldrich. Ammonium persulfate (APS, ACS grade)
and ethanol were purchased from Fisher Scientific. Dichloromethane (DCM),
ethyl ether, ethyl acetate, anhydrous toluene (99.8%), and sodium hydroxide
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were purchased from EMD Millipore. Whatman qualitative 413 filter paper was
purchased from VWR. The fine-fritted sparge/gas dispersion tube (CG-203-01)
was purchased from Chemglass. Cell culture reagents, Dulbecco’s minimum
essential growth medium (DMEM), fetal bovine serum (FBS), penicillinsterptomyosin, fungizone, trypsin-EDTA, and live/dead cell viability kit were
purchased from Thermos Fisher Scientific.
Synthesis of Oligo(Poly(Ethylene Glycol) Fumarate) (OPF)
Polyethylene Glycol (PEG) Drying
PEG was dried by azeotropic distillation prior to use as previously described.
(2) Briefly, 100g of PEG was added to 200 mL of toluene. At least 150 mL of
toluene and residual water were distilled off at 200˚C. Toluene was removed on a
rotary evaporator followed by drying in a vacuum oven overnight. Dried PEG was
stored in a desiccator until use.
OPF Oligomer Synthesis – Triethylamine (TEA-OPF)
TEA-OPF was prepared according to previously described methods. (1, 2)
Briefly, dried PEG (100g) was dissolved in 700 mL of dichloromethane (DCM) in
a 1 L 3-neck round bottom flask set in an ice bath. Air was removed and replaced
with a nitrogen (N2) environment. Using molar ratios of 1: 0.9 PEG to fumaryl
chloride (FuCl) and 1:2 FuCl to triethylamine (TEA), FuCl and TEA were
dissolved in 60 mL DCM in separate addition funnels and simultaneously added,
dropwise, to PEG over 4 hrs. The reaction was stirred vigorously using a stir bar.
Upon complete addition of FuCl and TEA to the PEG solution, the reaction was
allowed to progress in an ice bath overnight, followed by solvent removal in
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vacuo. The product was subsequently dissolved in warm ethyl acetate, chilled to
recrystallize OPF, and filtered to remove trimethylamine hydrochloride salts. This
process was repeated three times. After the final collection, the OPF was washed
with ethyl ether, and fully dried under reduced pressure overnight.
OPF Oligomer Synthesis - Nitrogen Sparging (N2-OPF)
Similar to the TEA-OPF, dried PEG (100 g) was dissolved in 700 mL DCM in
a three-neck round bottom flask with stir bar and nitrogen environment. Sparging,
using nitrogen (N2), was introduced through central arm with a 24/40 adaptor
fitted with a fine-fritted gas dispersion tip and forced out through 90˚ flow control
adapter into a secondary vessel containing 10 wt% sodium hydroxide in ethanol,
Figure 1B. Fumaryl chloride was dissolved in 60 mL DCM at a molar ratio of
1:0.9 PEG to FuCl and added dropwise to PEG over 4 hours while stirred
vigorously. Upon complete addition of FuCl to PEG solution, DCM was added to
the reaction mixture to bring the volume back up to 700 mL. The reaction was
allowed to progress overnight with sparging, followed by solvent removal in
vacuo.
Characterization of OPF
OPF Structure
OPF products were characterized by hydrogen nuclear magnetic resonance
(1H NMR) 300M Hz (Bruker Avance III 300, TopSpin V3.5) in CDCl3. Peaks were
assigned to confirm the hydrogen binding environment. The degree of
polymerization was assessed through comparison of using peak integration of
olefin (6.87 ppm) and PEG (3.38-3.85 ppm) functional groups.
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Molecular Weight and Oligomerization
Molecular weight of OPF was determined through gel permeation
chromatography (GPC). Styragel HR 4 + 4E, 7.8x300mm (WAT044225,
WAT044240) columns were used to elute the samples at a 1mL/min flow rate on
an Agilent 1100 Series high performance liquid chromatography system (HPLC,
Hewlett Packard, RID G1362A, Chemstation B.04.01). Samples (3 mg) were run
in tetrahydrofuran (1 mL). Sample weight-average (Mw) and number-average
molecular weights (Mn) were calculated as compared to polyethylene glycol
(PEG) standards (PL2070- 194, 440, 600, 1080, 1470, 4100, 7100, 12600,
23600, Polymer Laboratories/Agilent Technologies). The degree of
oligomerization (Xn) was determined using Equation 1:
#𝑋##"# = %&,()*
%

(1)

#𝑋##"# = ./0
./01203

(2)

&,)+,

Here, Mn,OPF and Mn,PEG represent the number average molecular weight (Mn)
of OPF and monomeric PEG, as determined by GPC. Carother’s equation
(Equation 2) was used to determine monomer conversion percentage, where r
represents the ratio of [fumaryl chloride]/[PEG] and p the monomer conversion
percentage. (35)
Changes in molecular weight over time were measured by removing a small
volume (1 mL) of OPF product from both TEA-OPF and N2-OPF synthesis
reaction vessels over the initial 14 hours of synthesis in parallel reactions.
Solvent was removed in vacuo and 3 mg of product were suspended in 1 mL
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tetrahydrofuran. Refractive index intensity was normalized to the highest peak of
the eluted product.
Fluorescent Byproduct
Fluorescence of the polymer product was detected during GPC through the
use of a fluorescence detector (Hewlett Packard, FLD G1321A, Ex 250 nm, Em
410 nm) upstream of the refractive index detector; retention time difference
approx. 1 min.
Melting Temperature and Crystallinity
Differential scanning calorimetry (DSC, TA instruments model 2920, Netzsch
Proteus) was carried out to determine the properties of OPF. The samples were
analyzed at a heating rate of 10 °C/min from 0 to 70 °C. Melting temperature (Tm)
and the heat of fusion, ¢Hm (cal/g), were obtained from the thermograms. The
percent crystallinity (X) of OPF was determined from the following equation:
45

𝑋 = 456∗ 𝑥 100

(3)

6

Here, H*m, is the theoretical heat of fusion of 100% crystalline PEG (49 cal/g).
(36)
Yield
Percent yield was calculated by weighing the product recovered from the
reaction and dividing it by the weight of reagents originally added.
ABCDEF GHI JC"KL 30MNOPF

% 𝑌𝑖𝑒𝑙𝑑 = ABCDEF HQR/ABCDEF IOSK0TL PELM0CNB
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(4)

Characterization of Crosslinked OPF Hydrogels
Crosslinking of OPF
OPF hydrogel products were crosslinked with and without polyethylene glycol
dimethacrylate (PEGDA) (Sigma Aldrich). The UV crosslinked formulations were
as follows: 25% (wt%) OPF, 0.5% Irgacure 2959 initiator, 74.5% deionized water
or 16.5% OPF, 8.5% PEGDA, 0.5% Irgacure 2959 initiator, 74.9% deionized
water. UV formulations were exposed to 365 nm UV light in a CL-1000 light box
(Ultra Violet Products, UVP) for 15 min. The thermally crosslinked hydrogels had
the same formulations stated above, except 17.6 x 10-6 wt% (0.1 mM) ascorbic
acid (AA) with 22.8 x 10-6 wt% (0.1 mM) ammonium persulfate (APS) was added
as a free-radical initiator instead of Irgacure 2959. Polymer solutions (1 mL) were
transferred to syringe molds before being crosslinked. (21) Thermally initiated
formulations were placed in the incubator (37° C) for 15 min to form hydrogels.
Final products were then dried overnight at room temp before being placed in the
vacuum oven for 24 hours. TEA-OPF product only formed solid hydrogels when
using thermal crosslinkers, 0.1 mM (AA/APS).
Water Ingress and Removal of Uncrosslinked Material
Hydrogels were weighed after drying in vacuum oven to measure the initial
mass of polymer (Wi). Hydrogels were then soaked in 5 mL of deionized water
and allowed to swell. Hydrogel weights were recorded each day, for 4 days, until
mass loss was negligible. The maximum swollen weight (Ws) was recorded.
Swollen gels were then removed from water and re-dried in the vacuum oven for
48 hrs before being weighed to measure the dry weight (Wd). The water ingress
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fraction was calculated by dividing the weight dry by the swollen weight (Equation
5). Sol fractions were calculated taking the weight initial minus the weight dry
divided by the weight initial (Wi) (Equation 6).
𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑖𝑜 =
𝑆𝑜𝑙 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =

]^ 1]_
]_

]b 1]_
]b

(5)
(6)

Hydrogel Elasticity
Twenty microliters (20 µL) of TEA-OPF and N2-OPF samples, using thermal
crosslinking formulations described above, were deposited onto metal specimen
discs (TedPella, 16218) and placed in the incubator (37° C) for 15 min to form
hydrogels. Samples were swollen for four days by immersion in deionized water.
Force maps, comprised of force distance curves, were gathered over 10 x10 µm
area of each hydrogel sample using a tip-less cantilever (Nanoworld, TL-FM)
affixed with 5 µm silica microsphere (Bangs Laboratory, SS05N) using thermalset epoxy (Momentive, Epon 1004F), see supplement for more information.
Elastic modulus and virtual deflection of each cantilever was calibrated prior to
hydrogel indentation using thermal methods,(37) followed by deflection on a rigid
substrate (glass).(38) The hydrogel elastic modulus was calculated using OliverPharr model fitting (Asylum Research V120804+5315).(39)
Cytotoxicity Analysis
NIH/3T3 cells were purchased from ATCC (CRL-1658) and cultured in DMEM
medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillinstreptomycin and fungizone (Gibco). Cell culture was maintained in a 37 ˚C
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incubator with 5% CO2 and >95% relative humidity, culture medium was changed
every two days while maintaining the exponential growth of the cells.
In vitro cytotoxicity was investigated using live/dead viability cytotoxicity kit
(Molecular Probes) consisting of calcein AM as an indication of living cells, and
ethidium homodimer-1 indicating dead cells. Cells were enzymatically removed
(0.25% trypsin-EDTA, Gibco), seeded in 24 well plates at 40,000 cells/cm2.
Following 24 hour attachment and incubation, the cells were treated by adding
500 µL of hydrogel solutions with and without thermal crosslinking initiators and
copolymer PEGDA (as described above). After a 15 minute incubation, 1 mL of
additional media was added to each well. After an additional 24 hours, cells were
washed 3x with PBS and stained with dye solutions according to manufacturer’s
instructions. Briefly, 4 µM ethidium homodimer-1 and 2 µm calcein AM were
reconstituted in growth media. 500 µL of die solution was added to each sample
followed by a 45 minute incubation under ambient conditions. Cells were imaged
using confocal microscopy (Olympus IX81, live: ex 488 nm / em BA505-525nm,
dead: ex 543 nm / em 560-660 nm) at a 40x magnification. Control samples
consisted of living cells, with media changes during solution exchange
procedures, and dead controls incubated with 70% ethanol for 30 minutes prior
to assay.
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Statistics
All groups were compared in Graph Pad Prism six starting with One-Way
ANOVA and 90% confidence interval. If significance was found then two-way ttest were used to determine statistical differences between groups.
Results
Increased oligomerization of OPF utilizing nitrogen sparging methods
Proton NMR of OPF synthesized using triethylamine (TEA-OPF) and nitrogen
sparge (N2-OPF) schemes both show the formation of an ester bond at 4.33 ppm
corresponding to the formation of PEG/fumarate oligomers. A shift in fumarate
olefin signal from 7.87 ppm to 6.87 ppm also denotes attachment of fumarate to
PEG, Figure 2. (40) As the same polymer product, DSC revealed no significant
difference between the melting temperature (Tm) and crystallinity of N2-OPF
(60.7 ± 0.4°C, 64.1 ± 2.1%) and TEA-OPF (60.3 ± 1.3°C, 58.3 ± 3.4%), Table 1.
However, the ratio of PEG hydroxyl end groups (3.01 ppm) to monomer units
was lower in N2-OPF as compared to TEA-OPF indicating increased
oligomerization.
Utilizing size exclusion chromatography, N2-OPF molecular weight,
(Mw=17,271 ± 3,632) and degree of polymerization (Xn=3.93 ± 0.8) confirmed
significant increases in OPF oligomerization over TEA-OPF (Mw=10,891 ± 1,368,
Xn=1.8 ± 0.2), Figure 3A, Figure 4A&B, Table 1. Furthermore, N2-OPF had a
significantly lower polydispersity index 1.3 ± 0.1 as compared to TEA-OPF 1.4 ±
0.04 indicating a more homogeneous product, Figure 3A and Table 1. OPF
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product removed during both reactions shows the difference in rate of
oligomerization during TEA-OPF and N2-OPF processing, Figure 4. However,
fluorescent analysis of eluted TEA-OPF revealed a fluorescent molecule
associated with the elution time of TEA-OPF oligomers that is absent from N2OPF, Figure 3B.
Characteristics of crosslinked hydrogels
Using the thermal initiator ascorbic acid and ammonium persulfate, N2-OPF
crosslinked by itself and had a significantly higher swell ratio that all other
groups, Figure 5. However, when crosslinked in the presence of PEGDA, there
was no difference in water uptake between TEA-OPF and N2-OPF hydrogels.
Using UV initiation, N2-OPF with PEGDA had a significantly lower sol fraction
than UV initiated N2-OPF without PEGDA but no comparison could be made with
TEA-OPF as it would not crosslink using the UV initiator even with the addition of
PEGDA, Figure 5. Furthermore, TEA-OPF by itself did not crosslink with either
photo initiated or thermal crosslinking methods while N2-OPF crosslinked under
all conditions, Figure 5.
The compressive modulus of resulting hydrogels, assessed using AFM,
revealed no significant difference between N2-OPF/PEGDA (7.72 ± 1.52 kPa) ,
TEA-OPF/PEGDA (5.37 ± 1.40 kPa), and PEGDA (6.92 ± 1.04 kPa) systems
when crosslinked using thermal initiators. However, when crosslinked without
PEGDA, N2-OPF had significantly lower compressive moduli than all other
groups at 2.30 ± 0.31 kPa, Figure 6.
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Cell viability in the presence of polymer products
The influence of OPF oligomer products on cell growth and viability was
examined by 24 hour incubation of NIH/3T3 cells in different OPF hydrogel
solutions. The cytotoxicity of all thermal initiator containing solutions were
significant and resulted in low viability in culture. With the addition of PEGDA,
little increase in viability was observed. Furthermore, PEGDA alone was shown
to be acutely toxic to cells, Figure 7. In order to assess the cytotoxicity of
individual OPF products, solutions containing 20 wt% N2 and TEA-OPF in
complete growth media were exposed to cells for 24 hours. As a result of
residual TEA-HCl salts cells exposed to TEA-OPF alone were also non-viable
after 24 hours, while cells exposed to N2-OPF were over 90% viable in culture,
Figure 7.
Discussion
The polymerization of oligo(poly(ethylene glycol) fumarate) produces a linear
polyester through the reaction of PEG and fumaryl chloride to form dimers,
trimers, and eventually oligomers, in a step-growth process. The primary
limitation of this reaction is the production of hydrochloric acid byproducts which
must be isolated to prevent secondary reactions. Previously, removal of
hydrochloric acid was accomplished by acid scavengers such as trimethylamine,
potassium carbonate, or sodium hydroxide. (16, 23-28) In the current work,
previously published OPF synthesis using triethylamine was compared to OPF
synthesis using nitrogen sparging. The use of sparging for the in situ removal of
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hydrochloric acid eliminates the need for an acid scavenger, thereby avoiding the
production of hard to remove TEA salts.
For both reaction methods, formation of PEG/fumarate oligomers were
confirmed by 1H-NMR. With a greater olefin (6.87 ppm) to PEG (3.38-3.85 ppm)
ratio as well as a reduction in signal from PEG hydroxyl end-groups (3.01 ppm),
nitrogen-sparged OPF (N2-OPF) resulted in a greater degree of oligomerization
and larger molecular weight than triethylamine OPF synthesis methods (TEAOPF). (1) Size exclusion chromatography confirms a significant increase in N2OPF molecular weight and a more uniform product over TEA-OPF, Figure 3AFigure 4A&B, Table 1.
In side-by-side TEA-OPF and N2-OPF reactions, temporal analysis of the
product demonstrates a limited maximum achievable molecular weight using
TEA-OPF methods. After 4 hours, the maximum molecular weight was obtained
by TEA-OPF with no additional oligomerization at subsequent time points. In
contrast, the oligomerization of the N2-OPF method continues through 12 hours,
Figure 4. In step-growth processes, the final conversion, and hence the average
molecular weight, is affected by the concentration of condensation byproducts.
(41) In situ removal of acid byproducts during nitrogen sparging eliminates TEA
salt formation allowing for the synthesis of a higher molecular weight OPF, Figure
4A. (1, 22)
In contrast to the nitrogen sparge method, TEA-OPF synthesis requires the
additional steps of filtration, re-crystallization, and solvent washing in order to
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remove acidic by-products. (1, 2) The incomplete removal of TEA salts during
work-up is apparent in 1H-NMR (1.4 ppm). The TEA-OPF also retains a brown
coloration even after repeated filtration steps. Alternatively, the pure N2-OPF
appears white immediately after synthesis and does not require additional
purification steps, supplemental Figure S1 & Figure S2 (Supplementary Data are
available online at www.liebertpub.com/tec). Fluorescent analysis of eluted
product through size-exclusion chromatography reveals the presence of a
fluorescent molecule within TEA-OPF that is absent from N2-OPF, Figure 3B.
The fluorescent signal corresponds with the elution time of TEA-OPF oligomers,
indicating that the TEA salts are complexed to the OPF backbone. Cai and
Wang, 2010 have previously reported the formation of a cell-cytotoxic TEA
complexes during polymerization of fumaryl chloride in the presence of TEA that
cannot be completely removed during purification. (22) This behavior is
confirmed in the cytotoxicity analysis of OPF products.
To examine the crosslinking capabilities of N2-OPF and TEA-OPF, two
different commonly used, free-radical initiators systems were applied: ascorbic
acid/ammonium persulfate, a thermally activated initiator and Irgacure 2959, a
UV activated initiator. (1, 2, 20, 21, 42) In addition, hydrogels were fabricated
with and without polyethylene glycol diacrylate (PEGDA), a copolymer commonly
used in the crosslinking of PEG-based hydrogels due to the presence of highly
reactive acrylic end groups. The use of PEGDA allows for more efficient network
formation of resulting hydrogels. (43, 44)
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Hydrogels successfully crosslinked with ascorbic acid/ammonium persulfate
and PEGDA for both TEA-OPF and N2-OPF. However, UV initiated TEAOPF/PEGDA and TEA-OPF hydrogels did not crosslink adequately to maintain
their 3D structure when placed in water, and subsequently fell apart. In
comparison, N2-OPF readily crosslinked using both initiator systems with and
without PEGDA, highlighting the versatility of N2-OPF product, Figure 5-Figure 6.
The inefficient removal of triethylamine salts in the TEA-OPF synthesis method
are likely a significant factor in the crosslinking behavior of TEA-OPF. The brown
color most likely limits UV intensity and penetration into the gels and the TEA
salts may interfere with the initiator as well as the crosslinking reaction. In order
to overcome the limitations of TEA-OPF, previous groups have increased
reaction time to an hour to fully crosslink TEA-OPF. (1, 18, 21) As OPF is
commonly used as a biomaterial for cell encapsulation, minimizing UV exposure
time reduces cellular cytotoxicity. (20, 21) Crosslinking of hydrogels was
therefore limited to a 15 minute exposure period, a time which has been shown
to optimally balance the crosslinking reaction with cell viability. (21)
Fully crosslinked OPF hydrogels exhibited swelling characteristics dependent
on the synthesis method and the use of the crosslinking molecule. Using
ascorbic acid/ammonium persulfate as the thermal initiator and PEGDA as the
crosslinker, there was no difference in swelling between TEA-OPF and N2-OPF
hydrogels. While TEA-OPF did not crosslink using the UV initiator, the choice of
initiator did not influence the swelling of the N2-OPF/PEGDA hydrogels.
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Furthermore, N2-OPF was able to form hydrogels without the addition PEGDA
but resulted in a looser N2-OPF hydrogel with greater water uptake capability,
Figure 5A. (17, 42)
Mechanical testing of OPF hydrogels with and without PEGDA was
conducted utilizing colloidal nano-indentation methods. This method allows for
the measurement of elastic modulus at the submicron level of molecular
interactions, a factor important in characterizing OPF applicability for biomedical
and microscale material applications. (14, 39, 45) Similar to swelling and sol
fraction results, the mechanical properties of crosslinked OPF hydrogels were
solely dependent on PEGDA, not OPF synthesis method, Figure 6. Since N2OPF is the only product that can be crosslinked with and without PEGDA and
utilize both light and heat activated free-radical initiatiors, N2-OPF can be
fabricated into hydrogels of with a wider range of mechanical properties,
increasing its utility beyond that of TEA-OPF. (46)
The importance of producing a polymer which can be cross-linked without the
addition of PEGDA becomes even more apparent when cell cytotoxicity is
analyzed. With the addition of PEGDA significant cytotoxicity of NIH/3T3 cells
was observed Figure S3. Similar behavior has been observed in low molecular
weight PEG methyl ether acrylate (Mn ~ 480) solutions, caused by a decline in
the antioxidant levels of glutathione (GSH) and increased intracellular reactive
oxygen cytotoxicity. (47) Furthermore, the exposure of cells to uncrosslinked N2-
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OPF showed little cytotoxicity while TEA-OPF solutions showed significant cell
death due to the persistence of cytotoxic HCl salts. (22)
Further considerations for scale up and industrial manufacturing of OPF
polymers should focus on recycling of dichloromethane solvent lost during
sparging. In the laboratory environment, the minor loss of solvent during the
reaction is replaced after initial addition of PEG and FuCl to the reaction vessel to
prevent any significant changes in viscosity of the reaction. While several
methods of industrial scale solvent recovery and recycling have been developed,
such procedures were not considered in this study due to possible reintroduction
of HCl with recycled solvent. (48) Furthermore, variation has been observed in
the maximum achievable oligomer length due to steric hindrance in the
presences of large PEG units. (1, 20, 49) Future studies should focus on
optimization of precursors in order to achieve the greatest oligomerization during
the step-wise polycondensation procedure.
Through the use of nitrogen sparging, we have shown that OPF can be
produced with decreased post-processing, increased product purity, greater
oligomerization, and cell viability. These properties lead to greater tunability in
mechanical properties and a more versatile hydrogel for biomedical applications.
Instead of using triethylamine as a proton scavenger, in situ nitrogen gas
sparging eliminates the need for post-processing washes using ethyl acetate and
ethyl ether, which have proven to be inefficient while also being acutely toxic and
potentially explosive through peroxide formation. With greater oligomerization,
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N2-OPF has more unsaturated double bonds per molecule that can be used for
crosslinking and addition of covalently bound side chains. This straightforward
method of fabrication should allow for facile production that eliminates postprocessing. The simplification of synthesis and elimination of impurities will
expand the utility of N2-OPF as a degradable hydrogel for cell culture, tissue
engineering, regenerative medicine, and therapeutic delivery, among other
applications.
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Figures

Figure 1. Glassware set-up for the polycondensation of fumaryl chloride (FuCl) with polyethylene
glycol (PEG) in dicholoromethane (DCM) using A) the acid scavenger triethylamine (TEA) or B)
nitrogen (N2) sparging to remove hydrochloric acid (HCl) byproducts. C) OPF reaction schemes
for triethylamine (TEA-OPF) and D) nitrogen sparging (N2-OPF). E) Crosslinking structure of OPF
oligomers through consumption of unsaturated double bonds.
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Figure 2. 1H NMR spectra of 4.6K OPF from A) nitrogen sparging or B) triethylamine acid
scavenging methods. The presence of ester groups (b, 4.33 ppm) and olefin groups (c, 6.87 ppm)
indicate bond formation and oligomerization of OPF. NMR (300 MHz) measurements were
carried out in CDCl3 (7.24 ppm). Some residual dichloromethane can be observed at 5.26 ppm
with triethylamine contaminates at 1.43 ppm.
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Figure 3. A) Representative elution profiles of OPF polymer products and pure 4.6K PEG as
determined by gel permeation chromatography. Decreased retention time indicates higher
molecular weight N2-OPF oligomers. B) Fluorescence profiles of OPF products and 4.6K PEG
were collected in series with GPC. A large fluorescence peak was detected only in TEA-OPF
indicating unremoved triethylamine hydrochloride, Ex 250 nm/Em 410 nm.
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Figure 4. During synthesis small samples of A) N2-OPF and B) TEA-OPF product were removed
periodically over fourteen hours to and analyzed by GPC. Each labelled peak (i-iv) corresponds to
an increasing oligomer length. TEA method limits molecular weight after addition of fumarate to
reaction vessel (4 hours).
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Figure 5. Swelling ratio of crosslinked OPF hydrogels using A) thermal and C) UV initiator
methods. Sol Fraction of crosslinked OPF hydrogels using B) thermal and D) UV initiator
methods. Swelling of N2-OPF without PEGDA was significantly greater than all other gels, †p <
0.05, n = 6. UV-initiated N2-OPF with PEGDA had significantly lower sol fraction than N2-OPF
without PEGDA, ††p < 0.05, n = 6. ∆ indicates gels did not crosslink sufficiently to be
characterized. N2-OPF is a more versatile polymer because it can be crosslinked with and
without PEGDA.
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Figure 6. Compressive modulus of thermally crosslinked TEA-OPF and N2-OPF with and without
PEGDA as compared to crosslinked PEGDA alone. Compressive modulus was determined using
atomic force cantilever nano-indentation with Oliver-Pharr fitting. N2-OPF without PEGDA was
significantly softer than hydrogels with PEGDA, * p < 0.05, n = 3. ∆ indicates gels did not
crosslink sufficiently to be characterized.
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Figure 7. Cell viability and cytotoxicity staining of living-green and dead-red A) NIH/3T3 controls
on TCPS as compared to cell exposed to B) Nitrogen sparged OPF, C) PEGDA, and D) TEA-OPF
solutions. TEA-OPF as well as the required secondary crosslinker PEGDA show acute toxicity,
while N2-OPF shows no toxicity over live cell controls. Scale 50 µm
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OPF Product

Figure S1. Samples of A) precursor PEG material and OPF product using B) triethylamine
synthesis (TEA-OPF) and C) nitrogen sparge synthesis (N2-OPF).
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Figure S2. Side-by-side synthesis of TEA-OPF (left) and N2-OPF (right) product. TEA-OPF reaction
mixture quickly takes on black coloration with the formation of triethylamine hydrochloride salt
byproducts.
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Atomic Force Microscopy Nano-Indentation
Fabrication of Colloid Probes
AFM nanoindentation cantilevers were fabricated using a Micromanipulator
(Model 4060) fitted with pulled glass capillaries (1B100-6, World Precision
Instruments). Capillaries were pulled using a Model P-97 capillary puller (Sutter
Instruments) and cut to 5µm using a Microforge, MF-830. Epon was first melted
using a custom built heating stage; Kapton Polyimide film (KHLV-103, Omega)
sandwiched between 0.125 in aluminum (2x3 in) and 0.125 in Fiberfrax
Duraboard RG insulation paper (Unifrax) using 0.5 in aluminum c-channel
(0.0625 in). The Kapton (Polyimide film, KHLV-103, Omega) heating element
was connected to 25 volts, 0.5 amps of current (Agilent 3631A DC power supply)
and monitored using a digital thermometer (HH11B, Omega) with type K PFA
insulated 36 gauge thermal couple (5TC-TT-K-36-36, Omega). The Epon was
heated to 95˚C to melt epoxy and coated onto a pulled glass capillary. The TLFM probe was then deposited with a small (<5µm) hemisphere of Epoxy. Glass
microspheres (Bangs Laboratory, 5µm, SS05N) were dropwise deposited onto a
clean glass slide and water removed through heating (80˚C for 30 sec).
Microspheres were electrostatically lifted from the slide using a pulled glass
capillary controlled using a micromanipulator. The glass microsphere was
deposited on the Epon coated AFM cantilever and removed from heat. AFM
colloid probes were imaged using a Nova Nano 450 scanning electron
microscope (10 eV energy, 50mV stage bias, Filed Electron and Ion Co./FEI).
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Figure S3. Electron Micrograph of A) TL-FM (tipless) atomic force microscope cantilever (scale,
100µm) with B) Epon 1004F epoxy and C) adhered silicon microsphere (scale, 5 µm).

Nano-Indentation Measurements
Prior to indentation, colloid probes were mounted onto an Asylum Research
MFP-3D atomic force microscope and calibrated using previously described
thermal oscillation methods and built in software tools (Get Real, MFP Software
V12.8, Asylum Research) in order to determine cantilever resonant frequency
and tune to 1 volt output signal.1 Further calibration was achieved through single
force indentation into a rigid glass prior to taking adhesion force measurements
as described previously.2 Briefly, a single force curve (1mm, 400 μm/s) was
captured in non-triggering contact mode with probe fully retracted from surface.
Change in inverse optical lever sensitivity (InvOLS) was calculated in order to
remove background drift of driving piezo. Multiple force vs. distance curves were
measured (50 nN, 400 μm/s) and an average deflection voltage measured within
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deflected region of force curves. Exact spring constant values were then
determined for each cantilever. Cantilevers were found to have a stiffness within
20% of manufacturers specifications.
Hydrogels were tested for elastic modulus using previously described
methods.3 Briefly, cross-linked hydrogels were placed into a glass petri dish and
fully hydrated with di-ionized water. Force measurements (256 points) were
taken over a 10 x 10 µm area (force map). Oliver-Pharr model fitting for elastic
modulus was used to determine the elastic modulus of the hydrogel.
Measurements were repeated over at least three different samples for each
treatment.
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Figure S4. A typical A) force map with calculated elastic modulus of hydrogel over 10µm area.
Each point represents a B) force-displacement curve of colloid probe during extension (red) and
retraction (blue) from the hydrogel.

235

References
1. Hutter, J. L.; Bechhoefer, J. Calibration of Atmoic-Force Microscope Tips.
Rev. Sci. Instrum. 1993, 64 (7), 1868-1873 DOI: 10.1063/1.1143970.
2. Proksch R, C. J. Quantifying Molecular Forces: Sensitivities and Spring
Constants without Touching a Surface. Asylum Research 2005.
3. Drira, Z.; Yadavalli, V. K. Nanomechanical Measurements of Polyethylene
Glycol Hydrogels using Atomic Force Microscopy. J. Mech. Behav. Biomed.
Mater. 2013, 18, 20-28 DOI: 10.1016/j.jmbbm.2012.09.015.

236

Chapter 7

Functionalization of Oligo(poly(ethylene glycol) fumarate) Using
Alkanethiol Click Chemistry
Kent E. Coombs1,2, Matthew N. Rush2,3, Quan Huynh2, Elizabeth L. Hedberg-Dirk2,4

1

Biomedical Science Graduate Program, 2Center for Biomedical Engineering,

3

Nanoscience and Microsystems Engineering, 4Department of Chemical and Biological
Engineering, University of New Mexico, Albuquerque, NM.

237

Abstract
Studies have shown that surface chemistry can affect valvular interstitial cell
behavior in two-dimensional cell culture systems, however the threedimensionality of tissues is poorly emulated in monolayer environments. To
create a more relevant model for the study of cell behavior, the degradable
hydrogel oligo(polyethylene glycol) fumarate was functionalized with walkanethiolate pendant groups to control charge in crosslinked three dimensional
(3D) hydrogels. Significant thiol functionalization using Michael’s type addition
showed incorporation along the OPF backbone through unsaturated olefin bond.
Following purification, the hydrogel systems showed effective crosslinking and
encapsulation of viable cells.
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Introduction
With an increasing elderly population, health care expenditures for aortic
valve disease (AVD) continue to rise. To address this increased burden better
treatments for AVD need to be developed [1]. Left untreated the likelihood of
death due to AVD is 50% within 2 years [2]. The current gold standard of
treatment for AVD is surgical replacement of the diseased valve. Typically,
mechanical or decellularized-biological valve replacements are used, but major
limitations in their requirement for anticoagulation therapy or their 5-10 year
limited lifespan requiring repeated surgery make these valves undesirable for
long term use [3]. Creating a replacement valve that could last a lifetime without
deleterious effects and could also be used as an accurate in vitro model for the
study of AVD is essential to advance AVD care.
In order to address these issues research is being conducted to develop
tissue engineered heart valves (TEHVs). With the ability to integrate into the
surrounding host tissue and utilize the body’s natural repair functions, TEHV’s
would perform in a similar manner to native tissue [4]. Well-designed TEHVs
could also be used as relevant in vitro testing platforms to study the cellular
mechanisms involved in AVD progression and as models to develop and test
therapeutic drugs. However, the technology to grow functional tissue is still in
nascent stages. Different strategies to create TEHVs utilizing natural polymers,
decellularized tissue, or synthetic polymers are popular in literature, but a gap in
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knowledge exists in how a cell’s growth, behavior, and differentiation are affected
by the scaffold environment in which they are grown [5-10].
Valvular interstitial cell (VICs), are the primary cells of heart valve utilized to
grow and study aortic valve tissue. Biological and mechanical cues from cellculture scaffolds have been shown to alter VIC phenotype and behavior, but the
cellular signaling mechanisms behind these changes are not yet well defined [1116].
Synthetic hydrogel platforms are used to study cell signaling mechanisms
because they offer the benefit of isolating the effects of cell behavior due to
changes in specific scaffold parameters. This is due to their innate ability to be
fabricated and modified to alter environmental conditions. In addition, these
synthetic scaffolds can be further organized and shaped into 3 dimensional (3D)
systems that better mimic the native tissue. By altering precursor molecule
properties synthetic scaffolds can span a range of mechanical stiffness and
hydrophobicity providing tunability of the cell-culture environment. However,
given their non-biological nature, synthetic materials often fail to adhere and grow
cells in a physiologically relevant manner, and require the addition of engineered,
biologically active pendant groups. As a result, synthetic cell culture systems can
be designed with well-defined bioactive molecules or with variations in
mechanical properties that can be reliably reproduced to control and study the
effect of specific environmental cues on cell behavior.
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A common synthetic polymer used to create hydrogels scaffolds for the
investigation of VIC behavior is polyethylene glycol (PEG) [8, 12, 17, 18]. PEG
hydrogels are desirable for their biocompatible hydrophilic properties, controllable
pore size, mechanical properties, and their ability to be chemically modified. In
addition, PEG can be polymerized and crosslinked through a number of
chemistries to create 3D cell culture environments. Recent examples of VICs
grown on top of PEG base hydrogels with an attached RGD, YGSIR, DEGA, or
VAPG peptides have shown that VICs attach and grow differently dependent on
the adhesion sequence [17]. When a similar PEG hydrogel system functionalized
with RGD, VGVAPG, or P15 peptides were used to encapsulate and culture VICs
over a 42 day period, differences in activation and extracellular matrix protein
production were observed [5].
While peptide functionalization of 3D hydrogels has been utilized in the
development of TEHVs, less research has been done to look at how the charge
of the hydrogel environment effects VIC behavior. Charge is of interest given the
high concentration of the negatively charged molecule hyaluronic acid during
valvulogenesis during the development of endocardial cushions in the early
heart. Hyaluronan also makes up 60% of the glycosaminoglycans in valve tissue
[19]. These data suggest VICs naturally exist within a negatively charge
environment and recapitulating this environment in a 3D scaffold may allow for
healthy aortic valve tissue.
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In a recent study VICs were grown on 2 dimensional (2D) surfaces with welldefined underlying chemistry [11]. It was found that VICs grown on negatively
charged 2D surfaces grew rapidly, did not express VIC osteoblastic markers, and
avoided confluence-based nodule formation. However, positively charged 2D
substrates caused VICs to rapidly undergo osteoblastic differentiation [11]. These
results highlight that the surface chemistry of the underlying substrate can affect
cellular behavior in monolayer culture.
In order to investigate the effects of chemical moieties on more
physiologically relevant 3D cell growth and behavior we used the PEG based
polymer, oligo(poly(ethylene glycol) fumarate) (OPF), to form chemically
functionalized hydrogels. Unlike previously described PEG hydrogels, OPF has a
repeating unsaturated fumarate unit along the polymer’s backbone which can be
used to crosslink or functionalize the molecule, while also allowing for
biodegradation of the scaffold over time. Hydrolytic degradation of the repeating
ester groups allows for the scaffold to be replaced with cell-secreted extracellular
matrix (ECM) tissue over time. Utilizing previously described alkanethiolates 11mercaptoundecanoic acid and 11-amino-1-undecanthiol should allow for the
addition of negatively (OPF-COO-) and positively charged (OPF-NH3+) pendant
groups to the OPF backbone. Based on the observation of VICs in 2D culture we
hypothesized that OPF-COO- 3D hydrogels will promote VIC proliferation and
prevent osteoblastic differentiation in vitro.
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Material and Methods
Synthesis of Oligo(Poly(Ethylene Glycol) Fumarate) (OPF)
OPF was synthesized as described previously. Briefly, 1K PEG (Sigma
Aldrich) was dried using azeotropic distillation in toluene at 200 ˚C and dried
toluene removed sing rotary evaporation. 100g of dried PEG was dissolved in
700 mL of dichloromethane (DCM)and placed in three-necked round bottom
flask. Sparging, using nitrogen (N2), was introduced with a fine-fritted gas
dispersion tip and forced out into a secondary vessel containing 10 wt% sodium
hydroxide in ethanol. Distilled fumaryl chloride (1:0.9, PEG:FuCl) was dissolved
in 60 mL DCM and injected at 10 mL/hour into the reaction vessel using a
syringe pump. As FuCl was added, DCM was added periodically added to
maintain the reaction volume at 700 mL. After the complete addition of FuCl
DCM volume was returned to 700 mL and the vessel was left stirring overnight
using nitrogen sparging. Upon completion, remaining solvent was removed by
rotary evaporation at 30°C followed by drying at a reduced pressure in a vacuum
oven overnight before being stored at -20 °C.
GPC of OPF
The molecular weight of OPF was determined using a Waters Breeze GPC
system equipped with a 2707 autosampler, a 1515 isocratic HPLC pump, and a
2414 refractive index detector. For each sample 10-20 mg of OPF and 1K PEG
were dissolved in 2 mL of chloroform, run at 1 mL/min, and compared to a PEG
standards A 16100, 3870, 1020, 410, 106; B 21160, 8160, 1450, 615, 194
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(Polymer Laboratories/Agilent Technologies) to determine the final molecular
weight and degree of oligomerization.
Dialysis of OPF
In order to remove unreacted PEG dried OPF was dissolved in 190 proof
ethanol (EtOH, ACS) at a 1:1 g/ml ratio and sealed inside Spectra/Pore 7
Dialysis Membrane Pre-Treated RC tubing MWCO 1000 (Spectrum Labs). The
membrane was transferred into a large covered beaker of 190 proof EtOH (100x
sample volume) and left stirring overnight. The dialyzed solution was collected
and dried using a rotary evaporator at 30°C to remove the majority of solvent
before being transferred to a Pyrex dish and dried at reduced pressure
environment overnight.
Functionalization of OPF
To functionalize polymer, OPF was dissolved in 0.1 M sodium bicarbonate in
water (6:1 Buffer:OPF). Different molar ratios of 11-mercaptoundecanoic acid
(COO-) or 11-amino-1-undecanthiol (NH3+) were added to the solution and
stirred overnight (Table 1). Following functionalization the reacted solution was
dried using rotary evaporation at 50° C for 30 min. The resulting solution was
poured into a Pyrex dish and fully dried under reduced pressure oven overnight.
The final product was collected and stored at -20 °C in an air tight container.
Nuclear Magnetic Resonance (NMR)
6-10 mg of functionalized and unfunctionalized OPF sample were dissolved in
2 mL of deuterated chloroform (Sigma-Aldrich) and filtered using a 0.45 um nylon
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Aerodisc syringe filter (Fisher Scientific). 700 μL of filtered solution was
transferred to 5 mm, 500 MHz NMR sample tubes (Wilmad LabGlass) and were
read on a Bruker Avance III 300 at 300 Hz for 1H NMR. The degree of
functionalization was calculated by using ratio of olefin (6.78 ppm) to PEG (3.44.0 ppm) peak integration values between un-functionalized and functionalized
OPF.
Crosslinking of Functionalized OPF Hydrogels
OPF and OPF-COO- molecules were crosslinked using a UV initiator and
polyethylene glycol dimethacrylate (PEGDA). The formulations were mixed as
follows; 25 wt% OPF, 5% PEGDA, and 0.05-1% Irgacure 2959 initiator, with 69 69.95% Dulbecco’s Phosphate Buffered Saline (DPBS) without calcium or
magnesium. Hydrogels were poured into 3 mL syringes to create a 2:1 height to
width sample before being exposed to 15 min of 365 nm UV light in a UVP light
box (CL-1000).
Primary Cell Extraction and Culture
VICs were isolated as previously described [20]. Porcine hearts were shipped
overnight from Hormel and aortic valve leaflets were excised. Leaflets were
incubated in collagenase type 2 (Worthington) in 199 medium (Hyclone) before
scraping to remove valvular endothelial cells (VECs). Residual VECs were
removed using CD31+ magnetic dynabeads (ThermoFisher Scientific). VICs
were cultured under normal conditions, 37 ⁰C with 5% CO2 in 199 EBSS Hyclone
growth media [10% Fetal Bovine Serum (FBS) (Hyclone), 1%
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Penicillin/Streptavidin (Hyclone), and 1% Fungizone (Hyclone)] and allowed to
reach ~80% confluence before being frozen down and stored in liquid nitrogen.
Encapsulation of Cells
Functionalized OPF 1:0.27, 1: 1.1, 1: 1.7 (Alkanethiol:PEG molar ratio) and
unfunctionalized OPF hydrogels were crosslinked using the following formulation;
25 wt% OPF/OPF-COO-, 2-5% PEGDA, 0.05-1% Irgacure 2959 initiator, and
remaining wt% DPBS, with 1 x 106-5 x 106 cells/mL. 500 μL of solution was
moved to 10 mL syringe molds before being exposed to 15 min of 365 nm UV
light in a UVP light box (CL-1000). The resulting gels had a diameter of 17.3 mm
and were ~3 mm thick. After crosslinking gels were placed in 6 well plates with 3
mL of growth media 199 medium a (Hyclone) with 10% FBS (Gibco), 1%
Penicillin Streptavidin (Gibco), 1% Fungizone (Gibco) and cultured at 37 ˚C, 5%
CO2, >95% RH.
Live/Dead assay
Immediately after crosslinking and after 24 hours of incubation VIC viability
was analyzed using a Live/Dead Mammalian Cell Assay Kit (Life Technologies).
Briefly, media was removed from the wells and replaced with live/dead solution
according to manufacturers instructions (2 µM calcein AM and 4 µM EthD-1 in
PBS). After 30 min of incubation hydrogels were washed 2x with DPBS with a 5
min incubation and imaged on a Nikon Eclipse TS100 fluorescent microscope.
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Results
Characterization and Functionalization of OPF
Using nitrogen sparging, 1K PEG and fumaryl chloride were used to
synthesize OPF. Proton NMR of synthesized OPF showed the formation of an
ester bond at 4.33 ppm corresponding to the formation of PEG/fumarate
oligomers. The presence of fumarate olefin groups at 6.87 ppm and PEG at 3.24 ppm further confirm OPF formation (Figure 1) [21]. GPC showed the average
molecular weight (Mw) of OPF was 6063 ± 706 and a polydispersity index (PDI)
of 1.5 (n=4).
Successful functionalization of OPF with 11-mercaptoundecanoic acid (COO-)
or 11-amino-1-undacenthiol (NH3+) was demonstrated via H1 NMR with the
appearance of a peak at 4.2 ppm and reductions of the olefin signal at 6.8 ppm,
indicating a successful reaction of the thiol group to the unsaturated double bond
of the OPF backbone (Figure 1). In addition, the amount of functionalization of
OPF with COO- was varied by adjusting the stoichiometry of COO- to OPF in the
reaction. Comparing the ratio of olefin (6.8 ppm) to PEG peak (3.2-4 ppm) before
and after functionalization indicated the percent of OPF double bonds consumed
during functionalized could be varied from 11-42% (Table 1). Although greater
concentrations of functionalized OPF were fabricated the resulting products did
not crosslink under conditions acceptable for cell encapsulation due to the
consuption of olefin groups used for crosslinking (data not shown).
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Viability of Encapsulated VICs
Initial Live/Dead assays were conducted on VICs encapsulated in 25 wt%
OPF using 0.05-1% Irgacure 2959, 2.5% PEGDA, and remaining wt% DPBS.
Immediately after encapsulation Live/Dead analysis showed greater viability
(~80%) was observed when Irgacure 2959 concentrations were limited to 0.1
wt% and below (Figure 2). Therefore, all experiments of VICs encapsulated in
OPF-COO- were run at 0.1 wt% Irgacure 2959 concentrations, 25 wt%
OPF/OPF-COO-, 5 wt% PEGDA, and 70% DPBS. VICs were again encapsulated
in OPF by itself with 1X106 VICs and in OPF-COO- (1:0.27) at a higher
concentration of 5X106 cells/ml. Optical images show cells were successfully
encapsulated at both cell concentrations however the majority of VICs died after
24 hours of incubation in all conditions (Figure 3).
Discussion
Previously, it is has been shown that VICs grown on 2D surfaces with either a
positive and negative surface chemistry induced an osteoblastic or proliferative
healthy phenotype, respectively. This work focused on developing a 3D hydrogel
system with charged functional groups. OPF was synthesized using a 1K PEG
and had a final molecular weight of 6046. Therefore, each OPF molecule had an
average of ~5.2 olefin bonds per molecule. Previous PEG hydrogels are typically
functionalized by the addition of acrylic end groups in order to be crosslinked into
3D scaffolds[22]. With OPF, however, the ~5 double bonds on available on the
backbone of each OPF can functionalization with more than one molecule and
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still are able to be crosslinked. Therefore, OPF has increased the utility and
versatility as a molecule to create controlled hydrogel environments.
Crosslinking OPF into a hydrogel using Irgacure 2959 is initiated by the
generation of free radicals using UV light. Free radicals are known to be
cytotoxic, therefore optimization of Irgacure 2959 concentration for OPF hydrogel
crosslinking while maintaining VIC viability was assessed. The greatest viability
was observed at 0.05% Irgacure 2959 however the efficient hydrogel formation
occurred with 1% Irgacure. With ~80% viability in 0.1% Irgacure hydrogels this
concentration was chosen as the ideal condition to encapsulated VICs while
forming solid hydrogels (Figure 2).
Next OPF was functionalized with the alkanethiols 11-mercaptoundecanoic
acid or 11-aminoundecanoic acid using a thiol-ene click chemistry to create OPF
molecules with negative (OPF-COO-) and positive (OPF-NH3+) charges (Figure
1). These OPF molecules were tailored to have increase or decrease
concentration alkanethiol moiety attachment by changing the stoichiometry of
alkanethiol to OPF used in the functionalization reaction (Table 1). This simple
method allows for the amount of charge within the final hydrogel to be tailored
while allowing for the possibility of attaching other molecules, like peptides, to the
same OPF molecule.
For VIC encapsulation studies OPF-COO- (1:1.7) 42% functionalization was
used to maximize the negative charge in the final hydrogel. We hypothesized that
this negative charge would be sufficient to help encapsulated VICs proliferate
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and remain in an activated phenotype over time. However, 12 hours after
encapsulation under normal culture conditions all the VICs died. The inability of
VICs to adhere to the modified OPF-COO and OPF hydrogels is likely the largest
contributing factor to cell death. Due to the result seen with OPF-COOhydrogels, OPF-NH3+ hydrogels systems will not be tested until VIC viability is
increased.
In the two-dimensional system cell adhesion wasn’t an issue because
proteins from the serum added to media were able to quickly absorb to the
modified surfaces when cells were seeded. The VICs could then attach to these
absorbed serum proteins and survive [11, 23, 24]. In the hydrogel system the
serum proteins would have a hard time moving into the hydrogel so cells are
forced to attempt to interact with the OPF backbone or the functionalized
alkanethiols. The OPF backbone is made of PEG, which has previously been
shown to resist protein absorption and cellular interactions creating a blank slate
material [25]. In many studies to help VIC attachment to PEG, bioactive
molecules such as attachments peptides were covalently attach to the PEG
molecules [5, 8, 17, 26]. The fact that VICs did not survive in OPF-COO- suggest
that proteins from the media did not penetrate the hydrogel fast enough and were
unable to absorb to the alkanethiol molecules in the hydrogel to support cell
attachment. Therefore, the negative environment provided by the OPF-COOhydrogels by itself was not sufficient to support VIC attachment.
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Previous studies have added adhesion peptide RGD, P15, and YGSIR to
special PEG hydrogels, showing VIC viability out to 48 days of culture [15]. In
future studies with OPF it would be prudent to add some attachment peptides to
OPF in addition to the alkanethiols. With the peptide being immediately available
for VIC attachment they could survive the initial encapsulation and cell culture,
but still allow for the long-term study of VIC growing in a charged 3D scaffolds.
A second theory for why the VICs didn’t survive is that there were not enough
alkanethiols present within the gel for VICs to bind. Unfortunately, increasing the
functionalization of OPF with alkanethiols above 42% inhibited crosslinking. A
strategy to overcome this issue would be to make OPF with a smaller molecular
weight PEG. The current length of OPF is limited by the steric hindrance caused
by the large PEG molecules. By decreasing the PEG molecular weight more
repeat units of PEG to FuCl could be oligimerized than our current system and
therefore would have more unsaturated double bonds per OPF molecule that
could be functionalized and crosslinking. The concentration of the alkanethiols
could then be increased and still have enough remaining functional groups for
crosslinking.
Conclusion
The understanding of how VICs react to scaffold cues is essential to the
production of healthy heart valve tissue. In this study the negative environment of
the pericardial cushion created by the high concentrations of hyaluronic acid was
mimicked in a unique PEG based hydrogel system [27]. The molecule OPF was
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functionalized with 11-mercaptoundecanoic acid to create a negatively charged
hydrogel environment with a carboxyl group being presented to encapsulated
cells. In contrast OPF was also functionalized with 11-aminoundecanoic acid to
create positively charge environment, which has been shown previously to
induce osteoblastic differentiation in 2D cultures [11].
Successful functionalization of OPF with COO- and NH3+ was demonstrated
as well as the ability to tailor the amount attached using stoichiometric controls.
This control creates a versatile hydrogel system were the concentration of
functionalized molecules can be easily altered for biological studies. As the
concentration of peptides has been shown to effect VIC behavior in PEG
hydrogels we hypothesized that changing the concentration of COO- in OPF will
similarly affect VICs in 3D hydrogels [17]. However, results showed that a
negative charge by itself was not enough to allow for VIC survival after being
encapsulated in this system.
In the previous 2D studies proteins could easily be absorb from the media
onto the surface that was completely covered in COO- or NH3+ surface
chemistries. The absorbed proteins in turn allowed for VIC to attach and grow on
the surface. In a 3D hydrogel system, however, the dominating the PEG
environment, a molecule known for its non-fouling properties prevents cell or
protein attachments. Adding the alkanethiol 11-mercaptoundecanol to the
backbone should have helped to increase protein absorption to the gel, however
it was either not at a high enough concentration to affect the overall PEG
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dominate environment or the proteins were not able diffuse into the hydrogel
quickly enough to help VICs adhere in the early stages of hydrogel swelling.
Therefore, future work with OPF functionalized with attachment peptides and
COO- need to be synthesized to create 3D hydrogel systems in which VICs can
survive initial encapsulation.
Figures and Tables
Table 1. Formulations for alkanethiolate functionalized of OPF
11-mercaptoundecanoic acid : OPF (molar

0.27:1

1.1:1

1.7:1

11.1 ± 5.7*

28.2 ± 8.0*

42.2 ± 2.5*

5.4

21.0

35.0

ratio)
OPF Functionalization (%)
Theoretical Functionalization (%)

* p=0.05, n=3
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Figure 1. A) Scheme of OPF functionalization with 11-mercaptoundecanoic acid or 11-amino-1undecanethiol in sodium bicarbonate buffer. H1 NMR spectra of OPF (blue) and OPF
functionalized with either B) 11-mercaptoundecanoic acid or C) 11-amino-1-undecanethiol.
Appearance of the c peak on functionalized OPF (red lines) indicates a covalent bond between
the thiol group and the backbone of OPF.
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Figure 2. Cell viability (living-green, dead-red) immediately following VIC (1x106 VICs/mL)
encapsulation in 25 wt% OPF hydrogels in DPBS using A) 0.05 wt%, B) 0.1 wt%, and C) 1 wt%
Irgacure 2959 with 15 min of UV exposure. At 0.1% Irgacure 2959 and below VICs show ≥ 80%
viability.
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Figure 3. Valvular interstitial cell viability (living-green, dead-red) after 24 hours in A) OPF and
B)OPF-COO- hydrogels.
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Chapter 8
Conclusions

Summary
In order to successfully control valvular interstitial cell (VIC) phenotype and
develop tissue engineered heart valve (TEHV) replacements, a more complete
understanding of VIC behavior as a result of cellular microenvironment needs to
be described. During valve development, endocardial cushion formation and
cellular infiltration result in the formation of VICs which secrete and remodel
extracellular matrix (ECM) proteins. As a result of the large amounts of
hyaluronic acid (HA) with negatively charged carboxylic acid side chains, the
tissue environment within which VICs grow and develop exhibits significant
charge, flexibility, and hydrophilicity.[1-3] However, VICs may spontaneously
differentiate into an osteoblastic phenotype leading to valve thickening and
ectopic calcification preventing proper flow and overall strain on the heart. In
order to recapitulate this environment and investigate the drivers for healthy and
diseased behavior in VICs we have examined the effect of surface chemistry and
protein deposition in phenotypic signaling and VIC differentiation. In the course of
doing so we have identified distinct subpopulations of VICs within the aortic valve
and developed a method for identifying and separating subpopulations for
investigation of healthy behavior in vitro. In an attempt to create a more
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physiologically relevant three-dimensional cell culture environment we developed
a novel synthesis technique for manufacturing degradable oligo(poly(ethylene
glycol) fumarate) (OPF) hydrogels. Finally, in order to translate the effects of
surface chemistry on VIC differentiation, we began functionalizing OPF hydrogels
and investigating VIC behavior in three-dimensional environment. The results of
this work should aid in the development of intelligently designed tissue scaffold
and disease models for the treatments of valvular heart disease (VHD).

Specific Aim 1: Identify VIC phenotypic behavior on well-defined chemically
functionalized surfaces.
The use of alkanethiol self-assembled monolayers (SAMs) for the
investigation of surface chemistry on cellular behavior and disease progression
has previously been described.[4, 5] The creation of well-defined uniform
substrates allows for the systematic study of specific changes during tissue
development and ECM remodeling of the surrounding microenvironment. Four
physiologically relevant functional groups [CH3 (hydrophobic), OH (hydrophilic),
COOH (COO-, negative at physiological pH), and NH2 (NH3+, positive at
physiological pH)] were used to determine the effects of substrate hydrophobicity
and charge on VIC phenotypic behavior. Given the negative charged
environment present during valvulogenesis, it was hypothesized that anionic
functional groups would result in VIC activation and tissue production.[2, 6]
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The results of culturing VICs on alkanethiol SAMs are described in Chapter 3,
Surface Chemistry Regulates Valvular Interstitial Cell Differentiation In Vitro, Acta
Biometerialia, 28, 2015:76-85.[7] While each surface resulted in distinct
phenotypic behaviors in VICs, newly described differences in osteoblastic
disease progression as well as activated, healthy behavior were observed as a
result of surface chemistry, without the addition of soluble growth factor signaling.
VICs cultured on hydrophobic CH3-SAMs resulted in dystrophic calcification
caused by a lack of cellular adhesion, cell sheet detachment, and apoptotic
nodule formation. In comparison, VICs cultured on positively charged, NH3+SAMs exhibited changes in cell morphology, adopting a rhomboidal shape, with
increased osteoblastic markers, a-smooth muscle actin and osteocalcin, along
with the development of rapid and robust calcified nodule formation. Similar
osteoblastic differentiation in VICs requires the addition of soluble growth factor
signaling and longer incubation periods before nodule formation is observed.
Furthermore, the growth of VICs on negatively charged, COO--SAMs exhibited
rapid proliferation, while maintaining an elongated spindle-shaped morphology.
Despite the tendency for VICs to develop calcified nodules due to confluence
induce changes in phenotype, VICs on COO--SAMs maintained a healthy, noncalcifying behavior.[8-10]
To our knowledge this is the first time that the differentiation of VICs has been
observed as a result of surface chemistry without the addition of soluble growth
factors. In comparison to classic osteoblastic media induction, which activates
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cellular signaling cascades with soluble factors like transforming growth factor
beta-1, dexamethasone, β-glycerolphosphate, or ascorbic acid, we hypothesized
that VICs on COO- and NH3+ SAMs are interacting with the culture surfaces
through protein deposition and integrin binding which induce VIC
differentiation.[11] This work indicates that special attention to surface chemistry
and the surrounding microenvironment she be observed when culturing VICs in
vitro. Furthermore, positive charged environments may be useful in the
development of disease models to study the development of VHD and develop
novel therapeutics.
VICs have previously been described as a heterogenous population as
extracted from the valve. As a result of observed differences in morphology and
cellular detachment, it was also hypothesized that VICs may contain
subpopulations with differences in disease potential.[12] However, previous
attempts to distinguish healthy from disease prone subpopulations has been
confounded by a lack of unique markers for the identification and isolation of
VICs.
The results of differential detachment of VIC subpopulations are described in
Chapter 4, Isolation and Characterization of Valvular Interstitial Cell
Subpopulations, to be submitted to the Journal of Heart Valve Disease. Utilizing
dilute trypsin treatments to remove more adherent and less adherent VICs,
distinct differences were observed which correlated with healthy and disease
potential in culture. The more adherent subpopulation exhibited increased
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expression of osteoblastic gene markers, proliferated slower, and had a
rhomboidal morphology similar to osteoblastic media induced VICs. In contrast,
the less adherent VIC subpopulation which proliferated rapidly, maintained an
elongated spindle-shape morphology, and did not express osteoblastic markers
exhibits a healthy activated VIC phenotype.
To further distinguish these subpopulations, integrin expression was
investigated due to involvement in protein adhesion, morphology, and cell
signaling. It was found that integrin αvβ3 was upregulated in the more adherent
VICs but was not present in the less adherent subpopulation. In combination with
data showing the osteoblastic nature of the more adherent VIC subpopulation we
can concluded that increased αvβ3 expression on the surface of the VICs
correlates with the osteoblastic phenotype and could be used as a surface
marker for isolation of disease prone VICs in primary culture. Utilizing cell sorting
techniques VICs could be separate directly from freshly excised valves creating
distinct healthy and diseased phenotypes for tissue engineering and investigation
of disease development. To our knowledge no other surface marker has been
identified that can be used to distinguish between activated and osteoblastic VIC
phenotypes, making this work significant to the field of VHD.
Given the identification of VIC subpopulations after investigating surface
chemistry on VIC behavior, the study of surface chemistry on specific
subpopulations was not investigated. However, it is likely that a the more
adherent VIC subpopulation may result in the dominating osteoblastic behavior
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observed on positively charged surfaces. Furthermore, the rapid proliferation and
activated behavior on negatively charged surfaces may be an indication of the
dominant behavior of the less adherent subpopulation of VICs. Future work
should study changes in activated and osteoblastic behavior among
subpopulations as a result of surface chemistry in order to determine if
differences in VIC differentiation are a result of phenotype or can be regulated by
cellular microenvironment.

Specific Aim 2: Characterize extracellular matrix protein affinity and integrin
signaling using chemically functionalized surfaces
The use of alkanethiol SAMs to investigate healthy and disease potential in
VICs in Chapter 3, highlighted surface chemistry dependent difference in VIC
phenotype. In order to fully understand the factors regulating changes in VIC
behavior in these microenvironments, adsorption of cell-adhesive and nonadhesive proteins was assessed on SAMs. In conjunction, the expression of
ECM specific integrin binding subunits by VICs along with changes in cell
spreading and focal adhesion formation were characterized.
The results of protein deposition and integrin expression by VICs is described
in Chapter 5, Surface Chemistry Modulates Protein Conformation and Directs
Integrin Binding to Control Cell Adhesion and Signaling, to be published in
Langmuir or Acta Biomterialia. While no single protein exhibited strong affinity for
NH3+-SAMs a lack of non-adhesive BSA and presence of FN, as well as the
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increased expression of αVβ5 and αVβ3 upon attachment indicate FN affinity may
play an important role in early osteoblastic differentiation in VICs.[2, 3, 8]
Interestingly, similarities exist between osteoblastic/glass surfaces and NH3+SAMs with regard to FN, COL, and FBS protein conformation. Furthermore,
significant upregulation of αVβ5, αVβ3, & α2β1 by media induced osteoblastic
differentiation corresponds with similar expression by VICs on NH3+-SAMs. Such
behavior indicates some level of shared signaling resulting in an osteoblastic
phenotype between treatments. Further studies should focus on blocking integrin
binding and signaling in order to confirm the importance of integrin signaling
during osteoblastic differentiation of VICs. While no unique integrin markers were
identified for healthy VIC behavior on COO--SAMs it is likely that the presence of
BSA, or other ECM adhesive proteins may be responsible for the rapid
proliferation and lack of osteoblastic behavior due to reduced focal adhesion
formation and a lack of cell spreading. However, the increased levels of laminin
observed on COO- surfaces may also be responsible for healthy phenotype. It
should be noted that laminin integrin expression was tested, but antibodies
exhibited no significant difference above immunoglobulin controls, suggesting
they were either not specific for use in porcine VICs, or laminin integrin levels
were not high enough to be detected. By correlating observed osteoblastic
behavior on chemically modified surfaces with fibronectin presence and
increased integrin expression, we have begun to identify possible signaling
mechanisms which initiate VIC differentiation and regulate disease progression.
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This work highlights protein expression and cellular signaling which may be
responsible for in vitro and in vivo VIC behavior and the understanding of VHD.

Specific Aim 3: Develop a modifiable 3D hydrogel system to elucidate the effects
of microenvironmental cues on VIC behavior
In order to translate the effects of surface chemistry, protein affinity, and
integrin binding into more physiologically relevant three-dimensional cell culture
environments required the development of a novel manufacturing method for
degradable hydrogels. Degradable hydrogels have been utilized for the growth of
VICs and investigation of cell behavior.[13-15] However, previous techniques
have resulted in significant residual cell cytotoxic components or were unable to
be utilized for the functionalization of pendant groups in order to investigate
microenvironmental chemistry.[16]
The development of an alternative synthesis scheme for oligo(poly(ethylene
glycol) fumarate) (OPF) was investigated in Chapter 6, Nitrogen Sparge
Synthesis and Characterization of Oligo(Poly(Ethylene Glycol) Fumarate)
Macromer, to be published in Tissue Engineering, Methods Part B. Originally
developed by Jo S. et al., the use of triethylamine to capture and remove
hydrochloric acid byproducts resulted in limited oligomerization and residual
cytotoxic triethylamine HCl salts.[17, 18] Through the introduction of gas
sparging, we have developed a one-pot, straight-forward, and improved method
for the production of OPF while simultaneously eliminating the complications of
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acid removal, cooling, filtration and post-processing, and working with peroxide
forming chemicals. Nitrogen sparging also resulted in a cleaner product for
downstream applications, such as modifying the OPF backbone. The
simplification of synthesis and elimination of impurities will also expand the utility
of N2-OPF as a degradable hydrogel for cell culture, tissue engineering,
regenerative medicine, and therapeutic delivery, among other applications.
Finally, in order to recapitulate the effects of surface chemistry in threedimensional scaffolds for the investigation of VIC behavior, Chapter 7,
Functionalization of Oligo(poly(ethylene glycol) fumarate) using Alkanethiol Click
Chemistry, describes the initial attempts of functionalizing OPF and VIC
encapsulation. As discussed previously, the surface chemistry of a scaffold
effects VIC behavior and can control protein deposition and binding in culture.
Through the addition of alkanethiols to the backbone of OPF the intent was to
create similar charged behavior in tunable hydrogels. Functionalization was
achieved through addition of alkanethiols to the unsaturated olefin unit on OPF.
OPF molecules were then crosslinked to form 3D cell culture environments. As
the crosslinking of OPF also utilizes the olefin unit for network formation, a
balance between functionalization and remaining double bonds for crosslinking
was investigated. In addition, PEDGA was added the help facilitate crosslinking
of modified hydrogels. This strategy allowed for 11-42% functionalization of OPF
while allowing for the formation of crosslinked hydrogels.
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After showing OPF-COO- could be crosslinked successfully, cell viability of
encapsulated VICs was assessed. Utilizing free-radical initiators for OPF
crosslinking required the optimization of initiator concentration while allowing
maintaining cell viability. This resulted in the in situ encapsulation of VICs in
functionalized OPF hydrogels. However, VICs did not survive past 24 hours. We
hypothesize this is due to the inability of VICs to bind to the OPF. As a result,
future work has already begun on the functionalizing OPF hydrogels with cell
adhesive peptides specific for protein integrin binding domains found to be
present in VIC culture, such as fibronectin, collagen, and laminin.[19, 20] This will
allow for translation of SAM behavior into three-dimensional systems.

Broader Impacts
Overall this work highlights the effects of surface chemistry on protein binding
and cellular adhesion which effect VIC behavior. Through increased
understanding of VIC phenotype and disease progression we may be able to
develop intelligently designed heart valve scaffolds and disease models for the
treatment of VHD. By utilizing adhesion-based separation techniques or integrin
expression, we may be able to isolate VIC subpopulations from primary cell
culture and investigate the effects of specific environmental factors on disease
development.
This work also reflects the first experiments to examine the effects of surface
chemistry on VIC behavior. In the process two distinct mechanisms for
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osteoblastic calcification were described, without the addition of soluble growth
factors. A dystrophic, tissue damage model was developed through use of nonadhesive CH3-SAMs along with a faster developing osteoblastic differentiation
model on NH3+-SAMs. Utilization of these environments for the study of VHD
without competitive soluble signaling factors may aid in the development of drug
targets. Furthermore, the identification of a cell culture environment which
maintains healthy activated VIC behavior should be helpful in the expansion and
growth of VICs without the confounding effects of contact induced nodule
formation in culture.
Finally, we have begun translating this work into a 3D cell culture system
using the polymer oligo(poly(ethylene glycol) fumarate) (OPF). With our new
synthesis method OPF can now be manufactured faster with greater unsaturated
double bonds and can be functionalized with bioactive molecules. In addition, the
variation of PEG precursor molecules allows for alterations in scaffold stiffness in
order to investigate the isolated effects of valve stiffening on VIC behavior.
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